Zusammenfassung
Die Vielfalt der mykotischen Erkrankungen wird durch die Reichhaltigkeit des antimykotischen Arzneischatzes noch übertroffen. Die verschwenderische Fülle der in den Arzneischatz aufgenommenen Präparate ist aber nur ein Bruchteil von dem, was in den verschiedensten Laboratorien der Welt im Verlauf von etwa zwei Jahrzehnten als „wirksam gegen Pilze“ ermittelt werden konnte.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abrahams, I., and J. K. Miller: The in vitro action of sulfonamides and penicillin of actinomyces. J. Bact. 51, 145 (1946).
Achten, G.: Les détersifs en mycologie. Dermatologica (Basel) 114, 360 (1957).
Adam, W.: (1) Externe und interne Therapie von Dermatomykosen und ihre Indikation. Medizinische 1959, 1980.
Adam, W.: (2) Die Indikation zur Behandlung bei mykotischen Infektionen. Therapiekongr. Karlsruhe 30. 8.—5. 9. 1959. Ref. Ärztl. Praxis 11, 1229 (1959).
Adam, W., u. K. Steitz: Zur Wirkung von Cycloheximid auf Pilzkulturen. Z. Haut- u. Geschl.-Kr. 25, 153 (1958).
Adamson, C. A., and G. Hagerman: On the treatment of actinomycosis with sulpha drugs and penicillin. Acta med. scand. 131, 23 (1948).
Adelson, L., and I. Sunshine: Fatal poisoning by a cationic detergent of the quaternary ammonium compound type. Amer. J. clin. Path. 22, 656 (1952).
Aichinger, F.: Praktische Erfahrungen bei der Bekämpfung von Epidermophytien in einem Eisengießereibetrieb. Berufsdermatosen 6, Nr 6 (1955).
Ainsworth, G. C.: Medical mycology. London: Sir Isaac Pitman & Sons 1953.
Ainsworth, G. C., and P. K. C. Austwick: Fungal diseases of animals. Farnham Royal, Bucks: Commonwealth Agricult. Bureaux 1959.
Ainsworth, G. C., A.M.Brown and G. Brownlee: “Aerosporin”, an antibiotic produced by Bacillus aerosporus Greer. Nature (Lond.) 160, 263 (1947).
Also, K.: J. Antibiot., Ser. A 8, 33 (1955). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics. Philadelphia and London: W.B.Saunders Company 1957.
Also, K., T. Arai, I. Shidara, K. Ogi and T. Tanaami: Studies on the streptomyces antibiotics active against fungi and yeast. IV. On the biological activity of mycelin. J. Antibiot. 5, 488 (1952).
Also, K., K. Miyaki, F. Yanagisawa, T. Arai and M. Hayashi: J. Antibiot. 3, 87 (1950). Cit. W. S. Spector, Handbook of toxicology.
Aizawa, H.: The influence of various antibiotics and antifungal drugs upon adaptive enzyme formation of Candida albicans. Chemotherapy (Tokyo) 3, 260 (1955).
Ajello, L.: Recent advances in medical mycology. Bull. nat. Ass. clin. Lab. 7, 11 (1955).
Albohn, H.: Klinische Erfahrungen mit dem Bortrioxybenzoesäureester als Antimykoticum. Z. Haut- u. Geschl.-Kr. 26, 117 (1959).
Alechinsky, A.: Efficacité de la pénicilline en application locale dans le traitement de la teigne du cuir chevelu. Arch, belges Derm. 4, 84 (1948).
Alkiewicz, J., C. Majewski and E. Janiakowa: (1) On the inhibiting effect of Pseudomonas aeruginosa on the growth of pathogenic fungi. Bull. Soc. Sci. Poznan, Sér. C. 1954, 19.
Alkiewicz, J., C. Majewski and E. Janiakowa: (2) Biochemical investigations on the fungistatic effect of Pseudomonas aeruginosa. Bull. Soc. Sci. Poznan, Sér. C 1955, 11.
Alkiewicz, J., C. Majewski and E. Janiakowa: (3) Über die fungistatische Wirkung des Saftes von Chelidonium majus. Przegl. derm. 5, 27 (1955).
Alkiewicz, J., C. Majewski, S. Moczko u. E. Janiakowa: Über die Hemmwirkung von Chelidonium majus auf das Wachstum pathogener Pilze. Przegl. derm. 4, 301 (1954).
Allemann, O., u. F. Ludwig: Über die Behandlung der Vagina mit Antibioticis. Ther. Rdsch. 9, H. 12 (1953).
Almeida, F. de, C. da S. Lacaz e A. C. Cunha: A terapêutica da blastomicose sul-americana e o seu contrôle de cura. Rev. bras. Med. 3, 187 (1946).
Almeida, F. de, C. da S. Lacaz e O. Forattini: Açao da sulfanilamida e seus derivados in vitro o Actinomyces brasiliensis. An. Fac. Med. Univ. Säo Paulo 22, 301 (1946).
Alperovitch, A.: Thérapeutique antifongique. Gaz. méd. Fr. 61, 707 (1954).
Alter, R. L., C. P. Jones and B. Carter: The treatment of mycotic vulvovaginitis with propionate vaginal jelly. Amer. J. Obstet. Gynec. 53, 241 (1947).
Alvarez, B. A., y R.M.Gonzalez: Moniliasis vaginal consecutiva al uso terapéutico de antibioticos. Obstet. Ginec. lat.-amer. 10, 295 (1951).
Amaya-Leön, H.: Moniliasis vulvo-vaginal. Rev. colomb. Obstet. Ginec. 6, 239 (1955).
Amman, A., D. Gottlieb, T. D. Brock, H. E. Carter and G. B. Whitfield: Filipin, an antibiotic effective against fungi. Phytopathology 45, 559 (1955).
Anchel, M., A. Hervey and W. J. Robbins: Proc. nat. Acad. Sci. (Wash.) 38, 655 (1952). Cit. W. S. Spector, Handbook of toxicology. Vol.11: Antibiotics.
Anders, W.: (1) Mikrosporie bei Jugendlichen und Erwachsenen. Arch. Derm. Syph. (Chicago) 59, 662 (1949). Ref. Zbl. Haut- u. Geschl.-Kr. 74, 167 (1950).
Anders, W.: (2) Die Behandlung der Mikrosporie mit der kombinierten Röntgen-Thallium-Epilation nach Buschke-Langer. Z. Haut- u. Geschl.-Kr. 18, 272 (1955).
Andleigh, H. S.: (1) Therapy in fungus diseases. Indian Practit. 10, 781 (1957).
Andleigh, H. S.: (2) In vitro study of antifungal activity of pentamidine and stilbamidine. Mycopathologia (Den Haag) 8, 135 (1957).
Andreoni, G., E. Cervini e D.Curatolo: (1) Influenza di alcuni antibiotici sulla patogenicità della Candida albicans nel topino. G. Mal. infett. 10, 722 (1958).
Andreoni, G., E. Cervini e D. Curatolo: (2) Azione del nystatin nel topolino inoculato con Candida albicans e antibiotici. G. Mai. infett. 10, 740 (1958).
Andriasyan, G. K.: Klinische Aspekte und Therapie der Fußmykosen. Surg. Assist. (Moskau) 1955, 14. Ref. Rev. Med. vet. Mycol. 2, 363 (1956).
Ansel, R.: Die Behandlung der Dermatomykosen mit J.K. 30. Diss. Heidelberg 1950.
Appel, B., M. J. Tye, W. Halpern and D. Paci: Microsporosis of the scalp. Evaluation of a new therapeutic agent. New Engl. J. Med. 245, 1003 (1951).
Applebaijm, E., and S. Shtokalko: Cryptococcus meningitis arrested with amphotericin B. Ann. intern. Med. 47, 346 (1957).
Arai, T., and Y. Takamizawa: J. Antibiot. Ser. A 7, 165 (1954). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics.
Arcamone, F., C. Bertazzoli, G. Canevazzi, A. di Marco, M. Ghione e A. Grein: La etruscomycina, nuovo antibiótico antifungino prodotto dallo Streptomyces lucensis n. sp. G. Microbiol. 4, 119 (1957).
Area Leao, E. de, and A. da E. Furt ad o: The fungistatic activities of vitamin K on dermatophytes. Mycopathologia (Den Haag) 5, 121 (1950).
Aretz, H.: Die Behandlung der Epidermophytie mit Cuprizinin. Derm. Wschr. 103, 1330 (1936).
Armangué, M., et Mestres: Arch. Med. Chir. 37, 1074 (1934). Zit. A. Delmotte, Bull. Rech. Sci. Stomat. 3, 35 (1960).
Arnold, H. L., u. E. R. Austin: Behandlung von Kiefer-Aktinomykose mit “Diasone”. J. Amer. med. Ass. 138, 955 (1948). Ref. Derm. Wschr. 124, 734 (1951).
Arnstein, H. R. V., A. H. Cook and M. S. Lacey: J. gen. Microbiol. 2, 111 (1948). Cit. S. A. Waksman and H. A. Lechevalier: Actinomycetes and their antibiotics.
Ashton, G.C.: Dermination of griseofulvin in fermentation samples. II. Isotopedilution assay. Analyst 81, 228 (1956).
Ashton, G. C., and A. P. Brown: Determination of griseofulvin in fermentation samples. I. Spectrophotometry assay. Analyst 81, 220 (1956).
Ashton, G. C., and A.Rhodes: Griseofulvin and dimethylformamide. Chem. and Ind. 1955, 1183.
Ashton, G. C., and J. P. R. Tootill: Determination of griseofulvin in fermentation samples. App. to I: Seven-point correction procedure. Analyst 81, 225 (1956).
Ata, S.: Zur Pathogenese und Trichomycintherapie der Candidiasis. Münch, med. Wschr. 1958, 187.
Ata, S., u. F. Staib: Experimentelle Untersuchungen zur Therapie der Torulose. Arzneimittel-Forsch. 8, 159 (1958).
Austin, E.R.: The use of antihistamine drugs in the treatment of epidermophytosis of the feet and epidermophytids. Ann. Allergy 9, 50 (1951).
Avram, A. I. Alteras, M. Carjewski et M. Ilescu: Microsporie observée chez un groupe de lions en captivité. Mycopathologia (Den Haag) 9, 288 (1958).
Aytoun, R. S. C.: The effects of griseofulvin on certain phytopathogenic fungi. Ann. Botany 20, 297 (1956).
Azulay, R. D., u. J. D. Azulay: Einige Betrachtungen zur Chromoblastomykose. Bericht über einen 5. Fall von Chromoblastomykose in der Glutäalregion. Hautarzt 10, 459 (1959).
Babbs, M., H. O. J. Collier, W. C. Austin, M. D. Potter and E. P. Taylor: Salts of decamethylene-bis-4-aminochinaldinium (“Dequadin”). A new antimicrobial agent. J. Pharm. (Lond.) 8, 110 (1956).
Baichwal, R. S., M. R. Baichwal and M. L. Khorana: (1) Antibacterial and antifungal properties of ß-naphthol derivatives. IV. J. Amer, pharm. Ass., Sci. Ed. 46, 603 (1957).
Baichwal, R. S., M. R. Baichwal and M. L. Khorana: (2) Antibacterial and antifungal properties of ß-Naphthol derivatives, V. J. Amer, pharm. Ass., Sci. Ed. 47, 537 (1958)
Baldwin, M. M.: Sulfur in fungicides. Industr. engng. Chem. 42, 2227 (1950)
Baliña, P. L., J. A. Herrera, P. Bosq y P. Negroni: Tercer caso argentino de histoplasmosis. Beneficio de la sulfamidoterapia. Rev. argent. Dermatosif. 27, 453 (1943)
Ball, E. G., C. B. Anfinsen and 0. Cooper: The inhibitory action of naphthoquinones on respiratory processes. J. biol. Chem. 168, 257 (1947)
Ballenger, C. N., and D. Goldring: Nocardiosis in childhood. J. Pediat. 50, 145 (1957)
Binerjee, A. K., G. P. Sen and P. Nandi: Action of isoniacid and antibiotics on Nocardia madurae. Lancet 1954 I, 1299
Baptista, L., N. Belliboni e R. M. Castro: Caso de esporotricose tratado pelo antimoniato de N-metilglucamina. Rev. paul. Med. 41, 24 (1952)
Barail, L. C.: (1) Testing of fungicidal materials against pathogenic fungi. J. Bact. 53, 127 (1947)
Barail, L. C.: (2) Testing of fungicidal materials against pathogenic fungi. Amer. Dyest. Rep. 37, 257 (1948); 87, 281 (1948). Ref. Rev. Med. vet. Mycol. 1, 343 (1950)
Barlow, A. J. E.: (1) The parasitism of the ringworm group of fungi. A.M.A. Arch. Derm. 77, 399 (1958)
Barlow, A. J. E.: (2) Treatment of fungous infections of the skin. Theoretical aspects. In R. W. Riddell and G. T. Stewart, Fungous diseases and their treatment
Barlow, A. J. E., F. W. Chattaway, G. K. Hargreaves and C. J. la Touche: Griseofulvin in treatment of persistent fungal infections of the skin. Brit. med. J. 1959 II, 1141
Barnes, R. A., and N. N. Gerber: The antifungal agent from osage orange wood. J. Amer, chem. Soc. 77, 3259 (1955)
Barr, W.: Current therapeutics, Nystatin. Practitioner 178, 616 (1957)
Baum, G. L., H. Rubel and J. Schwarz: Treatment of experimental histoplasmosis. Antibiot. Chem. 7, 477 (1957)
Baum, G. L., J. Schwarz and C. J. K. Wang: Treatment of experimental histoplasmosis with amphotericin B. Arch, intern. Med. 101, 84 (1958)
Baumeister, J.: Die Fußmykosen. Zbl. Arbeitsmed. 5, 166 (1955)
Bayo Bayo, J. M., y M. P. Miguens: La acción fungistática y fungicida de los esteres de acido bromoacético asociados al cloruro de alkil(cetil)-dimetil-bencil-amonio. Arch. Inst. Farmacol. exp. (Madr.) 4, 34 (1952)
Bazex, A., A. Dupré et Parant: Essai de la nysta- tine dans un cas de moniliase cutanéo-muqueuse de l’enfant. Bull. Soc. franç. Derm. Syph. 63, 218 (1956)
Beare, J. M.: (1) Tinea capitis due to Trichophyton sulphureum. Brit. J. Derm. 68, 193 (1956)
Beare, J. M.: (2) Critical survey of mycological research and literature for the years 1946–1956 in Ireland. Mycopathologia (Den Haag) 9, 65 (1958)
Beare, J. M., and D. Mackenzie: Griseofulvin in treatment of infections of scalp due to Microsporum canis. Brit. med. J. 1959 II, 1137
Beck, E. M., and H.H. Müntz: Experimental therapy of generalized torulosis in rats with streptomycin. J. Lab. clin. Med. 33, 1159 (1948)
Beck,F.: Die Fußmykosen im fränkischen Raum mit Behandlungs- und Prophylaxebeiträgen. Z. Haut- u. Geschl.-Kr. 19, 15, 41 (1955)
Beck, O., and H. Lacy: The effect of certain antibiotics, antimalarial drugs and amebicides on Candida albicans. Tex. Rep. Biol. Med. 9, 395 (1951)
Behrendt, P.: Antimykotica — Theorie und Praxis. Landarzt 14, 387 (1952).
Belcher, P. D.: Whitfield’s ointment. A suggested modification. Aust. J. Pharm. 31, 836 (1951)
Belisario, J. C., and M. T. Havyatt: A case of tinea imbricata in a white boy treated with griseofulvin. Dermatologica (Basel) 119, 158 (1959)
Bendow, E. P., D. T. Smith and K. S. Grimson: Sulfonamide therapy in actinomycosis. Two cases caused by aerobic partially acid-fast actinomyces. Amer. Rev. Tuberc. 49, 395 (1944)
Benedek, T.: (1) Blastomycosis Gilchrist (North American type). The first case on record successfully treated with penicillin. With a survey of the literature concerning the treatment of deep- seated mycosis by penicillin and/or sulfonamides. Urol, cutan. Rev. 53, 216 (1949)
Benedek, T.: (2) Critical survey of the mycological literature of the years 1939–1942. Mycopathologia (Den Haag) 5, 14 (1950)
Benedek, T.: (3) Die Pilze und: Die Pilzinfektionen. In A. Grumbach u. W. Ki- kijth, Die Infektionskrankheiten des Menschen und ihre Erreger. Stuttgart: Georg Thieme 1957
Benedek, T.: (4) Selective, chemical epilation in the treatment of tinea capitis as contrasted with the diffuse X-ray epilation. Mycopathologia (Den Haag) 9, 97 (1958)
Bereston, E. S.: Nystatin in the treatment of Candida albicans infections. Sth. med. J. (Bgham, Ala.) 50, 547 (1957)
Berg, F. T.: Über die Schwämmchen bei Kindern. Aus dem Schwedischen übersetzt von Gerhard von dem Busch. Bremen: Johann Georg Heyse 1848
Berg, H.: (1) Erfahrungen über die Behandlung der Mikrosporie des behaarten Kopfes mit dem Der matomykosepräparat V 741. Z. H. ut- u. Geschl.-Kr. 10, 456 (1951)
Berg, H.: (2) Erfahrungsbericht über die Lübecker Mikrosporie-Epidemie. Hautarzt 3, 443 (1952)
Berg, J. A. G. ten: De behandeling van actinomycose met aureomycine. Ned. T. Geneesk. 96, 2801 (1952).
Bergman, S.: In vitro studies on antimycotics. A comparison between different methods. Acta path, microbiol. scand. Suppl. 104, 127 (1955)
Bergmann, H. W.: (1) Ein Beitrag zur Therapie der Trichophytia profunda. Z. Haut- u. Geschl.-Kr. 6, 28 (1949)
Bergmann, H. W.: (2) Ein Beitrag zur Therapie der Trichophytia profunda. Derm. Wschr. 121, 63 (1950)
Bergmann, J. W.: Über Hautfadenpilzinfektionen und ihre Behandlung. Z. Haut- u. Geschl.-Kr. 16, 310 (1954)
Bernheim, F., and R. G. Gale: Effect of ß-propiolacton on metabolism of Pseudomonas aeruginosa and growth of certain fungi. Proc. Soc. exp. Biol. (N.Y.) 80, 162 (1952)
Bernstein, I. L, J. E. Cook, H. D. Plotnick and F. J. Tenczar: Nocardiosis; three case reports. Ann. intern. Med. 36, 852 (1952)
Bernstine, J. B., and A. E. Rakoff: Vaginal infections, infestations, and discharges. Philadelphia: Blakiston Comp. Incorp. 1953
Bertrand, P., et J. C. Martin: Essais in vitro de la trichomycine sur le Candida albicans et action comparative sur le bacille de Döderlein. Bull. Soc. gynéc. obstét. (Paris) 8, 378 (1956)
Bessière: Guérison rapide de teigne du cuir chevelu à “M. canis” par une pomade acide et iodée. Bull. Soc. franç. Derm. Syph. 65, 337 (1958)
Bethge, J. F. J., u. L. Rassfeld-Sternberg: Zur Hände-Schnelldesinfektion. Zbl. Chir. 79, H. 38 (1956)
Beyma toe Kingma, F. van: Mykosen der Hände und Füße. Med. heute 5, 437 (1956)
Bianchi Janetti, C.: La terapia penicillina e sulfamidica deH’actinomicosi. Minerva med. (Torino) 38, 17 (1947)
Bieberdorf, F. W.: A study of the growth respone of some fungi to various concentrations of isonicotinic acid hydrazide. Antibiot. Chemother. 3, 513 (1953)
Billington, R. W.: Actinomycosis treated with sulphapyridine. Brit. med. J. 1944 I, 326
Birt, A. R., J. Hoogstraten and M. Norris: Griseofulvin in the oral treatment of tinea capitis. Canad. med. Ass. J. 81, 165 (1959)
Bittersohl, G.: (1) Die Behandlung der Trichophytie mit Antiphytin. Dtsch. Gesundh.-Wes. 1949, 538
Bittersohl, G.: (2) Die Behandlung der Dermatomykosen mit Thioformolpräparaten. Z. Haut- u. Geschl.-Kr. 9, 249 (1950)
Blank, F.: A quantitative method for the in vitro assay of fungistatic agents. Canad. J. med. Sci. 30, 113 (1952)
Blank, H.: (1) Antifungal antibiotics in clinical medicine. A.M.A. Arch. Derm. 75, 184 (1957)
Blank, H.: (2) Moniliasis de la piel y las mucosas. Rev. Asoc. méd. argent. 71, 23 (1957)
Blank, H.: (3) Electron microscopic observations of the effects of griseofulvin in dermatophytes. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Blank, H., and F. J. Roth jr.: (1) The treatment of dermatomycosis with orally administered griseofulvin. A.M.A. Arch. Derm. 79, 259 (1959)
Blank, H., and F. J. Roth jr.: (2) Tratamiento de las dermatomicosis con griseofulvina. Amér. clin. 35, 229 (1959)
Blank, H., D. Tamplin and F. J. Roth jr.: Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/ Florida
Blaschke, R.: Persönliche Mitteilung über Wegesal
Blinov, N. O.: Erforschung der Antifungusantibiotica vom Typ des Candicidins. Antibiotika 3, 58 (1958). Ref. Rev. Med. vet. Mycol. 3, 182 (1959)
Blyth, W.: The influence of antibiotics on experimental moniliasis. I. Penicillin, streptomycin, chloramphenicol, and viomycin. Mycopathologia (Den Haag) 10, 91 (1958)
Boand, A., and M. Novak: Sensitivity changes of Actinomyces bovis to penicillin and streptomycin. J. Bact. 57, 501 (1949)
Boas, H.: (1) Behandling af eczema mycoticum ad modum Sylvest. Ugeskr. Laeg. 113, 639 (1951)
Boas, H.: (2) Die Behandlung des Eczema mycoticum ad modum Sylvest. Hautarzt 2, 233 (1951)
Bobbitt, O. B., I.H.Friedman and Ch. Lupton: Nocardiosis. New Engl. J. Med. 252, 893 (1955).
Bock, H. E.: Zur Klinik der Therapieschäden. Dtsch. med. Wschr. 1957, 1889.
Bocobo, F. C., A. C. Curtis, W. D. Block and E. R. Harrell: In vitro study of antifungal activity of nitrostyrenes. Proc. Soc. exp. Biol. (N.Y.) 85, 220 (1954).
Bocobo, F. C., A. C. Curtis, W. D. Block, E. R. Harrell, E. E. Evans and R. F. Haines: Evaluation of nitrostyrenes as antifungal agents. I. In vitro studies. Antibiot. and Chemother. 6, 385 (1956).
Bocobo, C., A. C. Curtis and E. R. Harrell: In vitro fungistatic activity of stilbamidine, propamidine, pentamidine and diethylstilbestrol. J. invest. Derm. 21, 149 (1953).
Bograd, N.: Treatment of tinea with ethylchloride. Arch. Derm. Syph. (Chicago) 48, 511 (1943).
Bohan, E. M., and G. S. Serino: Cervicofacial actinomycosis successfully treated by penicillin and repeated aspirations. Delaware med. J. 17, 213 (1945).
Bohnstedt, R. M., (1954) W. Fischer u. H. Füller: Beurteilung neuerer und älterer Antimykotica in vivo und in vitro. Medizinische 1953, 1032.
Bohonos, N., R. L. Emerson, A. J. Whiffen, M. P. Nash and C. de Boer: A new antibiotic produced by a strain of Streptomyces lavendulae. Arch. Biochem. 15, 215 (1947).
Bojalil, L. F., and J. A. Shiels: Estudio de la acción in vitro de algunos compuestos sobre e crecimiento de varias especies de nocardia. Rev. palud. méd. trop. Méx. 2, 133 (1950).
Bolhofer, W. A., R. A. Machlowitz and J. Char- ney: Abstr. pap. 122. Meeting Amer. Chem. Soc. 1952, 12 A. Cit. S. A. Waksman and H. A. Lechevalier: Actinomycetes and their antibiotics.
Bonfiglioli, H., y A. L. Longobardi: Sensibilidad “in vitro” de Cryptococcus neoformans a diversos antibióticos y quimioterápicos. Pren. méd. argent. 44, 2657 (1957).
Bonilla, E.: Treatment of chromoblastomycosis with calciferol. A.M.A. Arch. Derm. 70, 665 (1954).
Bonis, U. de, e S. Gaballo: Sul tratamento locale della pityriasis versicolor con penicillina. Minerva med. (Torino) 43, 1013 (1952).
Bonnevie, P.: Experimental investigations on the antimycotic effect of ethyl-para-oxybenzoate and of allied substances. Acta derm.-venereol. (Stockh.) 17, 576 (1936).
Booth, B.H.: Mouse ringworm. A.M.A. Arch. Derm. 66, 65 (1952).
Bornhauser, S.: Über eine Mikrosporie-Epidermie in einem Kinderheim. Dermatológica (Basel) 98, 222 (1949).
Borodin, N., F. J. Philpot and H. W. Florey: Brit. J. exp. Path. 28, 31 (1947). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics.
Bowman, F. W., and J. J. Wingenbach: A method for minimizing the fungistatic activity of sodium caprylate in sterility testing. Antibiot. and Chemother. 7, 5 (1957).
Brabant, H., et A. Delmotte: Inoculation expérimentale et activité lipolytique de Candida albicans. Activité fungicide du borate de phénylmercure. Arch, belges Derm. 15, 138 (1959).
Bra- betz, V.: Mykose-Therapie. Auswertung von über 1000 Berichten aus Klinik und Praxis. Ther. d. Gegenw. 91, 184 (1952).
Brachmann, F.: Aureomycintherapie bei Aktinomykose. Zahnärztl. Rdsch. 62, 290 (1953).
Bradley, S. G.: (1) Effect of nystatin on Candida stellatoidea. Antibiot. and Chemother. 8, 282 (1958).
Bradley, S. G.: (2) Interactions between phosphate and nystatin in Candida stellatoidea. Proc. Soc. exp. Biol. (N.Y.) 98, 786 (1958).
Brain, R. T., K. Crow, H. Haber, C. McKenney and J. W. Hadgraft: Treatment of ringworm of the scalp. Brit. med. J. 1948 I, 723.
Braun, H., u. H. Pinker: Zur Therapie röntgenrefraktärer Fälle von Aktinomykose, unter Berücksichtigung der Penicillinbehandlung. Dtsch. med. Wschr. 1951, 711.
Braun, W.: Über Erfahrungen mit dem Antimykoticum Ovitrol. Dtsch. Gesundh.-Wes. 10, 1251 (1955)
Bret, A. J., et M. Bardiaux: Traitement des mycoses vaginales par un nouvel antibiotique, la nystatine ou fongicidine. Presse méd. 64, 671 (1956)
Brett, M. S.: Advanced actinomycosis of the spine treated with penicillin and streptomycin; report of a case. J. Bone Jt Surg. B 33, 215 (1951)
Brewer, W. C.: Treatment of dermatophytes with propionate-caprylate mixtures. A.M.A. Arch. Derm. 61, 681 (1950)
Brian, P. W.: Studies on the biological activity of griseofulvin. Ann. Botany 13, 59 (1949)
Brian, P. W., P. J. Curtis, J. F. Grove, H. G. Hemming and J.C.McGowan: Nature (Lond.) 157, 698 (1946). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Brian, P. W., P. J. Curtis and H. G. Hemming: (1) A substance causing abnormal development of fungal hyphae produced by Pénicillium janczewskii Zal. I. Biological assay, production and isolation of “curling factor”. Brit. Mycol. Soc. Trans. 29, 173 (1946)
Brian, P. W., P. J. Curtis and H. G. Hemming: (2) A substance causing abnormal development of fungal hyphae produced by Pénicillium janczewskii Zal. III. Identity of “curling factor” with griseofulvin. Brit. Mycol. Soc. Trans. 32, 30 (1949)
Brian, P. W., P. J. Curtis and H. G. Hemming: (3) Glutinosin, a fungistatic metabolic product of the mould Metarrhizium glutinosum S. Pope. Proc. roy Soc. B 135, 106 (1947)
Brian, P. W., P. J. Curtis and H. G. Hemming: (4) Production of griseofulvin by Pénicillium raistrickii. Brit. Mycol. Soc. Trans. 38, 305 (1955)
Brian, P. W., and H. G. Hemming: Production of antifungal and antibacterial substances by fungi; preliminary examination of 166 strains of fungi imperfecti. J. gen. Microbiol. 1, 158 (1947)
Brian, P. W., and J. C.McGowan: Nature (Lond.) 156, 144 (1945); 157, 334 (1946). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Brian, P. W., J.M.Wright, J. Stubbs and A.M. Way: Uptake of antibiotic metabolites of soil microorganisms by plants. Nature (Lond.) 167, 347 (1951)
Brockman, D.D.: The in vitro effect of atabrine on Cryptococcus neoformans. Amer. J. trop. Med. 28, 295 (1948)
Brown jr., C., S. Propp, C. M. Guest, R. T. Beebe and L. Early: Fatal fungus infections complicating antibiotic therapy. J. Amer. med. Ass., 152, 206 (1953)
Brown, J. J., and T. Newbold: Chem. and Ind. 1953, 1151. Zit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Brown, R., and E.L.Hazen: (1) Nystatin and actidione: two antifungal agents produced by Streptomyces nourSci. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer
Brown, R., and E.L. Hazen: (2) Discovery of nystatin. Monogr. Ther. 2, 69 (1957)
Brown, R., and E.L.Hazen: (3) Present knowledge of nystatin, an antifungal antibiotic. Trans. N.Y. Acad. Sci., Ser. II 19, 447 (1957)
Brown, R., E.L.Hazen and A. Mason: Effect of fungicidin (nystatin) in mice injected with lethal mixtures of aureomycin and Candida albicans. Science 117, 609 (1953)
Browne, A.D.: Nystatin therapy in monilial vulvovaginitis. J. Irish med. Ass. 40, 86 (1957)
Bruck, H., and H. Moritsch: Über die Desinfektionskraft von Cetyltrimethylammoniumbromid (Cetavlon) bei der Vorbereitung zu chirurgischen Eingriffen. Wien. klin. Wschr. 68, 138 (1956)
Brün, R.: Activité de la dichloroxychinaldine (siostéran) après passage à travers le tube digestif. Schweiz, med. Wschr. 1956, 273
Brun, R., J. J. Mozer et W. Jadassohn: L’effet de quelques substances antimycotiques sur Candida albi¬cans. Schweiz, med. Wschr. 1953, 135
Bruwer, A.: Actinomycosis with special reference to its pathogenesis, its treatment, and its cure with penicillin. Clin. Proc. 5, 59 (1946)
Bryan, C. S., and F. W. Young: Phemerol as treatment for ringworm in calves. Mich. St. Coll. Vet. 5, 118 (1945)
Buckle, G., and D. R. Curtis: Therapy of human torulosis with actidione and “contramine”: a report of two cases. Med. J. Aust. 2, 854 (1955)
Bunka, H.: Zur lokalen Behandlung des vaginalen Fluors mit Hydrocortison. Med. Klin. 54, 2001 (1959).
Burgoon, C. F.: Histopathologic evaluation of the effect of griseofulvin in human hair follicle infections with Microsporum audouini. Symposium griseoulvin and dermatomycosis, 26. u. 27. 10.1959, Miami/Florida
Burke, R. C., J. H. Swartz, S. S. Chapman and W.-Y. Huang: Mycoticin, a new antifugal antibiotic. J. invest. Derm. 23, 163 (1954)
Burlin- game, E. M., and G. F. Reddish: Laboratory methods for testing fungicides used in the treatment of epidermophytosis. J. Lab. clin. Med. 24, 765 (1939)
Burr, A. H., and T. R. Huffines: Blastomycosis of the prostate with miliary dissemination treated by stilbamidine. J. Urol. (Baltimore) 71, 464 (1954)
Buschke, A., u. B. Peiser: Biologische und klinische Ausblicke der neueren Thalliumforschung mit besonderer Beziehung zu den Haarpilzkrankheiten. Mycopathologia (Den Haag) 2, 204 (1940)
Bushby, S. R. M., and Sh. Stewart: Experimental assessment of therapeutic efficiency of antifungal substances. Brit. J. Derm. 61, 315 (1949)
Bustinza, F.: (1) Contribución al estudio de las propriedades antibacterianas y antifungicas del ácido úsnico y de algunos de sus derivados. An. Jard. bot. Madr. 10, 151 (1951)
Bustinza, F.: (2) Actividad antibiótica del Pénicillium funiculosum Thom (estirpe C20-A). An. Inst. bot. A. J. Cavanilles 12, 197 (1954)
Byrne, E. A. J.: Effect of organic mercurial preparations on diseases of the skin. Brit. med. J. 1947 I, 90 (1947)
Byrne, E. A. J., and J. Croxon: Bactericidal and fungicidal action of organic mercurials with special reference to the dermatomycoses. Indian med. Gaz. 79, 357 (1944).
Cahn, M. M., and E. J. Levy: The use of triacetin (fungacetin) in the treatment of superficial dermatomy coses. Int. Rec. Med. 172, 303 (1959)
Calvery, H. O.: Warning on the use of phenol-campher in cases of “athlete’s foot”. J. Amer. med. Ass. 119, 366 (1942)
Campbell, A. H.: Present status of griseofulvin as a plant protectant. Meded. Landb. Opz. Stat. Gent 21, 519 (1956)
Campbell, C. C.: (1) Tinea pedis in United States Army troops stationed in Puerto Rico and the comparative effectiveness of an antihistamine (diphenylpyraline) and undecylenic acid in its treatment. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and Y. D. Newcomer, pp. 112–116
Campbell, C. C.: (2) Preliminary results with a new antibiotic, 1968 (nepera), in mice with experimental histoplasmosis, sporotrichosis, and candidiasis. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 160–163
Campbell, C. C.: (3) Therapeutic activity of mycostatin in mice infected with Histoplasma capsulatum, Coccidioides immitis, Cryptococcus neoformans, Candida albicans, or Sporotrichum schenckii. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer, pp. 255–259
Campbell, C. C.: (4) The therapeutic activity of mycostatin in mice experimentally infected with Candida albicans. Monogr. Ther. 2, 83 (1957)
Campbell, C. C., G. B. Hill and B. E. Brooks: Therapeutic activity of a new antibiotic 1968 in mice with experimental histoplasmosis, sporotrichosis and moniliasis. Antibiot. Ann. 1955/56, 240
Campbell, C. C., E. P. Hodges and G. B. Hill: Therapeutic effect of nystatin (fungicidin) in mice experimentally infected with Histoplasma capsulatum. Antibiot. and Chemother. 4, 406 (1954).
Campbell, C. C., and S. Saslaw: Enhancement of growth of certain fungi by streptomycin. Proc. Soc. exp. Biol. (N.Y.) 70, 562 (1949)
Campins, H.: Sintesis de las investigaciones micológicas realizadas en Venezuela durante los años 1946–1956. Mycopathologia (Den Haag) 9, 152 (1958)
Cap, J.: Zur Behandlung der Aktinomykose mit Penicillin und Sulfapyrimidin. Derm. Wschr. 124, 321 (1954)
Caplan, H.: Monilial (Candida) endocarditis following treatment with antibiotics. Lancet 1955 II, 957
Captjti, F.: LaMycotorula albicans nella patologia da antibiotici. Terap. antibiot. (Milano) 5, 176 (1955)
Carbonera,P.: Azione fungistatica e fungicida dell’acido undecilenico su alcuni ceppi fungine. Riv. 1st. Hdb. d. Haut- u. Geschlechtskrankheiten, Erg.-Werk V/I 01 sieroter. ital. 26, 43 (1951)
Caretta, G., e S. Füresz: Azione della tricomicina e della nistatina sulle candidae e sul Trichomonas vaginalis. G. Mal. infett. 10, 742 (1958)
Carlson, J. R., and J. W. Snyder: Candida albicans plate assay of nystatin. Antibiot. and Chemother. 9, 139 (1959)
Carpenter, A. M.: Studies on candida. II. Sensisivity tests on strains of candida. Antibiot. and Chemother. 5, 255 (1955)
Carpenter, A. M., and G. W. Janda: Studies in vaginal strains of candida. VI. Internat. Kongr. Trop. Mal., 5.—13. 9. 1958, Lissabon
Carrick, L.: (1) Methods of local therapy for tinea capitis due to Microsporum audouini. J. Amer. med. Ass. 131, 1189 (1946)
Carrick, L.: (2) Treatment of tinea capitis in general practice. J. Mich. med. Soc. 48, 213 (1949)
Carrick, L.: (3) Cutaneous cryptococcosis. Report of a case treated with potassium iodide and x-ray therapy. A.M.A. Arch. Derm. 76, 777 (1957)
Carrón, R., et P. Chavanis: Méningite à Candida albicans après antibiothérapie prolongée locale et générale. Pédiatrie 9, 387 (1954)
Carslaw, R. W.: The treatment of tinea capitis without fungicides. Brit. J. Derm. 63, 16 (1951)
Carson, L. E., and C. C. Campbell: The inhibitory effect of three antihistamine compounds on the growth of fungi pathogenic for man. Science 111, 689 (1950)
Carton, C. A.: Treatment of central nervous system cryptococcosis; a review and report of four cases treated with actidione. Ann. intern. Med. 37, 123 (1952)
Carton, C. A., and C. S. Liebig: Treatment of central nervous system cryptococcosis. Laboratory studies. Arch, intern. Med. 91, 773 (1953)
Carvajal, F.: Fluvomycin: an antibiotic effective against pathogenic bacteria and fungi. Antibiot. and Chemother. 3, 765 (1953)
Casanovas, M.: Las nuevas medicaciones en el tratamiento de las micosis cutáneas por dermatofitos. Ensayos con un nuevo quimioterápico, derivado del cresol. Med. clin. (Barcelona) 23, 381 (1954)
Celmer, W. D., and I. A. Solomons: (1) J. Amer. chem. Soc. 74, 1870 (1952). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Celmer, W. D., and I. A. Solomons: (2) The structure of thiolutin and aureothricin, antibiotics containing a unique pyrrolinodithiole nucleus. Amer. J. chem. Soc. 77, 2861 (1955)
Cercós, A. P.: (1) Antibiòtico DINR. 49-1 (fungocina) producido por bacillus subtilis con actividad sobre hongos patogénicos de animales y vegetales. Rev. invest, agrie. B. Aires 4, 13 (1950)
Cercós, A. P.: (2) Rev. argent, agron. 20, 53 (1953). Cit. S. A. Waksman and H. A. Lechevalier: Actinomycetes and their antibiotics
Chabás López, J.: Los progresos de la quimioterapia antimicótica. Clin, y Lab. 52, 179 (1951)
Chain, E.B., H.W. Florey, M. A. Jennings and D. Callow: Brit. J. exp. Path. 23, 202 (1942). Cit. W. S. Spector: Handbook of toxicology. Vol. II: Antibiotics
Chanton, E. F., W. J. Hollis and M. D. Hargrove: Actinomycosis: a report of six cases treated with penicillin and sulfadiazine. Sth. med. J. (Bghm., Ala.) 41, 1022 (1948)
Chanussot, P.: Fungistatic activity of some derivatives of solasodan. Ann. Asoc. quim. argent. 45, 113 (1957)
Chappaz, G., et P. Bertrand: La trichomycine. Press, méd. 65, 425 (1957)
Chappaz, G., P. Bertrand, J. A. Martin et R. Tayac: A propos de la fréquence actuelle des mycoses. Pathogénie par l’usage des antibiotiques et de la cortisone. Rapp. J. med. France, Sess. Clermont-Ferrand, 17.—21. 5. 1956
Charbonneau, P., et D. F. Raquet: Epilation des teigneux par l’acétate de thallium (54 cas). Maroc, méd. 35, 961 (1956)
Charney, J.: Antibiot. Ann. 1955/56, 228. Cit. W, S. Spector: Handbook of toxicology. Vol.11: Antibiotics
Cheng, W. W. F.: In vitro antifungal activity of some Chinese herbs on certain pathogenic and non-pathogenic fungi. Chin. med. J. 69, 427 (1951)
Cherniss, E. I., and B. A. Waisbren: North American blastomycosis: A clinical study of 40 cases. Ann. intern. Med. 44, 105 (1956)
Cheymol, J.: Accidents liés à la médication antibiotique. Act. d’Anésthés. 3, 335 (1955)
Child, K. J.: Distribution studies with griseofulvin in animals and man. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959, Miami/Florida
Childs, A. J.: (1) Effect of nystatin on growth of Candida albicans during antibiotic therapy. Brit. med. J. 1956 I, 660
Childs, A. J.: (2) The effect of various drugs on the growth of Candida albicans during antibiotic therapy, including amphotericin, a new antibiotic. Scot. med. J. 2, 400 (1957)
Childs, A. J.: (3) Further clinical trials of amphotericin: with report on the treatment of a probable generalized case of moniliasis. Scot, med. J. 4, 80 (1959)
Chinn, H. I., R. B. Mitchell and A. C. Arnold: Relation of chemical structure to fungistatic activity. J. invest. Derm. 20, 177 (1953)
Chinn, H. I., R. B. Mitchell, F. W. Bieberdorf and A. C. Arnold: Effectiveness of various compounds against Coccidioides immitis. Antibiot. and Chemother. 4, 982 (1954)
Chmel, L.: Critical survey of medical mycology in Czechoslovakia for the years 1946 to 1956. Mycopathologia (Den Haag) 12, 77 (1959)
Christie, A.: Treatment of disseminated histoplasmosis with ethylvanillate. Pediatrics 7, 7 (1951)
Christison, I. B., and N. F. Conant: Antifungal activity of some aromatic diamidines. J. Lab. clin. Med. 42, 638 (1953)
Christison, I. B., N. F. Conant, F. C. Brown and C. K. Bradsher: The sensitivity of Histoplasma capsulatum to rhodanine compounds. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and Y. D. Newcomer, p. 268–177
Chuckerbutty, B.: Clinical trials of a new antimycotic drug (multifungin). Indian J. Derm. 3, 118 (1958)
Ciferri, R.: (1) Attività antibiotica di alcuni dermatofiti. Mycopathologia (Den Haag) 4, 219 (1948)
Ciferri, R.: (2) Manuale di micologia medica. Pavia: Renzo Cortina 1958
Ciferri, R., G. Mazzetti e E. Giunchi: Micosi da antibiotici (discussione e risposta). G. Mal. infett. 10, 668 (1958)
Clark: Zit. K. W. Kalkoff u. D. Janke: Mykosen der Haut. In Gottron-Schònfeld
Clutterbuck, P. W., W. Koerber and H.Raistrick: Biochem. J. 31, 1089 (1937). Cit. W. S. Spector, Handbook of toxicology. Vol.11: Antibiotics
Coates, L. V., D. J. Drain, K. A. Kerridge, F. J. Macrae and K. Tattersall: The preparation and antifungal activity of some salicylic acid derivatives. J. Pharm. (Lond.) 9, 855 (1957)
Cochrane, Th., and A. Tullett: Griseofulvin treatment of acute cattle ringworm infections in man. Brit, med. J. 1959 II, 286
Cockshott, W. P.: The therapy of mycetoma. W. Afr. med. J., N. s. 6, 101 (1957)
Cohen, R.: (1) Four new fungicides for Coccidioides immitis. 1. Sodium caprylate. 2. Ethylvanillate. 3. Fradicin. 4. Thiolutin. Arch. Pediat. 68, 259 (1951)
Cohen, R.: (2) Fatalities following stilbamidine therapy. J. Amer. med. Ass. 150, 1332 (1952)
Cohen, R.: (3) Diethylstilbestrol. A coccidioidal fungicide. Arch. Pediat. 71, 291 (1954)
Cohen, R., and R. O’Connor: (1) Para-amino-benzoic acid as a fungicide for Coccidioides immitis. Arch. Pediat. 70, 404 (1953)
Cohen, R.: (2) A new fungicide for Coccidioides immitis. Arch. Pediat. 72, 154 (1955)
Cohen, R., and M. Persky: Sodium caprylate treatment for thrush. Arch. Pediat. 68, 33 (1951)
Cohen, T. M.: Dermatologie therapy in the tropics. Nav. med. Bull. Wash. 42, 1119 (1944)
Colbert, J. W., M. D. Strauss and R. H. Green: The treatment of cutaneous blastomycosis with propamidine. A preliminary report. J. invest. Derm. 14, 71 (1950)
Coletta, A., e E. Martucci: La nistatina per impiego locale nella terapia della moniliasi orale del neonato e del lattante. G. Mal. infett. 10, 745 (1958)
Collier, H. O. J., M.D.Potter and E.P.Taylor: Antifungal activities of bisisoquinolinium and bisquinolinium salts. Brit. J. Pharmacol. 10, 343 (1955)
Collins, A. P., and G. A. Wiese: The synthesis and investigation of some ethylene bis-dithiocarbamate esters as fungicides. J. Amer. pharm. Ass., sci. Ed. 44, 310 (1955)
Collins, J. G., T. H. McGavack and L. J. Boyd: The effect of tetrachloro-para-benzoquinone upon human fungus infections. I. In vitro and in vivo studies with tinea capitis. Urol, cutan. Rev. 50, 276 (1946)
Colmeiro-Laforet, C.: Vaginitis micóticas consecutivas a tratamientos con antibióticos. Cons. gen. Col. Méd. esp. 22, 45 (1959)
Colsky, J.: Treatment of systemic blastomycosis with 2-hydroxystilbamidine. Arch, intern. Med. 93, 796 (1954)
Colwell, C. A., and M. McCall: The mechanism of bacterial and fungus growth inhibition by 2-methyl-1,4-naphthoquinone. J. Bact. 51, 659 (1946)
Combes, F. C., R. Zuckerman and A. Bobroff: Copper undecylenate in the treatment of dermatomycoses. J. invest. Derm. 10, 447 (1948)
Conant, N. F., D. T. Smith. R. D. Baker, J. L. Callaway and D. St. Martin: Manual of clinical mycology, 2. edit. Philadelphia and London: W. B. Saunders Company 1954
Constant, E. R.: The treatment of tinea capitis with gliotoxin. J. invest. Derm. 8, 337 (1946)
Cook, E. S., C. W. Kreke, M. McDevitt and M. D. Bartlett: The action of phenylmercuric nitrate. I. Effects on enzyme systems. J. biol. Chem. 162, 43 (1946)
Cooper, Z. K., and M. F. Engman: A study of the stimulating effect of small doses of growth of thalliumacetate on the rate of growth of hair in the albino rat. A.M.A. Arch. Derm. 23, 1031 (1931)
Corbelli, G., L. Allegri, G. Casaglia e E. Tom at: Dati sperimentali e clinici sul ruolo del trattamento cortisonico nell’infezione candidosica. G. Mal. infett. 10, 749 (1958)
Corbelli, G., L. Allegri e A. Mazzoni: Casi clinici di candidosi. Minerva med. (Torino) 1957, 3812
Corbelli, G., L. Allegri e E. Tomat: (1) Studio sperimentale e clinico sull’efficacia della vaccino-profilassi anti Candida albicans. G. Mal. infett. 10, 702 (1958)
Corbelli, G., L. Allegri e E. Tomat: (2) La terapie vaccinica anti Candida albicans in campo sperimentale ed in quello clinico umano. Studio sperimentale clinico. G. Mal. infett. 10, 704 (1958)
Corbit jr., J. D., E. McElroy and J. H. Clark: Use of silver picrate in the treatment of vaginitis: a five year study. J. Amer. med. Ass. 117, 1764 (1941)
Cordero, A. A., y P. H. Magnin: Ensayo de dietilstilbestrol en blastomicosis y leishmaniasis sudamericanas. Rev. argent. Dermatosif. 40, 69 (1956)
Cormane, R. H.: Candida albicans en therapie met antibiotica. Diss. Leiden 1958
Cornbleet,Th.: Thyroid-iodide therapy of blastomycosis. A.M.A. Arch. Derm. 76, 545 (1957)
Cornbleet,Th., S. Barsky and C. del Busto: Blastomycosis. A.M.A. Arch. Derm. 73, 598 (1956)
Cornbleet, Th., S. Barsky and B. Firestein: The use of polyvinylpyrrolidone iodine in eczematoid ringworm. A.M.A. Arch. Derm. 77, 335 (1958)
Costello, M. J., Ch. P. de Feo and M. L. Littman: Chromoblastomycosis treated with local infiltration of amphotericin B solution. A.M.A. Arch. Derm. 79, 184 (1949)
Costigan, P. G.: A case of actinomycosis treated with streptomycin. Canad. med. Ass. J. 56, 431 (1947)
Coudert, J.: Guide pratique de mycologie médicale. Paris: Masson & Cie. 1955
Coudert, J., et J. C. Doucet: L’acide undécylénique dans le traitement des épidermomycoses et des teignes. Bull. Derm. Syph. 57, 233 (1950)
Coudert, J., et H. Jehl: Note complémentaire sur l’action de la tyrothricine sur certaines dermatophytes. Bull. Derm. Syph. 56, 74 (1949)
Cox, R. S., and J. L. Hannon: An evaluation of neomycin plus nystatin as a monilial suppressant in preoperative bowel preparation. Antibiot. Ann. 1957/58, 658 (1958)
Craps, M.: Considérations sur l’action locale de la pénicilline dans les teignes. Arch, beiges Derm. 4, 160 (1948). Ref. Zbl. Haut- u. Geschl.-Kr. 74, 168 (1950)
Cremer,C.: (1) Trichophytie en mikrosporie van het behaarde hoofd bij volwasenen, de invloed van ACTH en Cortison op dermatomykosen. Ned. T. Geneesk. 99, 3044 (1955)
Cremer,C.: (2) Critical survey of mycological research and literature for the years 1946–1956 in Holland. Mycopathologia (Den Haag) 9, 241 (1958)
Cremer, H. D., W. Tolckmitt u. J. Wenderhold: Beitrag zur Physiologie der Sorbinsäure. Klin. Wschr. 37, 304 (1959)
Crittenden, P. J., N. J. Westfield and L. S. Joiner: Cotton hose as a vehicle for a fungicide in treatment of athlete’s foot. J. Lab. clin. Med. 29, 606 (1944)
Cross, J. M., C. A. Discher and M. Jannarone: Synthesis and antifungal properties of 6-halothymols. J. Amer, pharm. Ass., Sci. Ed. 44, 637 (1955)
Crounse, R. G., and A.B. Lerner: Cryptococcosis: case with unusual skin lesions and favourable response to amphotericin B therapy. A.M.A. Arch. Derm. 77, 210 (1958)
Cummings, J.: Antagonistic activity of chaetomium globosum against fungi. Mycologia (N.Y.) 46, 289 (1954)
Cummins, C. R., B. Bairstow and L. A. Baker: Stilbamidine in treatment of disseminated blastomycosis. Arch, intern. Med. 92, 98 (1953)
Cunha, A.C. da: Açao “in vitro” de algumas sulfas sovre o crescimento do Paracoccidioides brasiliensis. Rev. Med. Sao Paulo 28, 399 (1944)
Curtis, A. C.: The aromatic diamidines, cinnamic acids, and nitrostyrenes in the treatment of fungus diseases. In: Therapy of fungus diseases. Edit, by Th.H. Sternberg and V. D. Newcomer, pp. 136–141
Curtis, A. C., and F. C. Bocobo: North American blastomycosis. J. chron. Dis. 5, 404 (1957)
Curtis, A.C., F. C. Bocobo, E. R. Harrell and E. D. Block: (1) Further studies on antifungal activity of some cinnamic acid derivatives and nitrostyrenes. A.M.A. Arch. Derm. 70, 786 (1954)
Curtis, A.C., F. C. Bocobo, E. R. Harrell and E. D. Block: (2) The effect of stilbenes and related compounds on the mycoses. U.S. armed Forces med. J. 5, 949 (1954)
Curtis, A. C., and E. R. Harrell: Use of two stilbene derivates (diethylstilbestrol and stilbamidine) in treatment of blastomycosis. A.M.A. Arch. Derm. 66, 676 (1952)
Curtis, P. J., H. G. Hemming and C.H. Unwin: Brit. Mycol. Soc. Trans. 34, 332 (1951). Cit. W. S. Spector, Handbook of toxicology, vol. II: Antibiotics.
Dameno, R.: El empleo de la tricomicina en el tratamiento del muguet. Pren. méd. argent. 65, 562 (1958)
Danowski, T. S., and M. Tager: Thiourea and the inhibition of growth of fungi. J. infect. Dis. 82, 119 (1948)
Darcissac, M.: Un nouvel antiseptique: l’A.T.S. (Association stabilisée d’acide trichloracétique et d’acide salicylique). Concours méd. 78, 504 (1956)
D’Atri, G.: L’acido undecilenico nella cura delle epidermomicosi. Ann. ital. Derm. Sif. 5, 265 (1950)
Davidson, A. M., P. H. Gregory and A. R. Birt: The treat¬ment of ringworm of the scalp by thallium acetate and the detection of carriers by the fluo¬rescence test. Canad. med. Ass. J. 30, 620 (1934)
Davisson, J. W., F. W. Tanner, A. C. Finlay and I.A.Solomons: Rimocidin, a new antibiotic. Antibiot. and Chemother. 1, 289 (1951)
Dawkins, S. M., J. M. B. Edwards and R. W. Riddell: Fungal infection of the female genital tract. Med. Illustr. 9, 767 (1955)
Degos, R., E. Rivalier et P. Lefort: (1) La griséofulvine dans le traitement des teignes. Bull. Soc. franç. Derm. Syph. 66, 281 (1959)
Degos, R., E. Rivalier et P. Lefort: (1) La griséofulvine dans le traitement des teignes. Sem. Hôp. Paris 35, 2723 (1959)
Dejou, L., et E. Aite: Radiosulfamido-pénicilline-thérapie dans un cas de mycétoma actinomycosique de la nuque propagé aux vertèbres. Presse méd. 1949, 131
Delaveau, P., et S. Brion: Traitement actuel des actinomycoses et des nocardioses. Thérapie 10, 87 (1955)
Delcambe, L.: C. R. Soc. Biol. (Paris) 146, 789, 1808 (1952). Cit. W. S. Spector: Handbook of toxicology. Vol. II: Antibiotics
Delmotte, A.: Action du borate de phénylmercure sur “Candida albicans”. Bull. Rech. Sci. Stomat. 3, 35 (1960)
Despois, R.: Les antibiotiques produits par les actinomyces. Prod, pharm. 7, 18 (1952)
Deuel jr., H. J.: The lipids: Their chemistry and biochemistry, vol. I. New York: Interscience Publishers 1951
Dietsch, H.: Behandlung des Fluor vaginalis. Ärztl. Praxis 9, Nr 25, 1 (1957)
Dijk, E. van, and P. J. der Kinderen: Sporotrichose. Ned. T. Geneesk. 102, 195 (1958)
Dillaha, C. J.: An evaluation of the dosage requirements of griseofulvin in the treatment of onychomycosis. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959, Miami/Florida
Dimmling, Th.: In vitro-Untersuchungen über die Aktivität von Trichomycin gegen Hefen und hefeähnliche Pilze. Zbl. Bakt., I. Abt. Orig. 163, 530 (1955)
Dimond, N. S., and K. W. Thompson: The effect of sulfonamide drugs on tricho¬phytons in vitro. J. invest. Derm. 5, 397 (1942)
Discher, C. A., J. M. Cross, P. F. Smith and M. Lannarone: The synthesis and antifungal properties of 6-fluorothymol. J. Amer, pharm. Ass., Sci. Ed. 47, 689 (1958)
Dixon, J. M.: Sulfanilamide therapy in madura foot. Virginia med. Monthly 68, 281 (1941)
Dobek, M.: Action de l’isoniazide sur Nocardia asteroides in vitro et in vivo. Ann. Inst. Pasteur 96, 116 (1959)
Dobes, W. L.: (1) Treatment of tinea capitis with estrogenic hormones. A.M.A. Arch. Derm. 62, 58 (1950)
Dobes, W. L.: (2) The effect of estrogenic hormones on tinea capitis due to M. audouini. A.M.A. Arch. Derm. 72, 252 (1955)
Dobias, B.: (1) Cutaneous moniliasis in pediatrics: diagnosis and treatment with nystatin. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer
Dobias, B.: (2) Treatment of cutaneous moniliasis in pediatrics with nystatin. Monogr. Ther. 2, 49 (1957)
Dobson, L., and W. C. Cutting: Penicillin and sulfonamides in the therapy of actinomycosis. J. Amer. med. Ass. 128, 856 (1945)
Dobson, L., E. Holman and W. C. Cutting: Sulfanilamide in the therapy of actinomycosis. J. Amer. med. Ass. 116, 272 (1941)
Dohrn, M., u. P. Diedrich: Zit. F. Mietzsch u. R. Behnisch, Therapeutisch verwendbare Sulfonamid- und Sulfonverbindungen
Dolan, M. M., J. J. Ebelhard, A. M. Kligman and R. C. Bard: A semi-in vivo procedure for testing antifungal agents for tropical use. J. invest. Derm. 28, 359 (1957)
Dolce, F. A., and W. J. Nickerson: Treatment of mycotic infections by inhibiting respiration of dermatophytes. A.M.A. Arch. Derm. 55, 379 (1947)
Dolfen, W.: Erfahrungen bei der Behandlung von Dermatomykosen in einem Staub- und Hitzebetrieb. Zbl. Arbeitsmed. 4, 73 (1954)
Domagk, G.: (1957) Dtsch. med. Wschr. 1935, 829. Zit. F. Staib u. S. Ata
Domagk, G.: (2) Über neue bakteriostatisch und chemotherapeutisch im Experiment hoch wirksame Chinonderivate. Dtsch. Z. Verdau.- u. Stoffwechselkr. 15, 165 (1955)
Donovick, R., F. E. Pansy, H. A. Stout, H. Stander, M.J.Weinstein and W.Gold: Some in vitro characteristics of nystatin (mycostatin). In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 176 bis 185
Doray, M., R. Guy, P. Dionne, B.-G. Begin et I. Lambert: Un cas de blastomycose nordaméricaine traitée avec succès par la 2-hydroxy-stilbamidine. Un. méd. Can. 86, 182 (1957)
Dôsa, A.: The effect of raphanin on the colonies of common pathogenic fungi. Experientia (Basel) 6, 18 (1950). Ref. Zbl. Haut- u. Geschl.-Kr. 78, 222 (1952)
Dostrovs- ky, A., and F. Sagher: Failure of sulphonamides and penicillin in maduromycosis. Lancet 1948 I, 177
Drouhet, E.: (1) Action de la nystatine (fungicidine) in vitro et in vivo sur Candida albicans et autres champignon levuriformes. Ann. Inst. Pasteur 1955, 298.
Drouhet, E.: (2) Traitement des infections mycosiques à Candida albicans par un nouvel antibiotique antifongique: la nystatine. Presse méd. 63, 620 (1955)
Drouhet, E.: (3) Therapeutic activity of nystatin (mycostatin) in Candida infections. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer, pp. 211–218
Drouhet, E.: (4) Antifongiques et thérapeutiques des mycoses. Sem. Hôp. Paris 1957, 843
Drouhet, E.: (5) Revue critique de la mycologie médicale entre 1946 et 1956 en France et dans l’Union Française. Mycopathologia (Den Haag) 10, 19 (1958)
Drouhet, E.: (6) Action de l’amphotéricine B dans l’histoplasmose africaine à grandes formes. Bull. Soc. Path. exot. 51, 76 (1958).
Drouhet, E., J. Graciansky, J.Hamburger, J.Marie et F. Signier: Les antifongiques modernes. Presse méd. 67, 1401 (1959)
Drouhet, E., L. Hirth et G. Lebeurier: Influence de l’amphotéricine B sur le métabolisme respiratoire de Candida albicans. R. Acad. Sci. (Paris) 247, 2416 (1958)
Drouhet, E., and J. Schwarz: Evaluation of the action of nystatin (mycostatin) on Histoplasma capsulatum in vitro and in hamsters and mice. In Therapy of fungus diseases. Edit, by Th.H. Sternberg and V. D. Newcomer, pp. 238–247
Drouhet, E., J. Schwarz and E. Bingham: Evaluation of the action of nystatin on Histoplasma capsulatum in vitro and in hamsters and mice. Antibiot. and Chemother. 6, 23 (1956)
Drouhet, E., et R. Wilkinson: Activité thérapeutique de l’amphotéricine B dans la blastomycose expérimentale. Ann. Inst. Pasteur 93, 631 (1957)
Dubos, R. J.: (1) J. exp. Med. 70, 1 (1939). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Dubos, R. J.: (2) Bacterial and mycotic infections of man. Philadelphia, London and Montreal: J. B. Lippincott Company 1948
Durie, E. B.: A critical survey of mycological research and literature for the years 1946–1956 in Australia. Mycopathologia (Den Haag) 9. 80 (1958)
Dutcher, J. D.: The chemistry of nystatin and related antifungal antibiotics. Monogr. Ther. 2, 87 (1957)
Dutcher, J. D., D. R. Walter and O. P. Wintersteiner: Studies of the chemical properties and structure of nystatin (mycostatin). In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 168–175
Dutta, S. K. Mazumdar and S. K. Bose: Studies on antifungal antibiotics: action against skin pathogens. Sci. and Cult. 20, 449 (1955).
Echols, D., and J.Garcia: Upjohn Laboratory Circular, Kalamazoo, Mich. 1949. Cit. M. L. Littman and L. E. Zimmerman, Cryptococcosis
Eckert, A.: Erfolgreiche Behandlung der menschlichen Aktionomykose mit Yatren. Klin. Wschr. 1, 1788 (1922)
Edelson, E., C. Craster and A. Haskin: Evaluation of a new drug for topical therapy of tinea capitis. A.M.A. Arch. Derm. 64, 444 (1951)
Edelson, E., and A. Haskin: (1) Treatment of superficial mycological infections with a new antifungal agent. A.M.A. Arch. Derm. 66, 244 (1952)
Edelson, E., and A. Haskin: (2) Asterol treatment of superficial dermatomycoses due to T. mentagrophytes and T. purpureum. A.M.A. Arch. Derm. 68, 627 (1953)
Edwards, R. W., and F. A. Barkley: Ethyl vanillate studies on embryonated eggs. IV. Lloydia 15. 50 (1952). Ref. Rev. Med. vet. Mycol. 1, 572 (1953)
Egeberg, R.O.: Coccidioidomycosis. Its clinical and climatological aspects with remarks on treatment. Amer. J. med. Sci. 227, 268 (1954)
Ehrmann, G., u. A. Wiedmann: Netzmittel bei Hautpilzerkrankungen. Derm. Wschr. 130, 1327 (1954)
Eichholtz, F.: Lehrbuch der Pharmakologie, 9. Aufl. Berlin- Göttingen-Heidelberg: Springer 1957
Ellerbroek, U.: Über die Brauchbarkeit der Thioglykolate zur Behandlung von Dermatomykosen. Z. Haut- u. Geschl.-Kr. 10, 415 (1951).
Ellis jr., F. F., R. J. Scott and J.Miller: Treatment of progressive disseminated histoplasmosis with ethyl vanillate and propamidine. Antibiot. and Chemother. 2, 347 (1952)
Elson, W. O.: The antibacterial and fungistatic properties of propamidine. J. infect. Dis. 76, 193 (1945)
Emmons, C. W.: (1) Fungicidal action of some common disinfectants on two dermatophytes. A.M.A. Arch. Derm. 28, 15 (1933)
Emmons, C. W.: (2) Fungicidal and fungistatic agents. Amer. J. pubi. Health 34, 887 (1944)
Emmons, C. W.: (3) Silver in the treatment of experimental crypto¬coccosis. Antibiot. and Chemother. 8, 598 (1956)
Emmons, C. W.: (4) Failure of griseofulvin to control experimental systemic mycoses in mice. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Emmons, C. W., and R. T. Haberman: Ascosin in the treatment of experimental histoplasmosis in mice. Antibiot. and Chemother. 3, 1204 (1953)
Emmons, C. W., and W. Piggott: Amphotericin B and griseofulvin in the treatment of experimental systemic mycoses. Antibiot. and Chemother. 9, 550 (1959)
English, A. R., and T. J. McBride: PA 150, PA 153, and PA 166: new polyene antifungal antibiotics. Antibiot. Ann. 1957/58, 893
English, A. R., T. J. McBride and J. E. Lynch: PA 132, a new antibiotic. II. In vitro and in vivo studies. Antibiot. Ann. 1956/57, 676
Erdos, J.: Über die fungizide Wirkung einiger Kupferäthylendiaminsulfonamidkomplexe. Experientia (Basel) 5, 343 (1950)
Erdtmann, H., and E. Rennerfelt: Fungicidal properties of some constituents of the heart wood of Tetraclinis articulata (Vahl) masters. Acta chem. scand. 3, 906 (1949). Ref. Zbl. Haut- u. Geschl.-Kr. 78, 222 (1952)
Erve jr., J. van de: Fungicidal activity of diphenylpyraline. A.M.A. Arch. Derm. 68, 572 (1953)
Esteves, J., e H. Neves: (1) Foliculites supuradas da barba provocadas por fongos (kerion da barba). J. Méd. Pòrto 38, 785 (1959)
Esteves, J., e H. Neves: (2) Griseofulvin. Therapeutic results in different dermatomycoses after 22 weeks of treatment. Effect on experimental dermatomycosis in man. Dermatologica (Basel) 119, 148 (1959)
Esteves, J., e H. Neves: (3) Vorläufige Untersuchung der experimentellen Infektion durch Trichophyton violaceum beim Menschen. Hautarzt 10, 151 (1959)
Esteves, J., e H. Neves: (4) A griseofulvina no tratamento da tinha do coiro cabeludo e de outras localizagoes desta doenga (Prim. obs.). J. Méd. Pòrto 39, 341 (1959)
Esteves, J., e H. Neves: (5) A griseofulvina no tratemento de dermatomicoses. J. Méd. Pòrto 39, 341 (1959)
Esteves, J., e H. Neves: (5) A griseofulvina no tratamento de dermatomicoses. J. Méd. Porto 41, 253 (1960)
Ettig, B.: (1) Untersuchungen zur Frage des Saprophytismus der Dermatophyten im Erdboden. I. Antagonisten hautpathogener Pilze aus natürlich belebten Böden. Arch. klin. exp. Derm. 207, 24 (1958)
Ettig, B.: (2) Influence of soil-microorganisms on the saprophytism of the dermatophytes in the soil. VI. Internat. Kongr. Trop. Mai., 5.—13. 9. 1958, Lissabon
Evans, E. E., R. F. Haines, A. C. Curtis, F. C. Bocobo, W. D. Block and E. R. Harrell: Evaluation of nitrostyrenes as antifungal agents. II. In vivo experiments. J. invest. Derm. 27, 43 (1956)
Evans, J. H., and R. D. Baker: Treatment of experimental aspergillosis with amphotericin B. Antibiot. and Chemother. 9, 209 (1959).
Fahlberg, W. J.: (1) A comparison of fungistatic properties of three aromatic diamidines. Proc. roy. Soc. exp. Med. 84, 84 (1953)
Fahlberg, W. J.: (2) In vitro studies on the fungistatic effect of anti¬histamine drugs. J. invest. Derm. 20, 171 (1953)
Fahlberg, W. J.: (3) The effect of di-paralene (chlorcyclizine hydrochloride) on systemic fungus infections in mice. J. invest. Derm. 21, 125 (1953)
Farago, L., u. P. Polgar: Das parachlorbenzoesaure Natrium als neues Anti- mycoticum. Börgyögy vener. Szle 4, 85 (1950). Ref. Zbl. Haut- u. Geschl.-Kr. 77, 288 (1951/52)
Fargel, H.: Einführung einer InvertScife als Wunddesinfektionslösung. Medizinische 1953, 57.
Farris, G.: Contributo personale alla conoscenza della paracoccidioidomicosi (cosidetta blastomicosi brasiliana). G. ital. Derm. Sif. 96, 321 (1955)
Featherston, W. M.: Convulsions following use of asterol dihydrochloride. Report of a case. J. Amer. med. Ass. 150, 1006 (1952)
Fegeler, F.: (1) Untersuchungen zu aktuellen Fragen der medizinischen Mykologie. Mykosen 1, 111 (1958)
Fegeler, F.: (2) Nebenwirkungen der Antibiotica- therapie vom mykologischen Standpunkt. Mykosen 2, 26, 50 (1959)
Fegeler, F.: (3) Diskussionsbemerkung. Tagg Hamburg. Dermat. Ges., 28. 11. 1959
Feinberg, A. W.: The use of brilliant green in the treatment of chronic ulcers of the skin. New Engl. J. Med. 239, 613 (1948)
Felkel, J.: Erfahrungen über die Behandlung der Pyodermien und Mycosen mit Sterosan. Prakt. Arzt 1954, 665
Felsenfeld, O., G.W. Mast and J. S. Ishihara: J. Parasit. Suppl. 36, 25 (1950). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Felsher, M. J.: Salicylanilide therapy in tinea capitis. A.M.A. Arch. Derm. 58, 56 (1948)
Felton, L. C., and C. M. McLaughlin: Some highly halogenated phenolic ethers as fungistatic compounds. J. organ. Chem. 12, 298 (1947)
Feo, Ch. P. de, and L. C. Harber: Chromoblastomycosis treated with local infiltration of amphotericin B solution. J. Amer. med. Ass. 171, 1961 (1959)
Fink, J. C., D. E.’ Vanderploeg and M. P. Moursund: Stilbamidine in the treatment of cutaneous blastomycosis. Report of a case. J. Amer. med. Ass. 151, 1395 (1953)
Fischer, E.: Klinischer Beitrag zur chirurgischen Händedesinfektion. Zbl. Chir. 82, 357 (1957)
Fischer, G. W.: Therapieversuche bei der experimentellen aureomyeinaktivierten Soorinfektion. Z. Hyg. Infekt.-Kr. 143, 140 (1956)
Fischmann, O., e A. T. Londero: Micetoma podal por “Nocardia brasiliensis” (Lindberg 1909) curado com sulf- isoxazol (Gantrisin) “Boche”. Rev. “Roche” 19, 20 (1959)
Fisher, A.M.: (1) The clinical picture associated with infections due to Cryptococcus neoformans (Torula histolytica); report of three cases with some experimental studies. Bull. Johns Hopk. Hosp. 86, 383 (1950)
Fisher, A.M.: (2) Inhibition of growth of Cryptococcus neoformans by cultures of Pseudomonas aeruginosa. Bull. Johns Hopk. Hosp. 95, 157 (1954)
Fisher, A. M., and J. C. Harvey: Actinomycosis: some concepts of therapy and prognosis. Postgrad. Med. 19, 32 (1956)
Fissi Marraccini, G.: Osservazioni sulla terapia con mycostatin dell’infezione sperimentale della cavia da Candida albicans. G. Mal. infett. 9, 325 (1957)
Fitzpatrick, M. J., H. Rubin and C. M. Poser: The treatment of cryptococcal meningitis with amphotericin B, a new fungicidal agent. Ann. intern. Med. 49, 249 (1958)
Flarer, F.: First results in Italy with a new antimycotic, nystatin. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, p. 219
Flint, A., R. R. Forsey and B. Usher: Griseofulvin, a new oral antibiotic for the treatment of fungous infections of the skin. Canad. med. Ass. J. 81, 173 (1959)
Floch, H.: Revue critique des investigations et de la littérature mycologique pour les années 1946–1956 en Guyane Française. Mycopathologia (Den Haag) 8, 194 (1957)
Flöter, W.: Kritische Bemerkungen zur Wirkungsweise des Antimykoticums Dermaphen. Landarzt 31, 330 (1955)
Florestano, H. J., and M. E. Bahler: Antifungal properties of the polymyxins. Proc. Soc. exp. Biol. (N.Y.) 79, 141 (1952)
Florey, H. W., and A. Jennings: Brit. J. exp. Path. 23, 202 (1942). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Földvari, F.: Du traitement de l’actinomycose (résultats obtenus par la pénicillinothérapie dans 15 cas). Dermatologica (Basel) 102, 77 (1951)
Földvari, F., et E.Florian: Actinomycose primaire de la peau. Dermatologica (Basel) 109, 222 (1954)
Foley, E. J., F. Herrmann and S. W. Lee: (1) The effects of pH on the antifungal activity of fatty acids and other agents. J. invest. Derm. 53, 1 (1947)
Foley, E. J., F. Herrmann and S. W. Lee: (2) The influence of experimental conditions on the results of in vitro tests for antifungal action (with special reference to the effect of maintaining solubility of the agents). J. invest. Derm. 8, 5 (1947)
Foley, E. J., and S.W. Lee: (1) Trimethyl cetylammon pentachlorphenate T.C.A.P. and fatty acids as antifungals. J. Amer, pharm. Ass. Sci. Ed. 36, 198 (1946)
Foley, E. J., and S.W.Lee: (2) Studies on the effect of pn and solubility on the antifungal properties of fatty acids, trimethyl cetyl ammonium pentachlorphenate and other agents. J. invest. Derm. 10, 249 (1959)
Foley, G. E., and W. D. Winter: Increased mortality following penicillin therapy of chick embryos infected with Candida albicans var. stellatoidea. J. infect. Dis. 85, 268 (1960)
Foote, M. W., J. E. Little and T. J. Sproston: Naphthoquinones as inhibitors of spore germination of fungi. J. biol. Chem. 181, 481 (1949)
Ford, J. H., and B. E. Leach: Actidione, an antibiotic from Streptomyces griseus. J. Amer. chem. Soc. 70, 1223 (1948)
Forni, P. V.: Antistaminici e micosi sperimentali da Candida albicans. Boll. Soc. ital. Pat. 3, 14 (1953)
Forsey, R. R., and R. Jackson: Toxic psychosis following use of stilbamidine in blastomycosis. A.M.A. Arch. Derm. 68, 89 (1953)
Foster, J. F., and H. B. Woodruff: Arch. Biochem. 3, 241 (1943). Cit. W. S. Spector, Handbook of toxikology. Vol. II: Antibiotics
Fostvedt, G. A., D. T. Kingston, L. L. Emmons and R. L. Voller: Coccidioidomycosis. Treatment with isonicotinic acid hydrazide. Calif. Med. 85, 167 (1956)
Fox, J. L.: Candicidin, a new antifungal antibiotic: First clinical report. Antibiot. Med. 1, 349 (1955)
Fragner, P.: Parasitische Pilze beim Menschen. Prag: Tschechische Akademie der Wissenschaften 1958
Frank, H.: Vergleichende Untersuchungen über den Wirkungsmechanismus des Phenylquecksilberborates und des Quecksilber (II) chlorides auf niedere Pilze. Zbl. Bakt., II. Abt. 108, 23, 660 (1955)
Franks, A. G.: Tinea capitis treated with thiolutin. J. invest. Derm. 19, 269 (1952)
Franks, A. G., W. L. Dobes and D. Romano: Penicillin in the treatment of cutaneous diseases. A.M.A. Arch. Derm. 52, 14 (1945)
Franks, A. G., and D. Fanelli: A new treatment for interdigital fungous infection. Urol, cutan. Rev. 51, 591 (1947)
Franks, A. G., and A. Sternberg: Treatment of onychomycosis with ammoniacal silver nitrate solution. A.M.A Arch. Derm. 62, 287 (1950)
Franks, A. G., C. L. Taschdjian and G.T. Gutierrez: Onychomycosis due to Scopulariopsis brevicaulis. Case concurrent with dermatophytosis and infestation with a tyroglyphidmite. A.M.A. Arch. Derm. 74, 241 (1956)
Franks, A. G., C. L. Taschdjian and G. A. Thorpe: Effect of candicidin in intertriginous and paronychial moniliasis. J. invest. Derm. 23, 75 (1960)
Frackmann, H.: Neues zum Thema Dermatomykosebehandlung. Medizinische 1955, 1147
Freeman, G. G.: Further biological properties of trichothecin, an antifungal substance from Trichothecium roseum Link, and its derivatives. J. gen. Microbiol. 12, 213 (1960)
Freeman, G. G., and R.I.Morrison: (1) Nature (Lond.) 162, 30 (1948); zit. W. S. Spector: Handbook of toxicology. Vol. II: Antibiotics
Freeman, G. G., and R.I.Morrison: (2) The isolation and chemical properties of trichothecin, an antifungal substance from Trichothecium roseum Link. Biochem. J. 44, 1 (1949). Ref. Zbl. Haut- u. Geschl.-Kr. 75, 237 (1950/51)
Freis, E. D.: Treatment of dermatophytosis and hyperhidrosis with formaldehyde and cupric sulphate iontophoresis. A.M.A. Arch. Derm. 53, 34 (1946)
Frey, J. R.: (1) Prüfung von Antimykotica unter Verwendung von Haaren als Keimträger. Dermatologica (Basel) 107, 88 (1953)
Frey, J. R.: (2) Prüfung von Antimykotica am Meerschweinchen. Dermatologica (Basel) 107, 69 (1953)
Frey, J. R., u. H. Geleick: Zur Wirkung von Griseofulvin auf die experimentelle Trichophytie des Meerschweinchens. Dermatologica (Basel) 119, 132 (1959)
Frey, J. R., P. Wenk y B. Fust: Nuevos métodos para el ensayo de antimicóticos “in vitro” e “in vivo”. Rev. argent. Dermatosif. 38, 93 (1954)
Freyschuss, S.K. L., S.O. Pehrson and Steenberg: Antibiot. and Chemother. 5, 218 (1955). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Friderich, H.: Beitrag zur Behandlung von Mykosen. Z. Haut- u. Geschl.-Kr. 15, 228 (1953)
Fuchs, H. K., u. K. Haack: Klinische Erfahrungen mit Myxal. Dtsch. med. Wschr. 1955, 374
Füller, H.: Klinische Erfahrungen mit Sterosan. Z. Haut- u. Geschl.-Kr. 16, 177 (1954)
Fuentes, C. A.: Revision de las investi¬gaciones sobre micologia médica y de la literatura en Cuba durante el decenio de 1945 a 1955. Mycopathologia (Den Haag) 9, 207 (1958)
Fuentes, C. A., F. Trespalacios, G. F. Baquero y R. Aboulafia: Effect of actidione on mold contaminants and on human pathogens. Mycologia (N.Y.) 44, 170 (1952)
Fuji, T.: Biochemical studies on pathogenic fungi. VII. The effect of synthetic fungicides and fatty acids on the respiration of Trichophyton gypseum. VIII. The effect of an antibiotic, trichomycin, on the respiration and metabolism of Trichophyton gypseum. Pharm. Bull. (Tokyo) 5, 503 (1957)
Fujikawa, F., Y. Hitosa, S. Nakazawa and T. Omatsu: Antibacterial and antifungal action of lichen substances and their derivatives. J. pharmaceut. Soc. Jap. 77, 307 (1957)
Fujimori, H., H. Takeda and T. Tomita: Clinical experience of nystatin for gynecological candidiasis. J. Antibiot. 11, 13 (1958)
Fujino, T., T. Miwatani, S. Takagi and K. Kimura: Effect of trichomycin on experimental cryptococcosis in mice. Med. J. Osaka Univ. 8, 579 (1958)
Fulton, O., N. E. Gibbons and R.L. Moore: The fungicidal effect of vegetable-tanned leather and various disinfectants on Trichophyton gypseum and T. interdigitale. Cañad. J. Res., F 22, 163 (1944)
Fumbarg, D.: Vulvovaginitis tricomoniásica y moniliásica. Su tratamiento con tricomicina. Pren. méd. argent. 44, 2591 (1957)
Funk, C. F.: Zur Mikrosporiebehandlung. Derm. Wschr. 138, 788 (1958)
Furcolow, M. L.: Experiences with the therapy of 60 cases of deep mycotic infections. In R. W. Riddell and G. T. Stewart, Fungous diseases and their treatment
Furcolow, M. L., and Ch. A. Brasher: Trials with 2-hydroxystilb- amidine, aminostilbamidine, MRD-112, and other agents in pulmonary histoplasmosis: experiments with more than twenty cases. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 289–291.
Gabito Farias, J.: Algunos aspectos de la infección por Candida albicans y su trata-miento por la nistatina. Arch. Pediatr. Uruguay 28, 82 (1957)
Gale, G. R.: (1) The effect of ß-propiolactone on the metabolism of Blastomyces dermatitidis. J. Bact. 65, 505 (1953)
Gale, G. R.: (2) The inhibition of respiration of certain dermatophytes by ß-propiolactone. J. invest. Derm. 22, 1 (1954)
Gale, G. R.: (3) The effect of pyribenzamine on the metabolism of Blastomyces dermatitidis. Antibiot. and Chemother. 4, 33 (1954)
Gale, G. R.: (4) The effects of ß-propiolactone on the metabolism of Candida albicans. J. infect. Dis. 96, 250 (1955)
Galmarini, O. L.: Quimica de los antibióticos fungicidas. Rev. Asoc. méd. argent. 71, 6 (1957)
Gantz, J. A., J. A. Nuetzel and L. B. Keller: Cryptococcal meningitis treated with amphotericin B. Arch, intern. Med. 102, 795 (1958)
Garcia, J., M. L. Littman, R. Birchall and D. Echols: Unpublished data. Cit. M. L. Littman and L.E.Zimmerman, Cryptococcosis
Garcia, P.M.: Sulfonas en el tratamiento del micetoma, estudio de un caso. Pren. méd. méx. 15, 262 (1950)
Garnier, G.: Traitement des affections levures des muqueuses par un nouvel antifongique. Bull. Soc. franç. Derm. Syph. 62, 320 (1955)
Gate, J., et J. Coudert: Traitement des mycoses. Paris: Doin & Cie. 1958
Gate, J., J. Cotjdert et J. Cotte: (1) Action expérimentale et clinique de la tyrothricine sur quelques dermatophytes. J. méd. Lyon 29, 528 (1948)
Gate, J., J. Cotjdert et J. Cotte: (2) Remarques sur l’utilisation de la tyrothricine dans le traitement des teignes et de quelques dermatomycoses. Bull. Soc. franç. Derm. Syph. 1948, 47
Gâté, J., J. Coudert et H. Jehl: Utilisation de la tyrothricine comme antifongique en dermatologie. Bull. Soc. franç. Derm. Syph. 1949, 127
Gatti, F., et R. Vanbreuseghem: Traitement des teignes du cuir chevelu par l’astérol chez les indigènes du Congo belge. Ann. Soc. belge Méd. trop. 35, 711 (1956)
Gatjsewitz, Ph. L., F. S. Jones and G. Worley jr.: Fatal generalized moniliasis. Report of a case. Amer. J. clin. Path. 21, 41 (1951). Ref. Zbl. Haut- u. Geschl.-Kr. 78, 309 (1952)
Gay Prieto, J., J. del Pozo: Tratamiento de las tiñas del cuero cabelludo. Act. dermosifiliogr. 45, 583 (1953/54)
Geiger, W. B., J. E.Conn and S. A. Waksman: J. Bact. 48, 531 (1944). Zit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Geiser, J. C.: Action antifongique in vitro de quelques antihistaminiques de synthèse et autres substances. Dermatológica (Basel) 110, 343 (1955)
Geister, R. S., and E. Meyer: The effect of aureomycin and penicillin on experimental actinomycosis infections in mice. J. Lab. clin. Med. 38, 101 (1951)
Gentles, J. C.: (1) The successful treatment of ringworm by systemic means. VI. Internat. Kongr. Trop. Mal. 5.—13. 9. 1958 Lissabon, Abstr. 156
Gentles, J. C.: (2) Experimental ringworm in Guinea pigs: Oral treatment with griseofulvin. Nature (Lond.) 182, 476 (1958)
Gentles, J. C.: (3) A report on animal experiments with griseofulvin. Symposium griseofulvin and dermatomycosis, 26./27. 10. 1959 Miami/Florida
Gentles, J. C.: (4) The treatment of ringworm with griseofulvin. Brit. J. Derm. 71, 427 (1959)
Gentles, J. C., M.J.Barnes and K. H. Fantes: Presence of griseofulvin in hair of guinea pigs after oral administration. Nature (Lond.) 183, 256 (1959)
Georg, L. K.: (1) Use of a cycloheximide medium for isolation of dermatophytes from clinical materials. A.M.A. Arch. Derm. 67, 355 (1953)
Georg, L. K.: (2) Dermatophytes. New methods in classification. Symposium: Classification of the dermatomycoses. XI. Internat. Congr. Derm., Stockholm, 1957
Georg, L. K., L. Ajello and M. A. Gordon: A selective medium for the isolation of Coccidioides immitis. Science 114, 387 (1951)
Georg, L. K., L. Ajello and C. Papageorge: Use of cycloheximide in the selective isolation of fungi pathogenic to man. J. Lab. clin. Med. 44, 422 (1954)
Georgi, C. E.: Inhibitory effect of monochlormercuricarvacrol on growth of pathogenic fungi. A.M.A. Arch. Derm. 48, 497 (1943)
Gephardt, M. C., and T. H. Hanlon: Treatment of disseminated coccidioidomycosis with stilbamidine (case history). J. Oklah. St. med. Ass. 47, 55 (1954)
Geraci, J. E., T. J. Dry, J. A. Ulrich, L. A. Weed, C. S. Maccarty and C. P. Sayre: Experiences with 2-hydroxystilbamidine in systemic sporotrichosis. Arch, intern. Med. 96, 478 (1955)
Gigli, L.: Azione in vitro di alcune sostanze coloranti verso la Candida. Arch. ital. Derm. 27, 208 (1955)
Gimble, A. I., J. G. Shea and S. Katz: Nystatin and tetracycline in the treatment of bacterial infections. Antibiot. Ann. 1955/56, 676
Girard, M., H. Fraisse et H. Simon: A propos d’entéro-colites graves consécutives aux traitements par les antibiotiques d’origine fungique. J. Méd. Lyon 1954, 833
Giunchi, G.: (1) Attinomicosi temporo-macellare da actinomicete anaerobio tipo “Wolff-Israel”, guarita con trattamento combinato sulfamidico e roentgenterapico. Policlinico, Sez. med. 53, 354 (1946)
Giunchi, G.: (2) Micosis secondarie a trattamenti antibiotici con particolare riguardo aile candidosi. G. Mal. infett. 10, 53 (1957)
Giunchi, G.: (3) Le micosi secondarie a trattamenti antibiotici con particolare riguardo aile candidosi. Recenti Progr. Med. 24, 18 (1958)
Glenn, W. R., and H. E. Halley: Fungous infections of the feet treated with a camphorphenol mixture. A.M.A. Arch. Derm. 47, 239 (1943)
Götz, H.: (1) Fortschritte der medizinischen Mykologie. Hautarzt 1, 49 (1950)
Götz, H.: (2) Über die Behandlung der Onychomykosen mit einem neuen Nagelerweicher (Kaliumthioglykolat). Hautarzt 1, 368 (1950)
Götz, H.: (3) Neuere diagnostische und klinische Erkenntnisse der Dermatomykologie. Ärztl. Wschr. 1950, 709
Götz, H.: (4) Hinweise zur Bekämpfung der Pilzkrankheiten. Volksgesundh.- Dienst 1950, 262
Götz, H.: (5) Merkblatt bei Pilzerkrankungen der Füße und Nägel
Götz, H.: (6) Über die Zunahme der Nagelpilzerkrankungen in der Gegenwart. Derm. Wschr. 124, 962 (1951)
Götz, H.: (7) Zur Behandlung der Epidermophytie. Münch, med. Wschr. 1952, 1523
Götz, H.: (8) Über ein neues Verfahren zur Behandlung der Nagelpilzkrankheit. Hautarzt 3, 552 (1952)
Götz, H.: (9) Fortschritte der medizinischen Mykologie. I. Hautarzt 4, 97 (1953)
Götz, H.: (10) Fortschritte der medizinischen Mykologie. II. Hautarzt 4, 145 (1953)
Götz, H.: (11) Untersuchungen über die pathogenetischen Faktoren und die Behandlung der Nagelpilzkrankheit. Arch. Derm. Syph. (Berl.) 195, 579 (1953)
Götz, H.: (12) Klinische und experimentelle Studien über das Granuloma Paracoccidioides (Morbus Lutz-Splendore-de Almeida). Arch. Derm. Syph. (Berl.) 198, 507 (1954)
Götz, H.: (13) Die Behandlung der Pilzkrankheiten der Haut und Haare. In: Fortschritte der praktischen Dermatologie und Venerologie, Bd. II. Herausgeg. von A. Marchionini unter Mitarb. v. C. G. Schirren.
Götz, H.: (14) Erkennung und Behandlung der Hautmykosen. Dtsch. med. Wschr. 83, 1189 (1958)
Götz, H.: (15) Griseofulvin, ein orales, die bisherige Dermatomykosetherapie revolutionierendes Antibioticum. Med. Klin. 54, 2162 (1959)
Götz, H.: (16). Diskussionsbemerkung, Symposium Griseofulvin und dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Götz, H.: (17) Experimentelle und klinische Beobachtungen bei der Behandlung der Tinea manuum, pedum, corporis et unguium mit Griseofulvin. Hautarzt 10, 539 (1959)
Götz, H., u. E. M. Hertlein: Förderung und Züchtung von Dermatophyten durch Cycloheximid-Kaliumtellurit-Selektivnährboden und Soforteinsaat des Untersuchungsmaterials. Derm. Wschr. 139, 8 (1959)
Götz, H., K.W. Kalkoff, J. Kimmig, A.M. Memmesheimer, R. Richter, H.Th. Schreus u.R. Schuppli: Welches sind heute die zweckmäßigsten Behandlungsverfahren für Pilzerkrankungen? Derm. Wschr. 126, 1092 (1952)
Gold, T. N., and B.V.Jones: The use of hexadecamethylene-1:16-bis-(isoquinoliniumchloride) in the treatment of ringworm in domestic animals. Brit. vet. J. 114, 376 (1958)
Gold, W., H. A. Stout, J. F. Pagano and R. Donovick: Amphotericin A and B: Antifungal antibiotics produced by a streptomycete. I. in vitro studies. Antibiot. Ann. 1955/56, 579
Goldberg, A. A.: Le dinaphthylméthane-disulfonate phenyl mercurique (penotrane), nouveau produit substantif résistant au lavage et protégeant les tissus contre les moisissures. Chim. et Industr. 64, 3 (1950)
Golden, M. J., and K. A. Oster: Studies on alcohol-soluble fungistatic and fungicidal compounds. II. Evaluation of a fungicidal laboratory test method. J. Amer, pharm. Ass., Sci. Ed. 36, 359 (1947)
Goldfarb, N.: Diskussionsbemerkung über Griseofulvin. A.M.A. Arch. Derm. 80, 630 (1959)
Goldman, L., A. B. Hinningsen, N. P. Ringelman, H. H. Fox and J. Hesselbrock: Evaluation of a fungicidal agent for fungous disease of the feet. A controlled hospital study. A.M.A. Arch. Derm. 47, 569 (1943)
Goldman, L., J. Schwarz, R. H. Preston, A. Beyer and J. Loutzenhiser: The factors of the resistance and relapse with griseofulvin therapy. Meet. Amer. Dermat. Ass., Atlantic City, 3. 6. 1959
Goldstein, N.: Encephalopathy occurring during the topical use of asterol. J. Pediat. 42, 726 (1953)
Gondesen, H., u. K. Schuster: Neuere Ergebnisse in der Auswertung antimykotischer Mittel. Dermat. Tagg Hamburg 24.—26. 9. 1948. Ref. Zbl. Haut- u. Geschl.-Kr. 73, 165 (1949)
González Ochoa, A.: (1) El micetoma toracopulmonar por Actinomyces bovis y Nocardia brasiliensis. Consideraciones etiopatogénicas, clínicas y terapéuticas. Gac. méd. Méx. 83, 109 (1953)
González Ochoa, A.: (2) Effectiveness of DDS in the treatment of chromoblastomycosis and of mycetoma caused by Nocardia brasiliensis. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 321–327
González Ochoa, A.: (3) Dos casos de esporotricosis curados con griseofulvin. Rev. Inst. Salubr. Enferm. trop. (Méx.) 19, 245 (1959)
González Ochoa, A., y M. Ahumada Padilla: El griseofulvin en el tratamiento de las dermatofitosis. Pren. méd. mex. 24, 189 (1959)
González Ochoa, A., y L. F. Bojalil: Actividades “in vitro” de complejos sulfacobre sobre algunos hongos patogenos. Rev. Inst. Salubr. Enferm. trop. (Méx.) 11, 79 (1950).
González Ochoa, A., L. Bojalil-Jaber y R. Soto Pacheco: Acción estimulante de las sulfonamidas-cobre y de la penicillina sobre el desarollo de Cryptococcus neoformans y Sporotrichum schencki, respectivamente. Rev. Soc. mex. hist. nat. 11, 35 (1950)
González Ochoa, A., L. Domínguez y E. Macotela: Tratamiento de la moniliasis oral con nystatin. Rev. Inst. Salubr. Enferm. trop. (Méx.) 15, 195 (1955)
González Ochoa, A., E. Hernandez y R. Colorado Iris: Experimentación con vanillato de etilo en dos casos de coccidioidomicosis y uno de micetoma actinomicósico por Nocardia brasiliensis. Rev. Inst. Salubr. Enform. trop. (Méx.) 13, 265 (1953)
González Ochoa, A., y E. Macotela: Tratamiento de micosis profundas con esteroides; inutilidad de la pregnenolona en un caso de micetoma por Nocardia brasiliensis. Rev. Inst. Salubr. Enferm. trop. (Méx.) 15, 9 (1955)
González Ochoa, A., J. Shiels y P. Vasquez: Acción de la 4,4’-diamino-difenil-sulfona frente a Nocardia brasiliensis. Estudios in vitro, en la infección experimental y en clínica. Gac. méd. Méx. 82, 345 (1952)
Goodman, L. S., and A. Gilman: The pharmacological basis of therapeutics. New York: Macmillan & Co. 1956
Gorbach, G., T. Terranova u. J. Terranova: (1) Über den Einfluß von Spurenelementen auf Wachstum und Saccharasebildung bei Aspergillus niger. I. Der Einfluß von Zink und Eisen allein und in Gegenwart der Spurenelemente Kupfer und Mangan. Arch. Mikrobiol. 26, 1 (1957)
Gorbach, G., T. Terranova u. J. Terranova: (2) Über den Einfluß von Spurenelementen auf Wachstum und Saccharasebildung bei Aspergillus niger. II. Der Einfluß von Kupfer und Mangan allein und in Gegenwart der Spurenelemente Zink und Eisen. Arch. Mikrobiol. 26, 11 (1957)
Gordon, L. E., and Ch. E. Smith: Mycostatin and aminostilbamidin treatment of experimental coccidioidomycosis. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer, pp. 249–254
Gordon, L. E., Ch. E. Smith, M. Tompkins and M. T. Saito: Sensitivity of Coccidioides immitis to 2-hydroxystilbamidine and the failure of the drug in the treatment of experimental coccidioidomycosis. J. Lab. clin. Med. 43, 942 (1954)
Gordon, L. E., Ch. E. Smith and D. S. Wedin: Nystatin (mycostatin) therapy in experimental eoccidoidomyeosis. Amer. Rev. Tuberc. 72, 64 (1955)
Gordon, M. A.: In vitro fungistatic effect of tetrachlorobenzoquinone. A.M.A. Arch. Derm. 66, 573 (1952)
Gottberg, H.: Neue Ergebnisse auf dem Gebiet der Antimykotica im Lichte der amerikanischen Literatur. Diss. Hamburg 1951
Gottlieb, D.: Filipin, an antibiotic inhibiting fungi. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 142–146
Gottlieb, D., and A. Amman: A new antifungal agent. Plant Dis. Rep. 39, 219 (1955)
Gottlieb, D., B. K. Bhattacharaya, H. E. Carter and H. W. Anderson: Endomycin, a new antibiotic. Phytopathology 41, 393 (1951)
Gottlieb, D., and H. E. Carter: U.S. Pat. 2, 746, 902 (1956). Cit. W. S. Spector, Handbook of toxikology. Vol.11: Antibiotics
Gottlieb, O.: Penicillin ved ceervico-facial actinomycose. Nord. Med. 42, 1807 (1949)
Gottron, H.: Der personale Faktor bei Hautkrankheiten. In: Individualpathologie von Adam und Curtius. Jena: Gustav Fischer 1939
Graciansky, P., de: Les atteintes cutanées et muqueuses dues aux levures au cours des traitements par les antibiotiques. Étude clinique. Sem. Hôp. Paris 1957, 2037
Graciansky, P. de, et J. Delaporte: Accidents à levures des traitements par les antibiotiques. Paris: Masson & Cie. 1956
Graciansky, P. de, et Ch. Grfpper: Un cas d’actinomycose guérie par le rimifon. Bull. Soc. franç. Derm. Syph. 60, 454 (1953)
Graciansky, P. de, R. Leclerq, J. Delaporte et P. Goijin de Roijmilly: (1) Les dermatoses à levures au cours des traitement par les antibiotiques. I. Introduction. Sem. Hfa. Paris 31, 2162 (1955)
Graciansky, P. de, R. Leclerq, J. Delaporte et P. Goijin de Roijmilly: (2) Étude clinique. Sem. Hôp. Paris 31, 2162 (1955)
Graciansky, P. de, R. Leclerq, J. Delaporte et P. Goijin de Roijmilly: (3) Etude pathologique et thérapeutique. Sem. Hôp. Paris 31, 2170 (1955)
Graham, J. H., E. T. Wright, V. D. Newcomer and Th. H. Sternberg: The use of nystatin as a topical antifungal agent. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 220–227
Grandbois, J.: The modern treatment of North American blastomycosis. Canad. med. Ass. J. 79, 828 (1958)
Grandbois, J., M. Graoux, J. Gravel et M. Beaulieu: Le 2-hydroxystilbamidine dans le traitement de la blastomycose nord-américaine. Laval méd. 24, 165 (1957)
Granits, J., u. R. G. Janke: Über die gegenScitige Beeinflussung von Chemotherapeutica und Anti- biotica. Arch. Derm. Syph. (Berl.) 197, 513 (1954)
Granits-Thurner, J.: In vitro-Untersuchungen über die Wirksamkeitsänderung antimykotischer Substanzen durch Zusatz von Netzmitteln. Mykosen 2, 121 (1959)
Granits-Thurner, J., u. H. Schirmer: Über die Wirkung von Zimtsäurederivaten auf pathogene Pilze. Mykosen 1, 60 (1957)
Grant, R.: Actinomycosis treated with aureomycin: report of case. J. oral Surg. 4, 334 (1951)
Grasset, E., E. Pongratz et W. Mesmer: Propriétés antifongiques et antimicrobiennes des esters de l’acide para-oxybenzoique et leur rôle correctif dans les complications mycosiques associées à la thérapeutique des antibiotiques. Rev. suisse Méd. 43, 728 (1954)
Gray, A.: The prevention and treatment of tinea pedis. Monthly Bull. Minist. Hlth Lab. Serv. 5, 100 (1946)
Gready, T. G.: Gynben in the treatment of vaginitis. Mississippi Doct. 33, 213 (1956)
Greco, G.: Azione in vitro délia soluzione satura di cremore di tartaro sui tessuti necrotici del favo. Boll. Soc. ital. Biol. sper. 25, 1037 (1950)
Greendyke, R. M., and N. L. Kaltreider: Chronic histoplasmosis. Report of a patient successfully treated with amphotericin B. Amer. J. Med. 26, 135 (1959)
Greenwood, K.: The treatment of tinea in Malaya. J. roy. Army med. Cps 97, 157 (1951)
Grèze, J.: Les médicaments antifongiques modernes dans le traitement des mycoses profondes. Strasbourg: Dern. Nouvl. 1956
Grimmer, H.: (1) Antibiotika und Pilzerkrankungen der Haut und Schleimhaut. Antibiot. et Chemother. (Basel) 1, 180 (1954)
Grimmer, H.: (2) Die tiefe Trichophytie der Meerschweinchen als Testobjekt für externe fungistatische Substanzen. Arch. klin. exp. Derm. 204, 288 (1957).
Grimmer, H.: (3) Diskussionsbemerkung über Griseofulvin. Tagg Hamburg. Dermat. Ges., 28. 11. 1959
Grimmer, H., u. S. Rust: Tierexperimentelle Untersuchungen über die Wirkung von Vitamin K auf die tiefe Trichophytie des Meerschweinchens. Z. Haut- u. Geschl.-Kr. 12, 106 (1952)
Grin, I. E.: Nova terapija dermatofitija vlasista oralnom upotrebom griseofulvina i mehanizam njegovog djelovanja. Neue Dermatophytie-Behandlung durch orale Zufuhr von Griseofulvin und Wirkungsmechanismus. Vojnosanit. Pregl. Brosch. Nr 10, 771 (1959)
Grin, I. E., and L. Ozegovic: Critical survey of mycological research and literature in Yougoslavia up to 1957. Mycopathologia (Den Haag) 9, 344 (1958)
Grogg, E.: Zur Therapie der Fußmykosen. Praxis 39, 315 (1950)
Grosch, W.: Zur Behandlung der Sycosis trichophytica. Z. Haut- u. Geschl.-Kr. 6, 415 (1949)
Grosjean, J.: Substanzen mit fungicider Wirkung in der Rinde von Laubbäumen. Nature (Lond.) 165, 853 (1950)
Grottenmüller, K.: Erfahrungen bei der Behandlung von Dermatomykosen. Dtsch. med. Wschr. 1954, 851
Grove, J. F.: The fungistatic activity of ethylenic and acetylenic compounds. II. Esters of halogenofumaric acids and acetylene dicarbolytic acid. Ann. appl. Biol. 35, 37 (1948)
Grove, J. F., D. Ismay, J. McMillan, T. P. C. Mulholland and M. A. Th. Rogers: (1) The structure of griseofulvin. Chem. and Ind. 1951, 219
Grove, J. F., D. Ismay, J. McMillan, T. P. C. Mulholland and M. A. Th. Rogers: (2) Griseofulvin. Part II. Oxidative degradation. J. chem. Soc. 1952, 3958
Grove, J. F., and J. C. McGowan: Identity of griseofulvin and “curling factor”. Nature (Lond.) 160, 574 (1947)
Grove, J. F., J. McMillan, T. P. C. Mulholland and M. A. Th. Rogers: (1) Griseofulvin. Part I. J. chem. Soc. 1952, 3949
Grove, J. F., J. McMillan, T. P. C. Mulholland and M. A. Th. Rogers: (2) Griseofulvin. Part IV. Structure. J. chem. Soc. 1952, 3977
Grunberg, E.: The fungistatic and fungicidal effects of the fatty acids on species of trichophyton. Yale J. Biol. Med. 19, 855 (1947)
Grunberg, E., and R. J. Schnitzer: A chemotherapeutic study of antimonials in the experimental infection of mice with Cryptococcus neoformans. Yale J. Biol. Med. 26, 132 (1953)
Grunberg, E., G. Soo- Hoo, E. Titsworth, D. Ressetar and R. J. Schnitzer: Mycological studies with a new benzothiazole with specific activity against dermatophytes. Trans. N.Y. Acad. Sci., Ser. II 13, 22 (1950)
Grunberg, E., and E. Titsworth: Experimental studies on drug resistance of dermatophytes. I. The development of drug resistance of trichophyton mentagrophytes and Microsporum lanosum to undecylenic acid and 2-dimethylamino-6-(diethylamino-ethoxy)-benzothiazole dihydrochloride (asterol). J. invest. Derm. 25, 113 (1955)
Grupper, Ch.: (1) Le traitement des dermatoses à levures et quelques dermatoses non moniliiques par la mycostatine. Sem. Hop. Paris 32, Nr 39, 5 (1956)
Grupper, Ch.: (2) Le traitement des moniliases cutanées. Sem. Hôp. Paris 33, 2048 (1957)
Grupper, Ch.: (3) La mycostatine dans le traitement des moniliases cutanéo-muqueuses. In: Thérap. dermat. allergol., pp. 361–371. Paris: Masson & Cie. 1957
Grutter, F. H.: Topical and parenteral administration of griseofulvin in experimental dermatophyte infections. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Guilbert, Y.: Un cas d’actinomycose cervico-faciale traité uniquement par la pénicilline. Rev. Méd. nav. 3, 296 (1948)
Guilhon, J., et P. Papin: Traitement des teignes animales par l’acide undécylénique. Bull. Acad. vét. Fr. 23, 275 (1950).
Haas, H.: Histamin und Antihistamine. Aulendorf: Cantor 1951
Haber, H., R. T. Brain and J. W. Hadgraft: Treatment of ringworm of the scalp. Brit. med. J. 1949 II, 626
Hadida, E., et A. Schousboe: Traitement des teignes par la griséofulvine. Algérie méd. 63, 9 (1959)
Hafner, A., u. O. Kym: Zur Therapie der Fußmykosen: Sterosan- Paste. Schweiz, med. Wschr. 77, 1369 (1947)
Hänig, E.: Zur Behandlung der Pilzerkrankungen mit Bradex bzw. Bradex-Vioform. Z. Haut- u. Geschl.-Kr. 16, 148 (1954)
Haensch, R., u. A. Szakall: Fette u. Scifen 53, 337 (1951). Zit. K. W. Kalkoff u. D. Janke in Gottron-Schönfeld
Hagborg, W. A. F.: The effect of antibiotics on infection of wheat by xanthomonas translucens. Canad. J. Microbiol. 2, 80 (1956)
Haggard, H. W., M. J. Stratjss and L. A. Greenberg: Fungous infections of the hands and feet treated by iontophoresis of copper. J. Amer. med. Ass. 112, 1229 (1939)
Halbeisen, Th.: Untersuchungen über die antimykotische Wirkung eines Stoffwechselproduktes von Penicillium notatum H 1929. Z. Haut- u. Geschl.-Kr. 26, 88 (1959)
Halde, C., V. D. Newcomer, E.T.Wright and Th. H. Sternberg: An evaluation of amphotericin in vitro and in vivo against Coccidioides immitis and Candida albicans, and preliminary observations concerning the administration of amphotericin B to man. J. invest. Derm. 28, 217 (1957)
Halde, C., and D. Newstrand: The sensitivity of pathogenic actinomycetes to various sulfonamide and sulfone compounds. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 147–153
Halde, C., E. T. Wright, W. H. Pollard II, V. D. New-comer and Th. H. Sternberg: The effect of amphotericin B upon the yeast flora of the gastrointestinal tract of man. Antibiot. Ann. 1956/57, 123
Hall, B. D., and R. E. Mardis: Treatment of cryptococcosis with terramycin. U.S. armed Forces med. J. 4, 1061 (1953)
Hamilton, A. J. C.: Actinomycosis successfully treated with penicillin. Report of two cases. Brit. med. J. 1945 I, 728
Hanf, U.: Untersuchungen über die in vitro-Empfindlichkeit des Actinomyces israeli gegen Erythromycin, Magnamycin, Polymyxin B, Bacitracin, Neomycin, Tyrothricin, Xanthocillin und Suprathricin. Z. Hyg. Infekt.-Kr. 143, 127 (1956)
Hanf, U., S. Heinrich u. F. Legler: Zur Frage der Antibiotica-Resistenz des Erregers der Aktinomykose. Med. Klin. 49, 250 (1954)
Hansen, P., u. G.List: Fußpilzfeindliches Schuhwerk aus Gummi. Berufsgenossenschaft 11, 4 (1956)
Hansen, P., u. H.Rieth: Pilzprobleme in der werksärztlichen Praxis. Berufsdermatosen 5, 244 (1957)
Harada, S., T. Konsiki, S. Kishi u. M. Honda: Drei Fälle von Sporotrichose. Jap. J. Derm. 69, Abstr. 80 (1959)
Harder, F. K.: The antimycotic effect of diethylstilbestrol. N.C. med. J. 7, 20 (1956)
Harmsen, H.: Bakteriologisch-mykologische Prüfung des Desinfektionsmittels Lysolin. Gutachten vom 5. 7. 1951
Harned, R. L.: Antibiot. and Chemother. 1, 594 (1951). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Harold, E., and J. Pierce: A clinical evaluation of dichloroxychinaldine in dermatology. J. nat. med. Ass. (N.Y.) 1953, 207
Harrell, E. R.: Griseofulvin in treatment of M. audouini caused tinea capitis. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Harrell, E. R., F. C. Bocobo and A.C.Curtis: (1) Sporotrichosis successfully treated with stilbamidine. Arch, intern. Med. 93, 162 (1954)
Harrell, E. R., F. C. Bocobo and A.C.Curtis: (2) A study of North American blastomycosis and its treatment with stilbamidine and 2-hydroxystilbamidine. Ann. intern. Med. 43, 1076 (1955)
Harrell, E. R., and A. C. Curtis: The treatment of North American blastomycosis with amphotericin B. A.M.A. Arch. Derm. 76, 561 (1957)
Harris, L. J., H. G. Pritzker, J. W. Steiner and L. Shack: The effect of nystatin (mycostatin) on neonatal candidiasis (thrash). A method of eradication trush from hospital nurseries. Canad. med. Ass. J. 79, 891 (1958)
Hartley, F.: Parachlorophenol-a-glycerol ether as an antibacterial and antifungal agent of pharmaceutical interest. Quart. J. Pharm. 20, 388 (1947)
Harvey, J. C., J. R. Cantrell and A. M. Fisher: Actinomycosis: its recognition and treatment. Ann. intern. Med. 46, 868 (1957)
Haskins, R. H., and J. A. Thorn: Canad. J. Bot. 29, 585 (1951). Zit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Haspel, R., J. Baker and M. B. Moore jr.: Disseminated Cryptococcus neoformans; case report. New Orleans med. surg. J. 101, 573 (1949)
Hata, J., M. Tstjrtjoka, I. Utsumi and A.T.Ida: Chemotherapeutics for dermatomycosis. I. Antifungal effect of 2,6-substituted benzothiazole derivatives. J. pharmaceut. Soc. Jap. 74, 245 (1954)
Hatch, R. D.: Spergon—fungicide for summer eczema in dogs. J. Amer. vet. med. Ass. 16, 818 (1945)
Hattori, Z.: Effect of antibiotics on Candida albicans and remedies for moniliasis. Rep. Takamine Lab. 5, 98 (1953). Ref. Rev. Med. vet. Mycol. 2, 343 (1956)
Havyatt, M.: The treatment of Microsporum canis infection of the scalp with dibromopropamidine isethionate. Aust. J. Derm. 1, 239 (1952)
Haxthausen, H.: Treatment of superficial trichophytosis with C02 snow. An attempt at artificial immunisation (“imitated kerion”). Acta derm.- venereol. (Stockh.) 30, 405 (1950)
Hayes, F. A.: Treatment of ringworm in chinchillas. J. Amer. vet. med. Ass. 128, 193 (1956)
Hazen, E. L., and R. Brown: (1) Two antifungal agents produced by a soil actinomycete. Science 112, 423 (1950)
Hazen, E. L., and R. Brown: (2) Fungicidin, an antibiotic produced by a soil actinomycete. Proc. Soc. exp. Biol. (N.Y.) 76, 93 (1951)
Hazen, E. L., R. Brown and G. N. Little: Moniliasis in experimental animals: prophylaxis and therapy with nystatin (mycostatin). In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 199–204
Hazen, E. L., R. Brown and A. Mason: Protective action of fungicidin (nystatin) in mice against virulence enhancing activity of Oxytetracycline on Candida albicans. Antibiot. and Chemother. 3, 1125 (1953)
Heilman, F. R.: (1) Experimental production of rapidly blastomycosis in mice for testing chemotherapeutic agents. J. invest. Derm. 9, 87 (1947)
Heilman, F. R.: (2) Effect of stilbamidine on blastomycosis in mice. Proc. Mayo Clin. 27, 455 (1952)
Heim, F., F. Leuschner u. G. Wunderlich: Über das intermediäre Verhalten des p-Oxybenzoesäureesters. Klin. Wschr. 35, 823 (1957)
Heinemann, B. D.: Fungistatic properties of salicil and related compounds. J. invest. Derm. 9, 277 (1947)
Heite, H.-J.: Diskussionsbemerkung über Griseofulvin, Tagg Hamburg. Dermat. Ges., 28. 11. 1959
Heite, H.-J., u. D. Janke: (1) Griseofulvin. Dtsch. med. Wschr. 1959, 2202
Heite, H.-J., u. D. Janke: (2) Griseofulvin. Verigg Südwestdtsch. u. Rhein.-westf. Dermat. 17.—18. 10. 1959, Dortmund
Heite, H.-J., u. D. Janke: (3) Unveröffentlichte Ergebnisse. Zit. K.-W. Kalkoff u. D. Janke in Gottron-Schönfeld
Hendrickson, G. G., and E. P. Lehman: Cervicofacial actinomycosis successfully treated by penicillin without surgical drainage. J. Amer, med. Ass. 128, 438 (1945)
Henriksen, E., S. M. Martin, J. W. Wilson and A. Yeaman: Vaginitis due to Candida (moniliasis) treated with a benzothiazole derivative. Amer. J. Obstet. Gynec. 68, 830 (1954)
Herrick, J. A.: (1) Antifungal properties of clavacin. Proc. Soc. exp. Biol. Med. (N. Y.) 59, 41 (1943). Ref. Rev. Med. vet. Mycol. 1, 108 (1946)
Heite, H.-J., u. D. Janke: (2) Effects of gliotoxin on Trichophyton gypseum. Ohio J. Sci. 45$145 (1945). Ref. Rev. Med. vet. Mycol. 1, 108 (1946)
Heunisch, A.: Die Behandlung von Hautpilzerkrankungen. Riedel-Archiv 41, 37 (1957)
Hewitt, J., J. J. Meyer de Schmid, P. Desvignes et J. Sclafer: Dermite du ciment associée à une allergie à “Candida albicans” et à “Trichophyton”. Traitement par extraits de “Candida albicans” et de “Trichophyton”. Reprise du travail. Traitement final par griséofulvine. Bull. Soc. franç. Derm. Syph. 66, 458 (1959)
Heymer, T.: Untersuchungen über den Einfluß des Griseofulvins auf die Mitose bei Vicia faba L. Dtsch. med. Wschr. 85, 438 (1960)
Hickey, R. J., C. J. Corum, P. H. Hidy, I. R. Cohen, U. F. B. Nager and E. Krepp: Antibiot. and Chemother. 2, 472 (1952)
Hickey, R. J., and P. H. Hidy: Crystalline fradicin. Science 113, 261 (1951)
Higuchi, K., H. Urabe, Stoshitani and S. Nakano: On the effect of nystatin for the cutaneous candidiasis and trichophytia. J. Antibiot. 11, 4 (1958)
Hillegas, A. B., and E. Camp: The testing of fungicides insoluble in water. J. invest. Derm. 6, 217 (1945)
Hincky, M. B.: L’acide undécylénique dans le traitement des épidermomycoses. Thérapie 5, 12 (1950)
Hinds, E. C., and E. J. Degnan: The use of achromycin and neomycin in the treatment of actinomycosis. Oral Surg. 8, 1034 (1955)
Hitch, J. M.: Neurotoxic symptoms following use of asterol dihydrochloride. Report of 3 cases. J. Amer. med. Ass. 150, 1004 (1952)
Hobby, G., P. Régna, N. Dougherty and W. E. Stieg: The antifungal activity of antibiotic XG. J. clin. Invest. 28, 927 (1949)
Högler, F.: Über die Kupfersulfatbehandlung von Hand- und Fußmykosen. Münch, med. Wschr. 99, 1860 (1957)
Hoffmann, E.: Weiteres zur Natriumthiosulfatbehandlung von Pilzflechten der Haut. Ärztl. Wschr. 1948, 278
Hoffmann, H.: Therapeutische Überlegungen zur Behandlung des bakteriellen Fluor genitalis. Fortschr. Med. 75, 224 (1957)
Hoffmann, R., R. Schweitzer and G. Dalby: Fungistatic properties of the fatty acids and possible biochemical significance. Food Res. 4, 539 (1939)
Hok, K. A., A. Y. Hamilton, K. S. Pilcher and R. Nieman: Antifungal activity of a new group of salicvlamide derivatives for dermatophytes. I. In vitro activity of N-butyl-3-phenyl salicylamide. Antibiot. and Chemother. 6, 456 (1956)
Holleman, A. F., u. F.Richter: Organische Chemie, 27. u. 28. Aufl. Berlin: W. de Gruyter & Co. 1951
Hollenbeck, W. F., and D. Turnoff: Actinomycosis treated with sulfadiazine. J. Amer, med. Ass. 123, 1115 (1943)
Holm, K.: (1) Treatment of dermatophytosis pedis with ethyl p-hydroxy benzoate ascertained by systematic examination for fungi. Acta derm.- venereol. (Stockh.) 25, 60 (1944)
Holm, K.: (2) Behandlung af fodsvamp med aetylparaoxybenzoat belyst ved systematiske svampeundersogelser. Nord. Med. 21, 9 (1944)
Holm, P.: Some investigations into the penicillin sensitivity of humanpathogenic actinomycetes and some comments on pencillin treatment of actinomycosis. Acta path, microbiol. scand. 25, 376 (1948)
Holtermaxn, H.: Erfahrungen mit Cuprizinin bei der Behandlung der Epidermo- phytien. Z. Haut- u. Geschl.-Kr. 16, 174 (1954)
Holtorf, E.: Untersuchungen über die keimtötende Wirkung des Dodecyl-triphenyl-phosphoniumbromids (Myxal). Diss. Würzburg 1951
Holz, H., u. H. Lohel: Die Sulfonamidbehandlung von Dermatomykosen unter besonderer Berücksichtigung der Trichophytia profunda. Z. Haut- u. Geschl.-Kr. 4, 44 (1948).
Hoops, E.-H.: (1) Klinische Beobachtungen einer modernen Chemotherapie mykotischer Hauterkrankungen. Med. Welt., N.S. 1954, 1109
Hoops, E.-H.: (2) Antimycin, ein Antibiotikum von vorwiegend fungistatischer Wirkung. Fortschr. Med. 75, 15 (1957)
Hoops, E.-H.: (3) Ein Beitrag zur modernen Therapie mykotischer Krankheiten. Z. Haut- u. Geschl.-Kr. 25, 252 (1958)
Hopf, G.: Zur Frage der internen Behandlung von Dermatomykosen mit Griseofulvin und Trichomycin. Tagg Hamburg. Dermat. Ges., 28. 11. 1959
Hopff, W.: Über Methoden zur Prüfung antimikrobieller Substanzen in vivo. Diss. Hamburg 1956
Hopkins, J. G., J. K. Fisher, A. B. Hillegas, R. B. Ledin, G. C. Rebell and E. Camp: Fungistatic agents for treatment of dermatophytosis. J. invest. Derm. 7, 239 (1946)
Hopkins, J. G., C. S. Lingamfelter, M. R. Kiesselbach and O. A. Hamilton: Treatment of tinea capitis with salicylanilide preparations. A.M.A. Arch. Derm. 67, 479 (1953)
Hopkins, J. G., J. T. Weld and B.M.Kesten: The treatment of Monilia (Candida albicans) infections with carbo- wax-sulphur-ointment. J. invest. Derm. 18, 419 (1952)
Hopkins, T., A. Hillegas, C. Camo, B. Ledin and G. Rebell: Treatment and prevention of dermatophytosis and related conditions. Bull. U.S. Army med. Dept. 77, 42 (1944)
Horácek, J., and M. Polster: Fungicide effect of phenol derivates. Dermatológica (Basel) 96, 342 (1948)
Hornung, H.: Münch, med. Wschr. 1939, 1231. Zit. F. Staib u. S. Ata
Horton-Smith, C., and P. L. Long: The effect of penotrane on the growth in vitro of Candida albicans and Aspergillus fumigatus. J. comp. Path. 62, 266 (1952)
Hosemann, G.: Aktinomykose und Penicillin. Langenbecks Arch. klin. Chir. 264, 198 (1950)
Hosoya, S., N. Komatsu and M. Soeda: (1) An antifungal agent isolated from mycelium of Streptomyces griseocarneus. Jap. J. exp. Med. 22, 23 (1952)
Hosoya, S., N. Komatsu and M. Soeda: (2) J. Antibiot. 5, 451 (1952). Zit. S. A. Waksman u. H. A. Lechevalier, Actinomycetes and their antibiotics
Hosoya, S., N. Komatsu, M. Soeda and Y. Sonoda: Trichomycin, a new antibiotic produced by Streptomyces hachijoensis, with trichomonadicidal and antifungal activity. Jap. J. exp. Med. 22, 505 (1952)
Hosoya, S., N. Komatsu, M. Soeda, T. Yamaguchi and Y. Sonoda: Trichomycin, a new antibiotic with trichomonadicidal and antifungal activities. J. Antibiot. 5, 564 (1952)
Hosoya, S., M. Soeda, S. Imamura, K. Okada, S. Nakazawa, N. Komatsu, T. Kobori and M. Ikenaga: Antimycotic activities of trichomycin with special reference to the experimental and clinical studies of trichomycin ointment. G. ital. Chemioter. 7, 217 (1954)
Hosoya, S., M. Soeda, N. Komatsu, S. Imamura, K. Okada, S. Nakazawa and T. Yamaguchi: Trichomycin, ein neues Antibiotikum aus Streptomyces hachijoensis mit trichomonadicider und antibiotischer Wirksamkeit. Ärztl. Forsch. 9, 46 (1955)
Hosoya, S., M. Soeda, N. Komatsu, K. Okada, S. Watanabe and Y. Onoda: Studies on trichomycin. II. Antibiotic activities against Trichomonas, Candida and Treponema pallidum. J. Antibiot. 6, 92 (1953)
Hosoya, S., M. Soeda, N. Komatsu, S. Watanabe, K. Okada and Y. Onoda: Studies on antibiotic activities of trichomycin in vitro and in vivo. J. Antibiot. 6, 49 (1953)
Ho-soya, S., M. Soeda, K. Okada, S. Watanabe and N. Komatsu: Studies on trichomycin. III. Excretion of trichomycin in the urine by oral or parenteral administration. J. Antibiot. 6, 98 (1953)
Hotchkiss, R. D.: Gramicidin, tyrocidine and tyrothricin. Advanc. Enzymol. 4, 153 (1944)
Hu, F.:,The effect of nystatin on experimental candidiasis in tissue culture. J. invest. Derm. 27, 25 (1956)
Huang, N. N., and R. H. High: Treatment of oral moniliasis in infants and children with nystatin. Monogr. Ther. 2, 60 (1957)
Huang, N. N., A. Sarria and R. H. High: Therapeutic evaluation of nystatin and amphotericin in oral moniliasis in infants and children. Antibiot. Ann. 1957/58, 59
Hubbard, R., and C. Rimington: Biochem. J. 46, 220 (1950). Cit. W. S. Spector, Handbook of toxicology. Vol.11: Antibiotics
Hull, Th. G.: Diseases transmitted from animals to man, 4. Aufl. Springfield, Ill.: Ch. C. Thomas 1955
Hunter, R. C., and E. S. Mongan: Disseminated coccidioidomycosis treated with amphotericin B. U.S. armed. Forces med. J. 9, 1474 (1958)
Huppert, M.: The antifungal activity of homologous series of parabens. Preliminary studies. Antibiot. and Chemother. 7, 29 (1957).
Iacapraro, G.: Antibióticos de amplio espectro y nistatina en urología. Rev. Assoc. méd. argent. 71, 64 (1957)
Igarasi, S., K. Ogata and A. Miyake: J. Antibiot. 9, 101 (1956). Zit. J. Úri, Menschenpathogene Pilze in der Antibioticum-Forschung. Arzneimittel-Forsch. 8, 687 (1958)
Igarasi, S., and S. Wada: J. Antibiot. Ser. B 7, 221 (1954). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Ikeda, Y., T. Hirai and T. Nishimaki: J. Antibiot. 3, 724 (1950). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Imamura, T.: Treatment of disseminated candidiasis (moniliasis) with oral administered trichomycin. Rinshö Hifu-Hinyökika 10, 801 (1956). Ref. Rev. Med. vet. Mycol. 3, 180 (1959)
Imholz, G.: Über die klinische Brauchbarkeit des Riseptin zur Händedesinfektion. Med. Klin. 52, 224 (1957)
Inouye, Y., Y. Iizika and T. Tazima: (1) Studies on leather fungi. II. Selection of the test strains and the antifungal action of phenolic compounds. Bull. Jap. Ass. Leath. Tech. 3, 167 (1958)
Inouye, Y., Y. Iizika and T. Tazima: (2) Studies in leather fungi. III. The antifungal activities of organic mercury compounds. Bull. Jap. Ass. Leath. Tech. 4, 163 (1958)
Iranzo-Prieto, V.: El tratamiento de las tiñas del cuero cabelludo en el medio rural. Medicamenta (Madr.) 27, 315 (1957). Ref. Rev. Med. vet. Mycol. 3, 103 (1958)
Ishigami, J.: Treatment of genitourinary candidiasis (moniliasis) with orally administered trichomycin in massive doses. Rinshö Hifu-Hinyökika 10, 565 (1956). Ref. Rev. Med. vet. Mycol. 3, 180 (1959)
Ito, K., and K. Kirita: Experimental studies on biological behaviors of pathogenic fungi against various remedies. II. On the growth of pathogenic fungi in the presence of vitamin K3-Ca. Bull, pharm. Res. Inst. Osaka H. 5, 28 (1953)
Ito, K., and P. K. Kuroda: Effects of photosensitizing dyes against pathogenic fungi. II. Effects of the photosensitizing dye, platonin, on the growth of fungi. Bull, pharm. Res. Inst. Osaka H. 3, 20 (1953)
Ito, K., and T. Kuroda: Biological behavior of pathogenic fungi against various remedies. I. Growth of pathogenic fungi in the presence of vitamin K3. Bull, pharm. Res. Inst. Osaka H. 3, 46 (1952)
Ito, K., S. Maeda and K. Kirita: Experimental studies on the effects of vegetable hormones against pathogenic fungi. II. Effect of 2,4-dichlorphenoxacetat and its allied remedies on the growth of some patho¬genic fungi. Bull, pharm. Res. Inst. Osaka H. 6, 28 (1954)
Ito, K., and N. Ota: Effects of crude drugs against pathogenic fungi. III. Effect of tannin-containing crude drugs on the growth of some fungi. Bull, pharm. Res. Inst. Osaka H. 3, 13 (1952)
Ito, K., H. Rieth, P. Hansen u. G. List: Trageversuche mit pilzfeindlichen Gummischuhen. Bull, pharm. Res. Inst. Osaka H. 18, 19 (1959)
Ito, K., and S. Sugano: Effects of photosensitizing cyanin lumin upon the growth of fungi. Bull, pharm. Res. Inst. Osaka H. 2, 36 (1951)
Ito, K., and M. Tsijyoshi: Experimental studies on effects of photosensitizing dyes against pathogenic fungi. IV. On the influence of NK No. 8 upon the growth of pathogenic fungi. Bull, pharm. Res. Inst. Osaka H. 5, 18 (1953)
Ito, T., and S. Miyamura: Supplement findings on the anti-fungal action of nystatin. J. Antibiot. 11, 52 (1958)
Ivady, Gy., u. E. Friedrich: Untersuchungen über die antimykotische Wirkung der Bor-, Wein- und Zitronensäure. Münch, med. Wschr. 101, 975 (1959).
Jadassohn, W., H. E. Fierz u. E. Pfanner: Ein neues Mittel zur Behandlung von Pyodermien. Schweiz, med. Wschr. 74, 168 (1944)
James, A. P. R.: Iodochlorohydroxy- quinoline (vioform) hydrocortisone cream and lotion in superficial fungus infections. Antibiot. Med. 5, 266 (1958)
James, T.: Interdigital ringworm treated with solution of sulphurated lime. Lancet 1945 II, 401
Janke, D.: (1) Experimentelle Untersuchungen über die antimykotische Wirkung verschiedener Antibiotica. Klin. Wschr. 30, 15 (1952)
Janke, D.: (2) Experimentelle Untersuchungen zur Stimulation von Pilzen durch Penicillin. Arch. klin. exp. Derm. 204, 124 (1957)
Janke, D.: (3) Zum Wirkungsmechanismus der penicillinbedingten Stimulation des Wachstums von Pilzen. Arch. klin. exp. Derm. 208, 470 (1959)
Janke, D., u. K. W. Kalkoff: Zur Kenntnis der Hautaktinomykose unter Berücksichtigung der Abhängigkeit cutaner Strahlenpilzhaftung von der terminalen Strombahn. Arch. Derm. Syph. (Berl.) 198, 81 (1951)
Janke, D., u. H. Newig: Trichophyton verrucosum als Erreger von Trichophytien bei Mensch und Tier in Oberhessen. Mykosen 2, 75 (1959)
Janke, R. G.: Studien über die Antibiotika-Wirkung bei Sproßpilzen. Zbl. Bakt., I. Abt. Orig. 160, 628 (1954)
Jansen, E. F., and D. J. Hirschman: Arch. Biochem. 4, 297 (1944). Cit. W. S. Spector, Handbook of toxicology. Vol.11: Antibiotics
Jefferys, E.G., P.W.Brian, H. G. Hemming and D. Love: Antibiotic production by the microfungi of acid heath soils. J. gen. Microbiol. 9, 314 (1953)
Jennison, R. F., and P. Stenton: Sensitivity of Candida strains to nystatin. J. clin. Path. 10, 219 (1957)
Jensen, J.: An epidemic of microsporia. Acta derm.-venereol. (Stockh.) 39, 178 (1959)
Jentsch, M.: Zur Behandlung der Aktinomykose. Ther. d. Gegenw. 1949, 114
Jerchel, D.: (1) Über InvertScifen. XI. Mitt. Ber. dtsch. ehem. Ges. 76, 600 (1943)
Jerchel, D.: (2) InvertScifen und Tetrazoliumsalze. Naturforsch, in Dtschld. 89, 59 (1946)
Jerchel, D.: (3) Über Benzimidazolderivate. Vortr. 27. 9. 1951 Köln
Jerchel, D., u. H. Fischer: Über Amidrazone. Justus Liebigs Ann. Chem. 574, 85 (1951)
Jerchel, u. J. Kimmig: InvertScifen als Antimycotica. Zusammenhänge zwischen Konstitution und Wirkung. Chem. Ber. 83, 277 (1950)
Jirovec, O., R. Peter, J. Jira u. M. Petrü: Über einige Probleme der vaginalen Mikrobiologie und der geschlechtlichen Trichomoniasis. J. Hyg. Epid. Microbiol. 1959, 195
Johne, H. O.: Über die Anwendung der Antibiotika mit begrenztem Wirkungsbereich bei der örtlichen Behandlung von Hautkrankheiten. 2.Mitt. Die Lokalbehandlung mit einer Kombination von Tyrothricin und Xanthocillin (TyrocidX). Z. Haut- u. Geschl.-Kr. 20, 318 (1956)
Johnson, B. A., H. S. Anker and F. L. Meleney: Science 102, 376 (1945). Zit. W. S. Spector, Handbook of toxicology. Vol. II.: Antibiotics
Johnson, C. W., J. W. Joyner and R. P. Perry: The inhibitory effect of four thiosemicarbazones on Cryptococcus neoformans. Antibiot. and Chemother. 2, 636 (1952)
Johnson, A.: Abstr. of papers of the 1949 Meet. Soc. Amer. Bact. pp. 68–69. Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Johnson, E. A., and K. L. Burdon: Eumycin—a new antibiotic active against pathogenic fungi and higher bacteria, moulding bacilli of tuberculosis and diphtheria. J. Bact. 51, 591 (1946)
Johnson, S. A. M.: Candida (Monilia) albicans: Effect of amino acids, glucose, pn, Chlortetracycline (Aureomycin), dibasic sodium and calcium phosphates, and anaerobic and aerobic conditions on its growth. A. M. A. Arch. Derm. 70, 49 (1954)
Jones, T. E., and T. S. Brownell: Treatment of actinomycosis with penicillin. Cleveland Clin. Quart. 12, 32 (1945). Ref. Rev. Med. vet. Mycol. 1, 81 (1946)
Jonez, H. D.: Coccidioidomycosis treatment with histamine. Ann. Allergy 7, 395 (1949)
Joyce, T. M.: Thymol therapy in actinomycosis. Ann. Surg. 108, 910 (1938)
Jules, L. H., J. A. Faust and M. SanYun: Derivatives of 3-, 4-, and 5-phenylsalicylamides. J. Amer. pharm. Ass., Sci. Ed. 45, 277 (1956)
Jung, H.-D.: (1) Antiparasitär-biologische Therapie der Trichophytia barbae profunda. Z. H. ut- u. Geschl.-Kr. 6, 515 (1949)
Jung, H.-D.: (2) Zur Mecklenburger Mikrosporie-Epidemie. Derm. Wschr. 127, 337 (1953)
Jung, H.-D.: (3) Zur fungistatischen Wirksamkeit einiger Diphenyldisulfid-Abkömmlinge (Ovitrol). Z. ärztl. Fortbild. 48, 191 (1954)
Jung, H.-D.: (4) Zur Diagnose und Therapie des Favus. Hautarzt 9, 12 (1955)
Jung, H.-D., u. H. Schröder: Zur antimykotischen Wirksamkeit pflanzlicher Extrakte. Arch. Derm. Syph. (Berl.) 197, 130 (1954).
Kaden, R.: (1) Experimentelle und klinische Erfahrungen mit Chlorisept. Z. Haut- u. Geschl.-Kr. 12, 368 (1952)
Kaden, R.: (2) Antimykotische Effekte durch Dibromsalicylkombinationen. Therapiewoche 1953, H. 23/24, 1
Kaden, R.: (3) Experimentelle Untersuchungen über die antimykotische Wirkung von Fettalkoholsulfonaten. Z. Haut- u. Geschl.-Kr. 14, 383 (1953)
Kaden, R.: (4) Vergleichende Versuche über die Resistenzsteigerung von Epidermophyton Kaufmann- Wolf. Z. Haut- u. Geschl.-Kr. 15, 1 (1953)
Kaden, R.: (5) Antimykotischer Lack in Experiment und Klinik. Z. Haut- u. Geschl.-Kr. 17, 209 (1955)
Kaden, R.: (6) Neue Untersuchungsergebnisse in der Pilzbiologie. Mykosen 1, 3 (1957)
Kircher, K. H.: Moderne Mykosetherapie mit dem fungiciden Kunststoffverband Nobecutan. Z. Haut- u. Geschl.-Kr. 21, 190 (1956)
Kaffka, A., u. H. Rieth: Laboratoriumstiere als Ursache einer Berufsdermatose und Maßnahmen zur Verhütung weiterer Pilzinfektionen. Zbl. Bakt., I. Abt. Orig. 170, 319 (1958)
Kaiser, B.: Die Behandlung der Epidermophytie und Trichophytia superficialis mit Chlorisept. Riedel-Archiv 34, 40 (1950)
Kalkoff, K.-W., u. D. Janke: Mykosen der Haut. In H. A. Gottron u. W. Schönfeld, Dermatologie und Venerologie einschließlich Berufskrankheiten, dermatologischer Kosmetik und Andrologie, Bd. II, Teil 2, S. 991–1153. Stuttgart: Georg Thieme 1958
Kaplan, W., and L. Ajello: Oral treatment of spontaneous ringworm in cats with griseofulvin. J. Amer. vet. Med. Ass. 135, 253 (1959)
Kaplan, M. A., B. Heinemann, I. Mydlinski, J. L. Buckwalter and I. R. Hooper: An antifungal antibiotic (AYF) produced by a strain of Streptomyces aureofaciens. Antibiot. and Chemother. 8, 491 (1958)
Karasaki, T.: (1) Studies on the blood concentration of trichomycin. I. T. rbidimetric micro-determination of trichomycin. Antibiot. and Chemother. 7, 209 (1957)
Karasaki, T.: (2) Studies on the blood concentration of trichomycin. II. Applikation of the turbidimetric method to blood samples. Antibiot. and Chemother. 7, 218 (1957)
Karasaki, T., and N. Watanabe: (1) Studies on the blood concentration of trichomycin. III. Blood concentrations of trichomycin following intravenous, intraperitoneal, and intramuscular injections. Antibiot. and Chemother. 7, 227 (1957)
Karasaki, T., and N. Watanabe: (2) Studies on the blood concentration of trichomycin. IV. Individual difference in trichomycin blood concentrations in rabbits receiving intravenous administration. Antibiot. and Chemother. 8, 130 (1958)
Karasaki, T., N. Watanabe and S. Kumada: Studies on the blood concentration of trichomycin. V. Blood concentration following oral administration of trichomycin. Antibiot. and Chemother. 8, 180 (1958)
Kashkin, P. N.: Review of works on medical mycology published in U.S.S.R. between 1946–1956. Mycopathologia (Den Haag) 10, 227 (1959)
Kaufmann, H. P.: Arzneimittelsynthese. Berlin: Springer 1953
Kavanagh, F.: Proc. nat. Acad. Sci. (Wash.) 36, 1 (1950). Zit. W. S. Spector
Kavanagh, F., A. Hervey and W. J. Robbins: (1) Proc. nat. Acad. Sci. (Wash.) 85, 343 (1949). Zit. W. S. Spector
Kavanagh, F., A. Hervey and W. J. Robbins: (2) Proc. nat. Acad. Sci. (Wash.) 36, 102 (1950). Zit. W. S. Spector
Keddie, F., G. F. Hexter and A. S. Brown: Treatment of cutaneous fungus infections with a phenylsalieylamide derivative. A.M.A. Arch. Derm. 74, 504 (1956)
Keeney, E. L.: (1) The fungistatic and fungicidal effect of sodium propionate on common pathogens. Bull. Johns Hopk. Hosp. 73, 379 (1943).
Keeney, E. L.: (2) New preparations for the treatment of fungous infections: in vitro and in vivo experiments with fatty acid salts, penicillin and sodium sulphathiazole. J. clin. Invest. 23, 929 (1944).
Keeney, E. L.: (3) New drugs for the treatment of fungous infections. Bull. Johns Hopk. Hosp. 74, 266 (1944)
Keeney, E. L.: (4) Sodium caprylate, a new and effective treatment for moniliasis of the skin and mucous membranes. Bull. Johns Hopk. Hosp. 78, 333 (1946)
Keeney, E. L.: (5) Practical medical mycology. Oxford: Blackwell Scientific Publ. 1955
Keeney, E. L., L. Ajello, E.N. Broyles and E. Lankford: Propionate and undecylenate ointments in the treatment of tinea pedis and an in vitro comparison of their fungistatic and antibacterial effects with other ointments. Bull. Johns Hopk. Hosp. 75, 417 (1944)
Keeney, E. L., L. Ajello and E. Lankford: Studies on common pathogenic fungi and on Actinomyces bovis. I. In vitro effect of fatty acids. II. In vitro effect of penicillin. Bull. Johns Hopk. Hosp. 75, 377 (1944)
Keeney, E. L., L. Ajello, E. Lankford and M. Lois: Sodium caprylate. A new and effective treatment for dermatomycosis of the feet. Bull. Johns Hopk. Hosp. 77, 422 (1945)
Keeney, E. L., and E.N. Broyles: Sodium propionate in the treatment of superficial fungous infections. Bull. Johns Hopk. Hosp. 73, 479 (1943)
Keeney, E. L., E. J. Santora and G. German: The fungistatic and fungicidal effect of sodium propionate on common pathogens. Bull. Johns Hopk. Hosp. 73, 379 (1943)
Keining, E.: Therapeutische Umfrage: Behandlung der Fußmykosen. Derm. Wschr. 100, 570 (1935)
Keller, Ph.: Die Behandlung der Haut- und Geschlechtskrankheiten in der Sprechstunde, 3. Aufl. Berlin- Göttingen-Heidelberg: Springer 1952
Kesten, B. M., R. Benham and M. Silva: Treatment of onychomycosis due to Trichophyton rubrum. A.M.A. Arch. Derm. 71, 52 (1955).
Kiesel: Zit. E. Drotthet, Antifongiques et thérapeutiques des mycoses. Sem. Hôp. Paris 33, 843 (1957)
Kies sling, W.: Zur Epidemiologie der Mikrosporie im Heidelberger Bezirk und eine neuzeitliche Behandlung der Mikrosporie. Derm. Wschr. 125, 145 (1952)
Kiessling, W., J. Schönfeld und E. Bender: Über eine von Katzen übertragene Mikrosporieepidemie durch Mikrosporon canis in Kaiserslautern. Arch. klin. exp. Derm. 207, 71 (1958)
Kikuchi, K.: J. Antibiot. 8, 145 (1955). Cit. W. S. Spector, Handbook of toxicology. Vol. II: Antibiotics
Kile, R. L., E. Rockwell and J. Schwarz: Topical use of polymyxin-bacitracin ointment in dermatology. A.M.A. Arch. Derm. 68, 290 (1953).
Kimmig, J.: (1) Beziehungen zwischen chemischer Konstitution und chemotherapeutischer Wirkung. Arch. Derm. Syph. (Berl.) 186, 156 (1947)
Kimmig, J.: (2) Die Behandlung der Dermatophytien mit neuen pilzabtötenden Verbindungen. Arch. Derm. Syph. (Berl.) 189, 265 (1949).
Kimmig, J.: (3) Die Behandlung der Dermatomykosen mit neuen pilzabtötenden Verbindungen. Z. Haut- u. Geschl.-Kr. 6, 213 (1949)
Kimmig, J.: (4) Die Anwendung von polyoxäthylierten quartären Ammoniumbasen vom Typus der “InvertScifen” in der Dermatologie. Arch. Derm. Syph. (Berl.) 187, 547 (1949)
Kimmig, J.: (5) Antibiotica in der Behandlung von Haut- und Geschlechtskrankheiten. Arch. Derm. Syph. (Berl.) 191, 213 (1950)
Kimmig, J.: (6) Experimentelle Untersuchungen über neue Antihistaminverbindungen und deren Wirksamkeit bei allergischen Hauterkrankungen. Arch. Derm. Syph. (Berl.) 191, 563 (1950)
Kimmig, J.: (7) Neuzeitliche Behandlung der Dermatomykosen unter besonderer Berücksichtigung der Mikrosporie. Dtsch. med. Wschr. 1950, 1137
Kimmig, J.: (8) Dermatomykosebehandlung mit Griseofulvin. Wiss. Sitzg ärztl. Verein, Hamburg 19. 1. 1960
Kimmig, J., u. D. Jerchel: Die Wirkung von InvertScifen auf die durch Pilze und Kokken bedingten Hautkrankheiten. Klin. Wschr. 28, 429 (1950)
Kimmig, J., u. H. Rieth: (1) Antimykotica in Experiment und Klinik. Arzneimittel-Forsch. 3, 267 (1953)
Kimmig, J., u. H. Rieth: (2) Aktuelle Chemotherapie erprobter Antimykotica. Ärztl. Praxis 5, H. 16, 1 (1953)
Kingman, H. E., and J. S. Palen: Streptomycin in the treatment of actinomycosis. J. Amer. vet. med. Ass. 118, 886 (1951)
King West, M., and W. F. Verwey: Effect of stilbamidine therapy on experimental Blastomyces dermatitidis infections in mice. J. invest. Derm. 22, 363 (1954)
Kipphan, T.: Experimentelle Prüfung der fungiciden Wirkung neuer Verbindungen im Kulturversuch. Diss. Heidelberg 1949
Kirk, H.: Organomercury compounds in veterinary medicine. Vet. Rec. 58, 299 (1946)
Kirk, J. M.: Griseofulvin in childhood tinea capitis. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Kirk, J. M., and L. Ajello: Use of griseofulvin in the therapy of tinea capitis in children. A.M.A. Arch. Derm. 80, 259 (1959)
Kitamijra, S., and I.Mori: Nystatin treatment on cutaneous moniliasis. J. Antibiot. 11, 4 (1958)
Kitamura, T.: Fundamental experimentation of media containing furan derivatives for the isolation of dermatophyte. Jap. J. Derm. 65, 325 (1955)
Klapper, M. S., D. T. Smith and N. F. Conant: Disseminated coccidioidomycosis apparently cured with amphotericin B. J. Amer. med. Ass. 167, 463 (1957)
Klein, E.: Erfahrungen mit einer neuen Antimykoticum-Tinktur. Zbl. Arbeitsmed. 6, 61 (1956)
Kleine-Natrop, H. E.: (1) Die therapeutische Wirkung von Kupfersalzen bei der experimentellen Meerschweinchentrichophytie. Arch. Derm. Syph. (Berl.) 187, 114 (1948)
Kleine-Natrop, H. E.: (2) Beiträge zur Epidemiologie und Klinik der Mikrosporie. I. Verbreitung der Mikrosporie in Deutschland. Weiterer Verlauf der schleswigholsteinischen Epidemie. Klinisches Bild und therapeutische Entwicklungslinien. Derm. Wschr. 182, 1190 (1955)
Kleine-Natrop, H. E.: (3) Aktuelle Richtlinien für die Behandlung gehäufter Mikrosporie-Erkrankungen bei Kindern. Z. Haut- u. Geschl.-Kr. 25, 48 (1958)
Kligman, A. M., G. D. Baldridge, G. Rebell and D. M. Pillsbury: The effect of cortisone on the pathogenic responses of guinea pigs injected intravenously with fungi, viruses and bacteria. J. Lab. clin. Med. 57, 615 (1951)
Kligman, A. M., and F. S. Lewis: In vitro and in vivo activity of candicidin on pathogenic fungi. Proc. Soc. exp. Biol. (N.Y.) 82, 399 (1953).
Kligman, A. M., and W. Rosenzweig: (1) A simple quantitative method for the laboratory assay of fungicides. J. invest. Derm. 10, 51 (1948)
Kligman, A. M., and W. Rosenzweig: (2) Studies with new fungistatic agents. I. For the treatment of superficial mycoses. J. invest. Derm. 10, 59 (1948)
Kligman, A. M., and F. D. Weidman: Experimental studies on treatment of human torulosis. A.M.A. Arch. Derm. 60, 726 (1949)
Klövekorn, G. H.: Ein Beitrag zur Dermatomykose-Behandlung. Dtsch. med. J. 7, 80 (1956)
Knight, S. G.: (1) The mechanism of triglyceride therapy in dermatomycoses. J. invest. Derm. 28, 363 (1957)
Knight, S. G.: (2) The in vitro antifungal activity of triacetin. Antibiot. and Chemother. 7, 172 (1957)
Knöfel, R.: Erfahrungen über die Behandlung verschiedener Dermatomykosen mit dem Antimykoticum Ovitrol. Z. ärztl. Fortbild. 49, 892 (1955)
Kobori, T., M. Ikenaga, S. Hosoya, M. Soeda, S. Imamtjra, K. Okada, S. Nakazawa and N. Komatsu: Über die antimykotische Wirkung von Trichomycin. Die experimentellen und klinischen Untersuchungen der Trichomycinsalbe. Jap. J. Derm. 64, 51 (1954)
Koch, H.: (1) Experimentelle Untersuchungen über den Einfluß neuerer Sulfonamide auf hautpathogene und andere Pilze. Arch. klin. exp. Derm. 205, 1 (1957)
Koch, H.: (2) Klinische und experimentelle Erfahrungen mit Griseofulvin. Tagg Hamburg. Dermat. Ges., 28. 11. 1959
Koch, H., H.Rieth u. E.Rüther: Beitrag zur Diagnose, Klinik und Therapie der genitalen Candidamykosen. Hautarzt 10, 393 (1959)
Köhler, B.: Kemoterapi vid aktinomykos. Nord. Med. 42, 1603 (1949)
Königsbauer, H.: (1) Experimenteller Beitrag zum Mechanismus der Thalliumepilation bei der weißen Maus. Arch. Derm. Syph. (Berl.) 190, 1 (1950)
Königsbauer, H.: (2) Über die Wirkung von ACTH und Corton auf die experimentelle Histoplasmose der Ratte. Zbl. Bakt., I. Abt. Orig. 159, 473 (1953)
Königsbauer, H.: (3) Über die Wirkung von D 25 (2,2’-Dioxy-5,5’-dichlordiphenylsulfid) auf die experimentelle Haplosporangiose der Ratte. Arch. Derm. Syph. (Berl.) 197, 521 (1954)
Königsbauer, H.: (4) Über die Wirkung von Corton auf die experimentelle Torulose und Chromoblastomykose. Arch. Derm. Syph. H. b. d. Haut- u. Geschlechtskrankheiten, Erg.-Werk V/1 co (Berl.) 160, 637 (1954)
Königsbauer, H.: (5) Experimenteller Beitrag zur Behandlung der Torulose mit D 25 (2,2’-Dioxy-5,5’-dichlordiphenylsulfid). Zbl. Bakt., I. Abt. Orig. 164, 466 (1955)
Königsbauer, H.: (6) Experimenteller Beitrag zur Bedeutung des Cerumens für die Pathogenese der Otomykose. Mykosen 1, 96 (1958)
Komatsu, E.: Biochemistry of geodin. I.Isolation of the antibiotic geodin from the newly isolated Penicillium sp. F 29. Nippon Nogei Kagaku Kaishi 31, 349 (1957). Ref. Rev. Med. vet. Mycol. 3, 136 (1959)
Korger, G., u. G. Nesemann: Halogen-hydroxy-benzoesäure-Derivate als Antimykotica. Arzneimittel-Forsch. 10, 104 (1960)
Kornfeld, E. C., and R. G. Jones: The structure of actidione, an antibiotic from Streptomyces griseus. Science 108, 437 (1948)
Kornfeld, F.: (1) Neuzeitliche Desinfektionsverfahren im Dienste der Krankheitsprophylaxe im Bergbau. “Kompaß” Bergbau- Berufsgen. 62, H. 11 (1952)
Kornfeld, F.: (2) Verbesserung der Desinfektionstechnik. Maschinenmarkt 61, Nr 60 (1955)
Körting, G. W., and D. K. Miowski: On the fungistatic features of histamine on pathogenic fungi. Acta med. iugosl. 5, 123 (1951)
Kozinn, P. J., and C. L. Taschdjian: Oral thrush treated with lyophilized nystatin. Antibiot. Ann. 1957/58, 75
Kozinn, P. J., C. L. Taschdjian, D. Dragtjtsky and A. Minsky: (1) Therapy of oral thrush: a comparative evaluation of gentian violet, mycostatin, and amphotericin B. Monogr. Ther. 2, 16 (1957)
Kozinn, P. J., C. L. Taschdjian, D. Dragtjtsky and A. Minsky: (2) Treatment of cutaneous candidiasis in infancy and childhood with nystatin and amphotericin B. Antibiot. Ann. 1956/57, 128
Kraemer, H.: Zur abdominalen Aktinomykose und ihrer Behandlung. Münch, med. Wschr. 101, 2009 (1959)
Krämer, H., u. H. Geisenhöfer: Über den Candida-Fluor und Scine Behandlung mit Moronal. Med. Klin. 54, 1432 (1959)
Krantz, W.: Tiefe Trichophytie und Sulfonamide. Z. Haut- u. Geschl.-Kr. 6, 33 (1949)
Krassilnikoff, N. A.: (1) La classification des acti- nomycetes producteurs d’antibiotiques. A. n. Inst. Pasteur 92, 597 (1957)
Krassilnikoff, N. A.: (2) On species significance of antibiotic compounds in actinomycetes. Mikrobiol. (Moskau) 28, 179 (1959)
Kratz, Ch.: Über Hautwirkungen von Teerpräparaten mit besonderer Berücksichtigung des Präparates “Cellichnol”. Z. Haut- u. Geschl.-Kr. 22, 291 (1957)
Kraushaar, A.: Chemotherapeutische Wirksamkeit von halogenierten Salicylaniliden in Abhängigkeit von der Konstitution. Arzneimittel-Forsch. 4, 548 (1954).
Kuhn, B. H.: (1) Finaf, a new cutaneous fungicide. A.M.A. Arch. Derm. 74, 627 (1956)
Kuhn, B. H.: (2) Stilbamidine-resistant North American blastomycosis. A.M.A. Arch. Derm. 73, 556 (1956)
Kulesza, J. S.: Report from the laboratory. The Squibb Institute for Medical Research 25. 4. 1957 u. 21. 5. 1957
Kull, F. C., G. A. Castellano and R. L. Mayer: The in vitro antimicrobial activities of certain aminosteroids. J. invest. Derm. 21, 227 (1953)
Ktjrogochi, Y., T. Kitamura, M. Minami and Y. Ueda: Chemotherapy of dermatomycosis. II. In vitro test of some antifungal agents on trichophyton. J. Nara med. Ass. 6, 101 (1955)
Kurung, J. M.: Science 102, 11 (1945). Zit. W. S. Spector
Kushner, D. S., I. Snapper, M. Senderi and S. McMillen: Aminostilbamidin—a fungistatic agent. In vitro sensitivity studies, tissue fluorescence-distribution, and therapeutic trials in coccidioidomycosis. J. invest. Derm. 28, 69 (1957)
Kutscher, A. H., L. Seguin, S.Lewis, J.D.Piro and E. Y. Zegarelli: (1) Growth inhibiting properties of phenoxy-ethyl-dimethyl-dodecyl-ammonium bromide (PDDB) (bradosol) against Candida albicans in vitro. Antibiot. and Chemother. 4, 1045 (1954)
Kutscher, A. H., L. Seguin, S.Lewis, J.D.Piro and E. Y. Zegarelli: (2) Fungicidal properties of phenoxy-ethyl-dimethyl-dodecyl-ammonium bromide (PDDB) against Candida albicans in vitro. Antibiot. and Chemother. 6, 400 (1956)
Kwoczek, J., u. W. v. Moers-Messmer: Über die Wirkung der Sulfonamide auf pathogene Hautpilze. Derm. Wschr. 120, 97 (1949).
Lacaz, C. da S.: Manual de micologia medica. Sao Paulo: Liteci 1953
Lacaz, C. da S., and S. A. P. Sampaio: Treatment of South American blastomycosis with amphotericin B. Rev. paul. Med. 52, 443 (1958)
Lacaz, C. da S., M. S. Silva e M. Fernandes: Asao da tirotricina “in vitro” sobre o Paracoccidioides brasiliensis. Ensaio terapeutico na blastomicose sulamericana. Rev. bras. Med. 3, 356 (1946)
Lacaz, C. da S., e C. M. Ulson: Abäo “in vitro” da trichomicina (cabimicina) sobre leveduras. Rev. lat.-amer. Microbiol. 1, 215 (1958)
Lack, A.: Prodigiosin. I. Antibiotic action on Coccidioides immitis in vitro. Proc. Soc. exp. Biol. (N.Y.) 72, 656 (1949)
Lagace, A.: Toxic and therapeutic evaluation of stilbamidine and hydroxystilbamidine in canine blastomycosis. Diss. Abstr. 18, 1065 (1958)
Lahey, W. J., and J. E. Byrnes: The copper ionization treatment of fungous infections. U.S. nav. med. Bull. 46, 554 (1946)
Lamb, J. H.: Combined therapy in histoplasmosis and coccidioidomycosis; methyltestosterone and meth-dimer-sulfonamides. A.M.A. Arch. Derm. 70, 695 (1954)
Lamb, J. H., F. Kelly, P. O. Shackelford, G. Rebell and R. C. Koons: Pregnenolone acetate in treatment of mycetoma (nocardiosis). A.M.A. Arch. Derm. 67, 141 (1953)
Lammers, Th.: Zur Netzfähigkeit und Eindringtiefe von Desinfektionsmitteln. Desinfektion u. Gesundh.-Wes. 11, 170 (1954)
Lampen, J. O., E. R. Morgan and A. Slocum: Effect of nystatin on the utilization of substrates by yeast and other fungi. J. Bact. 74, 297 (1957)
Landes, E.: Heutiger Stand der Therapie der Hautkrankheiten. Berlin-Göttingen-Heidelberg: Springer 1956
Landis, L., D.Kley and N. Ercoli: Antifungal activity of a series of thiocyanates. J. Amer. pharm. Ass., Sci. Ed. 40, 321 (1951)
Landis, L., and S. Krop: Influence of histamine upon fungistatic action of antihistamines. Proc. Soc. exp. Biol. (N.Y.) 76, 538 (1951).
Landy, M., S. B. Rosenman and G. H. Warren: An antibiotic from Bacillus subtilis active against pathogenic fungi. J. Bact. 54, 24 (1947)
Landy, M., G.H.Warren, S. B. Rosenman and L. G. Colio: Bacillomycin: an antibiotic from Bacillus subtilis active against pathogenic fungi. Proc. Soc. exp. Biol. (N.Y.) 67, 539 (1948)
Lane, S. L., A. H. Kutscher and R. Chaves: Oxytetracycline in the treatment of orocervicofacial actinomycosis. Report of seven cases. J. Amer, med. Ass. 151, 986 (1953)
Lange-Brock, Th.: Untersuchungen zur Frage der Wachstums-stimulierung von Candida albicans durch Antibiotica. Diss. Hamburg 1957
Langer, E., u. W. Anders: Zur Epidemiologie und Therapie der Berliner Mikrosporie-Epidemie. Z. Haut- u. Geschl.-Kr. 5, 16 (1948)
Langer, E., u. R. Kaden: Lackförmige fungistatische Wirkstoffe. Münch, med. Wschr. 96, 674 (1954)
Langeron, M., et R. Vanbretjseghem: Précis de mycologie, 2. édit. Paris: Masson & Cie. 1952
Lapa, C.: Tratamento de quatrocentos casos de tinha pelo acetato de tálio. Gaz. méd. port. 3, 808 (1950)
Larocca, J. P., J. M. Leonard and W. E. Weaver: The resolution and fungistatic action of 1,4-Cyclohexan- diol bis (bromacetate). Science 118, 278 (1953)
Larsh, H. W., A. Hinton and S. L. Silberg: The use of the tissue culture method in evaluation antifungal agents against systemic fungi. Antibiot. Ann. 1957/58, 988
Larsh, H. W., S. L. Silberg and A. Hinton: Use of the tissue culture method in evaluation antifungal agents. Antibiot. Ann. 1956/57, 918
Larsonnetjr, B.: Zweijährige Erfahrungen in der Wundbehandlung mit Sterosan-Puder. Landarzt 32, 584 (1956)
Latapi, F.: (1) Griseofulvina, un nuevo antimicótico por via oral. Sem. méd. Méx. 64, 113 (1959)
Latapi, F.: (2) Symposium griseofulvin and dermatomycosis, 26. u. 27.10.1959 Miami/Florida
Latapi, F., P. Lavalle, J. Novales y Y. Ortiz: Griseofulvina en micosis cutáneas profundas. Nota preliminar sobre resultados terapéuticos en un caso de micetoma porN. brasiliensis y en uno de esporotricosis por S. schenckii. Dermatología (Méx.) 3, 34 (1959)
Lauder, I. M., and J. G. O’Sullivan: Ringworm in cattle. Prevention and treatment with griseofulvin. Vet. Rec. 70, 949 (1958)
Lawonn, H.: Kasuistischer Beitrag zur Penicillinbehandlung der Thoraxaktinomykose. Z. ges. inn. Med. 8, 120 (1953)
Lawson, R. N.: Therapy of tinea. Milit. Surg. 94, 301 (1944)
Leach, B. E., J. H. Ford and A. J. Whiffen: Actidione, an antibiotic from Streptomyces griseus. J. Amer. ehem. Soc. 64, 474 (1947)
Leao, A. T., and F. W. Eichbaum: Fungistatic and fungicidal action of hexylresorcinol. Rev. bras. Biol. 8, 281 (1948)
Leben, C., and G. W. Keitt: Phytopathology 38, 16 (1948). Zit. W. S. Spector
Leben, C., G. J. Stessel and G.W.Keitt: Mycologia (N.Y.) 44, 159 (1952). Zit. W. S. Spector
Lechevalier, H.A.: Les antibiotiques antifongiques produits par les actinomycètes, la candicidine. Presse méd. 61, 1327 (1953).
Lechevalier, H. A., R.F. Acker, C. T. Corke, C. M. Haenseler and S. A. Waksman: Candicidin, a new antifungal antibiotic. Mycologia (N.Y.) 45, 155 (1953)
Ledig, R.: Die Behandlung von Mykosen mit einem neuartigen Kombinationspräparat. Z. Haut- u. Geschl.-Kr. 25, 190 (1958)
Lehan, P. H., and M. L. Fttrcolow: Epidemie histoplasmosis. J. chron. Dis. 5, 489 (1957)
Lehan, P. H., M. L. Ftjrcolow, C. E. Brasher and H. W. Larch: Therapeutic trials with the newer antifungal agents. Antibiot. Ann. 1956/57, 467
Leifer, W., and K. Steiner: (1) Diodoquin as a topical therapeutic agent in cutaneous diseases. J. invest. Derm. 12, 203 (1949)
Leifer, W., and K. Steiner: (2) Das Dijodohydroxychinolin in der dermatologischen Therapie. A.M.A. Arch. Derm. 62, 46 (1950). Ref. Derm. Wschr. 124, 726 (1951)
Leinbrock, A.: (1) Neue Behandlungsversuche bei Mikrosporie. Ach. Derm. Syph. (Berl.) 191, 498 (1950)
Leinbrock, A.: (2) Die Kopfpilzerkrankungen und ihre Behandlung. Strahlentherapie 98, 155 (1955)
Leinbrock, A., H. Schuster u. J. Zinzitjs: Die Behandlung der Mikrosporie mit einem dem Conteben nahestehenden Chemotherapeuticum (V 741). Hautarzt 2, 222 (1951)
Leminieux, R. TL, J. A. Thorn, C. Bride and R. H. Haskins: Cañad. J. Chem. 29, 409 (1951). Zit. W. S. Spector
Lesser, M. A.: Newer fungicidal products. Drug and Cosmet. Industr. 69, 468 (1951)
Levin, O. L., and T. H. Behrman: The diagnosis and treatment of epidemic ringworm of the scalp. J. Mt Sinai Hosp. 10, 455 (1943)
Levine, S., and M. Novak: The effect of fatty acids on the oxygen uptake of Blastomyces dermatitidis. J. Bact. 57, 93 (1949)
Levy, E. S., and D. B. Cohen: Systemic moniliasis and aspergillosis complicating corticotropic therapy. A.M.A. Arch, intern. Med. 95, 118 (1955)
Lewis, G. M., and M. E. Hopper: (1) Effect of sulfonamide and its derivates on fungi. Preliminary in vitro experiments. A.M.A. Arch. Derm. 44, 1101 (1941)
Lewis, G. M., and M. E. Hopper: (2) Antifungal agents derived from bacteria (further experience with fungistatin). Proc. IV. Internat. Congr. Trop. Med. Mai. Washington 1948, Abstr. 1274.
Lewis, G. M., M. E. Hopper and S. Schultz: In vitro fungistasis by a bacterium (Bacillus subtilis var. XG and XY). A.M.A. Arch. Derm. 54, 300 (1946)
Lewis, G. M., M. E. Hopper, J. W. Wilson and O. A. Plttnkett: An introduction to medical mycology, 4. edit. Chicago: The Year Book Publ. 1958
Lewis, J. H., and W. J. Morginson: Treatment of trichophytosis with ethyl chloride. A.M.A. Arch. Derm. 50, 243 (1944)
Lichstein, H. C., and V. F. van de Sand: (1) J. infect. Dis. 76, 47 (1945). Zit. W. S. Spector
Lichstein, H. C., and V. F. van de Sand: (2) J. Bact. 52, 145 (1946). Zit. W. S. Spector
Line, F. G.: A caseofcryptococcus (Torula) meningitis treated with ethyl vanillate. J. Tenn. med. Ass. 47, 292 (1954)
Linke, A., u. K. Mechelke: Über die Behandlung der Aktinomykose mit Sulfanilamides Ärztl. Wschr. 1948, 299
Lipnik, M. J., A. M. Kligman and R. Strauss: Antibiotics and fungous infections. J. invest. Derm. 18, 247 (1952)
Littman, M. L.: (1) Antimycotic effect of chlorchinaldol. Trans. N.Y. Acad. Sci. 18, 161 (1955)
Littman, M. L.: (2) The systemic macosis. Amer. J. Med. 27, 1 (1959)
Littman, M. L., M. A. Pisano and R. M. Lancaster: Unduced resistance of candida species to nystatin and amphotericin B. Antibiot. Ann. 1957/58, 981
Littman, M. L., and L.E. Zimmerman: Cryptococcosis. New York and London: Grune & Stratton 1956
Livingood, C. S.: The effect of prolonged administration of griseofulvin on the liver, hematopoietic system and kidney. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Locher, A.: Über die Wirkung des Jods bei Sporotrichose. Das Verhalten von Sporotrichon- kulturen gegen freies Jod. Z. Immun.-Forsch. 64, 441 (1929)
Lodder, J., and N. J. W. Kregervan Rij: The yeasts. A taxonomic study. Amsterdam: North Holland Publ. Comp. 1952
Loefer, J. B., and R. G. Weichlein: Growth response of certain fungi to polymyxin and neomycin. Tex. St. J. Sci. 4, 541 (1952)
Loewenthal, K.: The action of culture filtrates of Aspergillus clavatus on dermatophytes. In vitro experiments. J. invest. Derm. 9, 41 (1947)
Loewenthal, K., and J. Tolmach: Action of clavacin on some dermatophytes. Final report. J. invest. Derm. 8, 357 (1957)
Loewke, Ch.: Experimentelle Untersuchungen antimykotischer Lacke. Z. Haut- u. Geschl.-Kr. 25, 29 (1958)
Lomholt, S.: Med. Klin. 34, 118 (1938)
Lones, G. W., and C. L. Peacock: Alterations in Candida albicans during growth in the presence of amphotericin B. Antibiot. and Chemother. 9, 535 (1959)
Long, L. M., and H. D. Troutman: Chloromycetin. Synthesis of a-dichloroacetamido-ß-hydroxy-p-nitro-propiophenone. J. Amer. chem. Soc. 73, 481 (1951)
Louria, D. B., N. Feder and C. W. Emmons: Amphotericin B in experimental histoplasmosis and cryptococcosis. Antibiot. Ann. 1956/57, 870
Lubowe, J. J.: Chlorchinaldol- hydrocortisone in dermatologie therapy. Antibiot. Med. 2, 6 (1957)
Lubowe, J. J., H. H. Perlman, J. Uscavage and M. G. Mulinos: Evaluation of ascosin in the treatment of tinea capitis. Antibiot. Ann. 1956/57,135
Ludwig, F., u. O. Allemann: Bakteriologische Unter¬suchungen über den Einfluß der Kombination von Antibiotica und Sulfonamiden auf den vaginalen Fluor. Gynaecologia (Basel) 136, Fase. 5 (1953)
Lübben, B.: Über eine neue Behandlungsmöglichkeit der Folliculitis barbae. Med. Mitt. (Schering) 17, 108 (1956)
Luna, D. F.: Regresión del granuloma paracoccidioidico bajo la acción de la sulfamerazina. VI. Internat. Kongr. Trop. Mal. 5.—13. 9. 1958 Lissabon
Lurie, H. I., and E. Brookfield: Aspergillus sp. causing otomycosis: fungicidal action of various therapeutic substances. S. Afr. med. J. 23, 158 (1949)
Luteraan, P. J.: De l’action empêchante de diverses substances sur la croissance de champignons pathogènes pour l’homme. C.R. Soc. Biol. (Paris) 140, 832 (1946)
Lutz, A., et M.-A. Witz: (1) Recherches sur la fréquence des champignons levuriformes et la thérapeutique des mycoses à candida. II. Antifongiques et thérapeutique des mycoses à candida. Strasbourg méd. 8, 803 (1957)
Lutz, A., et M.-A. Witz: (2) L’action comparée in vitro de la nystatine et de la trichomycine sur des champignons levuriformes du genre candida provenant de vulvo-vaginites. Ann. Inst. Pasteur 92, 272 (1957)
Luyendijk, W., A. J. Welman en R. H. Cormane: Candidiasis met intracraniele lokalisatie (neurologische, myco- logische en therapeutische aspecten). Ned. T. Geneesk. 103, 2320 (1959)
Lyck: (1) Über die Behandlung des mykotisch superinfizierten Ekzems. Med. Mitt. (Schering) 17, 11 (1956)
Lyck: (2) Beitrag zur Behandlung von Dermatomykosen bei Ekzematikern. Z. Haut- u. Geschl.-Kr. 20, 117 (1956)
Lyons, C., C. R. Owen and W. B. Ayers: Sulfonamide therapy in actinomycotic infections. Surgery 14, 99 (1943)
Lyons, R. E., and C. S. Livingood: Laboratory test for evaluation of fungicidal solutions. A.M.A. Arch. Derm. 68, 566 (1953)
Lyons, R. E., C. W. Weller, J. W. McNamara and J. L. Derzavis: The treatment of Trichophyton purpureum infections. U.S. armed Forces med. J. 4, 1175 (1953).
Ma, R., and T. D. Fontaine: In vitro antibiotic activity of crystalline tomatine toward candida albicans. Antagonistic effect of rutin and quercetin. Arch. Biochem. 16, 399 (1948)
Machado Filho J., e J. Lisbóa Miranda: Sobre a açao da sulfametoxipiridazina na blastomicose sulamericana. Rev. bras. Med. 16, 168 (1959)
MacKinnon, J. E.: Revisión crítica de la investigación y de la literatura micologica en el Uruguay en el periodo 1946–1956. Mycopathologia (Den Haag) 9, 224 (1958)
MacKinnon, J. E., R. C. Artagaveytia-Allende y N. García-Zorrón: (1) Diamidinodifenilamina y coccidioidomicosis experimental. An. Fac. Med. Montevideo 42, 196 (1957)
MacKinnon, J. E., R. C. Artagaveytia-Allende y N. García-Zorrón: (2) The inhibitory effect of chemotherapeutic agents on the growth of the causal organisms of exogenous mycetomas and nocardiosis. Trans, roy. Soc. trop. Med. Hyg. 52, 78 (1958)
MacKinnon, J. E., A. Sanjines y R. C. Artagaveytia-Allende: Quimioterapia de la blastomicosis sudamericana. An. Fac. Med. Montevideo 42, 131 (1957)
Madsen, E.: Undersogelser af nogle praeparater til behand- ling af fodsvamp. Dansk. T. Farm. 25, 329 (1951)
Maeda, K., Y. Okami, O. Taya and H. Umezawa: Antifungal substances, phaeofadin and moldin, produced by streptomyces. Jap. J. med. Sci. 5, 327 (1952)
Magara, M., E. Yokouti, T. Senda and E.Amino: The action of a new antibiotic, trichomycin, upon trichomonas vaginalis, Candida albicans, and anaerobic bacteria. Antibiot. and Chemother. 4, 433 (1954)
Magnin, P. H., y N. A. Vivot: Tratamiento de las micosis superficiales con tricomicin. Rev. Asoc. méd. argent. 71, 25 (1957)
Mahn, G.: Über Carbolbehandlung von Mykosen. Z. Haut- u. Geschl.-Kr. 19, 373 (1955)
Mallinckrodt-Haupt, A. St. v.: Zur Biologie der pathogenen Hautpilze. Der Antagonismus der Pilze untereinander. Z. Haut- u. Geschl.-Kr. 15, 74 (1953)
Mallinckrodt-Haupt, A. St. v., u. M. Geldmacher-Mallinckrodt: Die Isolierung der Antibiotika aus pathogenen Hautpilzen. Mycopathologia (Den Haag) 7, 261 (1956)
Mandel, M., F. Hood and J. R. Cohen: On the apparent stimulation of Candida albicans by Chlortetracycline. Antibiot. and Chemother. 8, 187 (1958)
Mangiaracine, A. B., and S. D. Liebman: Fungus keratitis (Aspergillus fumigatus). Treatment with nystatin (mycostatin). Arch. Ophthal. (Chicago) 58, 695 (1957)
Manheim, S. D., and R. M. Alexander: Further observations on anorectal complications following aureomycin, terramycin and Chloromycetin therapy. N.Y. St. J. Med. 54, 231 (1954)
Mankowski, Z.T., and B.J.Littleton: Action of cortisone and ACTH on experimental fungus infections. Antibiot. and Chemother. 4, 253 (1954)
Manson-Bahr, Ph.: Tropical diseases, 14. edit. Baltimore: Williams & Wilkins Company 1954
Manten, A., and J. C. Hoogerheide: The influence of a new antifungal antibiotic, pimaricin, on the yeast flora of the gastrointestinal tract of rats and mice during tetracycline administration. Antibiot. and Chemother. 8, 381 (1958)
Manten, A., L. Klöpping and G. J. M. van der Kerk: Investigations on organic fungicides. II. A new method for evaluationing antifungal substances in the laboratory. Antonie Leeuwenhoek 16, 282 (1950)
Marchionini, A.: (1) Wasserstoffionenkonzentration des Schweißes. Klin. Wschr. 8, 924 (1929)
Marchionini, A.: (2) Säurebehandlung intertriginöser Epidermophytie. Derm. Z. 1929, 248
Marchionini, A., u. H. Götz: (1) Penicillinbehandlung der Hautkrankheiten. Berlin-Göttingen-Heidelberg: Springer 1950
Marchionini, A., u. H. Götz: (2) Über Kopfpilzerkrankungen in Anatolien mit besonderer Berücksichtigung des Favus. Arch. Derm. Syph. (Berl.) 190, 75 (1950)
Marchionini, A., u. H. Götz: (3) Fortschritte der praktischen Dermatologie und Venerologie. Berlin-Göttingen-Heidelberg: Springer 1952
Marchionini, A., u. C. G. Schirren: Fortschritte der praktischen Dermatologie und Venerologie. Berlin-Göttingen-Heidelberg: Springer 1955
Marciissen, P. V.: Effektiviteten af antimycotisk behandling av fodsvamp. Ugeskr. Laeg. 113, 633 (1951)
Margarot, J., P. Rimbaud, P. Izarn et J.-A. Rioux: Action locale fungicide de certains antihistaminiques en solution aqueuse. Bull. Soc. franç. Derm. Syph. 59, 426 (1952)
Mariat, F.: (1) The action of nystatin on the growth of sporotrichum schenckii and on its behavior in vivo. In: Therapy of fungus diseases. Edit, by Th.H. Sternberg and V. D. Newcomer, pp. 233–237
Mariat, F.: (2) Action de la nystatine, de la streptomycine et de la pénicilline sur la croissance de Sporotrichum schenckii. Ann. Inst. Pasteur 88, 261 (1955)
Mariat, F.: (3) Action in vitro de la 4,41-diaminodiphényl sulfone sur les actinomycètes aérobies pathogènes. C.R. Acad. Sci. (Paris) 244, 3095 (1957)
Mariat, F., et M. Vieij: Action fongi- statique du propionate de sodium et du lauryl sulphate de sodium, leur synergie en association. Ann. Inst. Pasteur 91, 678 (1956)
Markees, S.: Stimulieren hohe Dosen von Vitamin B12 das Wachstum von Pilzen ? Dtsch. med. Wschr. 81, 641 (1956)
Marples, M. J.: A critical survey of medical and veterinary mycology in New Zealand, from 1946–1956. Mycopatholagia (DenHaag) 9, 45 (1958).
Marquardt, F.: Die Pilzerkrankungen der Hände und Füße und ihre Behandlung. Ärztl. Praxis 1949, 2
Marselou, TL, et G. Segretain: Action des antibiotiques in vitro sur la croissance des Candida. Ann. Inst. Pasteur 87, 229 (1954)
Marsh, P. B., and M. L. Butler: Industr. engng. Chem. 38, 701 (1946). Zit. R. Pfleger, E. Schraufstätter, F. Gehringer u. J. Sciuk, Zur Chemotherapie der Pilzinfektionen
Marsh, W. C.: Treatment of tinea capitis with local medication. U.S. armed Forces med. J. (1968) 1105 (1950)
Marshak, A.: Publ. Hlth. Rep. (Wash.) 62, 3 (1947). Zit. W. S. Spector
Marshak, L. C.: Cutaneous blastomycosis treated with 4,41-stilbenedicarboxyamidine (stilbamidine). A.M.A. Arch. Derm. 68, 94 (1953)
Martin, A. R.: (1) The systemic treatment of dermatomycoses (letter to the editor). Vet. Rec. 70, 1232 (1958)
Martin, A. R.: (2) The systemic and local treatment of experimental dermatophytosis with griseofulvin. J. invest. Derm. 32, 525 (1959)
Martin, H. L.: The inhibitory effect on the growth of certain fungi by a strain of Escherichia coli intermediate. Antibiot. and Chemother. 3, 861 (1953)
Maruzzella, J., and P. A. Henry: The antimicrobial activity of perfume oils. J. Amer, pharm. Ass., Sci. Ed. 47, 471 (1958)
Matsumoto, K. K., D. S. Amatuzio, T. L. Lomasney, W. W. Ayres and T. D. Cuttle: North American blastomycosis treated with pulmonary resection and stilbamidine. Amer. J. med. Sci. 229, 172 (1955)
Mayer, H.: Pilzerkrankungen der Haut (Epi- dermomykosen). Ther. Ber. (Bayer) 28, 48 (1956)
Mayer, R. L., E. Konopka, S. Geftic and J. Lanzola: Sulfonamides and experimental histoplasmosis. In: Therapy of fungus diseases. Edit, by T.H. Sternberg and V. D. Newcomer, pp. 292–301
Mazzetti, G., G. Gargani e G. Fissi Marraccini: La biologia dei miceti del genere Candida e il problema delle micosi secondarie a terapia antibiotica. G. Mal. infett. 10, 27 (1957)
Mazzini, M. A., y J. P. Elena: Tratamiento de las tiñas tonaurantes. Rev. argent. Dermatosif. 32, 267 (1948)
McCombie, H., and H.A. Scarborough: J. chem. Soc. 1923, 3279. Zit. W. S. Spector
McCrea, A.: (1) A proposed standard method for evaluation of fungicides. J. Lab. clin. Med. 17, 72 (1931)
McCrea, A.: (2) Fungicidal testing. Comparison of methods. J. Lab. clin. Med. 25, 538 (1940)
McCttistion, C. H.: Human pharmacologic studies with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27.10.1959 Miami/Florida
McGavack, T. H., D. Weiner, A. Lo Cascio, M. Bell and L. J. Boyd: Influence of tetrachloro-para-benzoquinone on human fungous infections. A.M.A. Arch. Derm. 59, 94 (1949)
McGivney, J.: Anorectal complications of broad spectrum antibiotic therapy. Tex. St. J. Med. 51, 16 (1955)
McGowan, J. C.: A substance causing abnormal development of fungal hyphae produced by Penicillium janczewskn ZAL. II. Preliminary notes on the chemical and physical properties of “curling factor”. Brit. Mycol. Soc. Trans. 29, 188 (1946)
McGray, K.J., and E. S. McDonottgh: Antimycotic effects of an extract of catalpa. Mycologia (N. Y.) 46, 463 (1954)
McGuire, J. M., R. L. Bunch, R. C. Anderson, H. E. Boaz, E. H. Flynn, H. M. Powell and J. W. Smith: “Ilotycin”, a new antibiotic. Antibiot. and Chemother. 2, 281 (1952)
McKee, C. M., D. M. Hamre and G. Rake: Proc. Soc. exp. Biol. (N.Y.) 54, 211 (1943). Zit. W. S. Spector
McLeod, C.: J. Bact. 56, 749 (1948). Zit. W. S. Spector
McLeod, J.: Effect of griseofulvin in human spermatogenesis. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
McMillan, J.: Griseofulvin. Part IX. Isolation of the bromoanalogue from Penicillium griseofulvum and Penicillium nigricans. J. chem. Soc. 1954 II, 2585
McMillen, Sh., D. S. Kushner and I. Snapper: The in vitro sensitivity of Blastomyces dermatitidis to six diamidine derivatives. J. invest. Derm. 24, 455 (1955)
McNall, E. G.: Biochemical studies on the metabolism of griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
McVay, L. V., and D. S. Carroll: Aureomycin in the treatment of systemic North American blastomycosis. Amer. J. med. 12, 289 (1952)
McVay, L. V., F. Guthrie and D. H. Sprtjnt: Aureomycin in the treatment of actinomycosis. New Engl. J. Med. 245, 91 (1951)
McVay, L. V., and D. H. Sprunt: (1) A study of moniliasis in aureomycin therapy. Proc. Soc. exp. Biol. (N.Y.) 78, 759 (1951)
McVay, L. V., and D. H. Sprunt: (2) Treatment of actinomycosis with isoniazid. J. Amer. med. Ass. 83, 95 (1953)
McVay, L. V., and D. H. Sprunt: (3) A long term evaluation of aureomycin in the treatment of actinomycosis. Ann. intern. Med. 38, 955 (1953)
McVickar, D. L.: An evaluation of the laboratory methods for testing fungicides. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 31–34
Mellody, M., and E. Bigg: The fungicidal action of triethylene glycol. J. infect. Dis. 79, 45 (1946)
Meló, N. L., y V. F. Meló: Talioterapía. Guatemala méd. 1942, Nr5, 15. Ref. Rev. Med. vet. Mycol. 1, 61 (1945)
Melton, F. M.: The effect of various substances on the oxygen uptake of Microsporum canis grown in submerged culture. J. invest. Derm. 17, 27 (1951)
Memmesheimer, A. M.: (1) Zur Bekämpfung von Hautpilzerkrankungen mit pilzabtötenden Mitteln und Prüfung solcher Mittel. Klin. Wschr. 11, 982 (1940)
Memmesheimer, A. M.: (2) Wie können die therapeutischen Schwierigkeiten bei der Epidermophytie und Schizosaccharomykose überwunden werden? Ärztl. Wschr. 1948, 68
Memmesheimer, A. M.: (3) Zur Behandlung der Onychomykosen mit besonderer Berücksichtigung der Nagelerkrankungen. Z. Haut- u. Geschl.-Kr. 6, 213 (1949)
Memmesheimer, A. M.: (4) Zur Behandlung der Mykosen mit besonderer Berücksichtigung der Nagelerkrankungen. Arch. Derm. Syph. (Berl.) 189, 261 (1949)
Memmesheimer, A. M.: (5) Gutachten über die fungistatische und fungicide Wirkung von Kodan. 13. 12. 1951
Memmesheimer, A. M., u. H. Kijhlmann: Über die Prüfung pilzabtötender Mittel. Derm. Wschr. 127, 459 (1953)
Mendizabal, A. F., R. Inza y J. A. Salaber: El tricomicin. Nuevo antibiótico para el tratamiento de colpitis por Tricomonas y Candida albicans. Rev. Asoc. méd. argent. 71, 48 (1957)
Menzel, A. E., O. Wintersteiner and J. C. Hoogerheide: J. biol. Chem. 152, 419 (1944). Zit. W. S. Spector
Metzger, W. J., L.T.Wright and J. C. Dilorenzo: Effect of esters of parahydroxybenzoic acid on candida and yeast-like fungi. J. Amer. med. Ass. 155, 352 (1954)
Meyer, E., and Z. J. Ordal: (1) Pathogenicity of Candida species for the chick embryo. J. Bact. 52, 615 (1946)
Meyer, E., and Z. J. Ordal: (2) The action of streptothricin and other antibiotic agents on Blastomyces dermatitidis infections of the chick embryo. J. infect. Dis. 79, 199 (1946)
Meyer-Rohn, J.: (1) Zur Behandlung von Hautpilzerkrankungen. Dtsch. med. Wschr. 79, 129 (1954)
Meyer-Rohn, J.: (2) Klinik und Therapie der Aktinomykose und Nocardiose. Ther. Ber. (Bayer) 30, 135 (1958)
Meyer-Rohn, J.: (3) Sulfonamide und Antibiotica bei “Bagatellerkrankungen” der Haut. Dtsch. med. J. 10, 469 (1959)
Meyer-Rohn, J., W. Hopff u. Th. Lange-Brock: Experimentelle Untersuchungen über Wirkungsweise und therapeutische Effekte von Nystatin. Arzneimittel-Forsch. 7, 355 (1957)
Michel, P. J., et P. Laurent: Teigne microsporique guérie par la tyrothricine (selon la méthode de Gate et Coudert). Bull. Soc. fran9. Derm. Syph. 1949, 410
Michener, H. D., and N. Snell: Two antifungal substances from Bacillus subtilis cultures. Arch. Biochem. 22, 208 (1949). Ref. Zbl. Haut- u. Geschl.-Kr. 76, 158 (1951)
Mietzsch, F., u. R. Behnisch: Therapeutisch verwendbare Sulfonamid- und SulfonVerbindungen, 2. Aufl. Weinheim: Chemie GmbH 1955
Miguens, M. P.: (1) Nota previa sobre la acción antibiótica de un “pénicillium” frente a los dermatofitos. Act. dermosifiliogr. (Madr.) 42, 806 (1951)
Miguens, M. P.: (2) Un caso de microsporia de la barba. Act. dermosifiliogr. (Madr.) 46, 3 (1955)
Miguens, M. P.: (3) La micologia en España. Revisión de la bibliografía desde el año 1946 al 1956. Mycopathologia (Den Haag) 9, 23 (1958)
Mikhovskaya, N. D., M. N. Rotmistrov, A. V. Stetsenko and G. V. Kulik: Study of the antifungal properties of chloranil derivatives of salicylic acid and carvacrol. Proc. Lenin Acad, agrie. Sci. 21, 35 (1958). Ref. Rev. Med. vet. Mycol. 3, 166 (1959)
Millberger, H., u. E. Blank: Versuche zur Nachprüfung der Wirkung von Mycostatin auf die experimentelle Candida-albicans-Infektion der weißen Maus. Naturwissenschaften 41, 503 (1954)
Miller, C. R., and W. O. Elson: Dithiocarbamic acid derivatives. I. The relation of chemical structure to in vitro antibacterial and antifungal activity against human pathogens. J. Bact. 57, 47 (1949)
Miller, J. M., M. Ginsberg, H. R. Johnson and A. Bogosian: Treatment of histoplasmosis with amphotericin B (fungizone). Antibiot. Med. 5, 593 (1958)
Miller, J. M., P.H.Long and E. B. Schoenbach: Successful treatment of actinomycosis with “stilbamidine”. J. Amer. med. Ass. 150, 35 (1952)
Miller, J. M., E. B. Schoenbach, P. H. Long, J. S. Shuttleworth and G. E. Snider: Treatment of infections due to Cryptococcus neoformans with stilbamidine. Antibiotics 2, 444 (1952)
Miller, J. M., G. W. Smith and W. H. Headley: Treatment of Cryptococcus neoformans in mice with stilbamidine. Science 118, 3053 (1953)
Mintzer, I., and A. Eliassow: Topical treatment of tinea capitis. N.Y. St. J. Med. 51, 1310 (1951)
Miranda, H., y M. Troncoso: Revision de los casos de micosis estudiados en el Perú en el decenio 1946–1956. Mycopathologia (Den Haag) 9, 56–64 (1958)
Mirande, L. M., y A. Barbero: Tratamiento de una epidemia de tiña microsporica con hormonas sexuales y ácidos grasos. Arch, argent. Derm. 8, 201 (1958)
Mitchell, R. B., A.C.Arnold and H. J. Chinn: Fungistatic activity of antihistamines. J. Amer, pharm. Ass., Sci. Ed. 41, 472 (1952)
Mitchell, H. S.: Sulfapyridine in actinomycosis. Cañad, med. Ass. J. 46, 584 (1942)
Mitra, S. C., and B. N. Banerjee: Further work on evaluation of the new antimycotic drug (bradexvioform). Ind. J. Derm. 3, 65 (1957).
Miura, O.: (1) Applications of chitinase in the treatment of dermatomycosis. I. Report: The influence of Bacillus chitinovorus Benecke on the culture of dermatophyte. Jap. J. Derm. 63, 551 (1953)
Miura, O.: (2) Applications of chitinase in the treatment of dermatomycosis. II. Report: The influence of crude chitinase fluid from Bacillus chitinovorus on the culture of dermatophyte. Jap. J. Derm. 63, 553 (1953)
Miura, O.: (3) Utilization of chitinase in treatment of dermatomycosis. I. Influence of Bacilli chitinovori on the culture of dermatophytes. Tôhoku J. exp. Med. 59, 403 (1954)
Miura, O.: (4) Influence of crude chitinase fluid on the culture of fungi. Tôhoku J. exp. Med. 59, 407 (1954)
Miura, Y., u. K. Taguchi: Über die antimykotische Wirkung des Vitamin K. I. Mitt. In vitro-Untersuchungen über die statische und fungizide Fähigkeit der Vitamin K-Substanzen. Jap. J. Derm. 65, 334 (1955)
Mizuno, S., S. Yoshimoto, T. Nagamine and Ykinoue: Therapeutic effect of nystatin in vaginal and vulvar candidiasis. J. Antibiot. 11, 14 (1958)
Möller, K. O.: Pharmakologie als theoretische Grundlage einer rationellen Pharmakotherapie, 3. Aufl. Basel: Benno Schwabe & Co. 1958
Moers, H., u. K. Dropmann: Sepsis durch aerobe Strahlenpilze. Ein Beitrag zur Kenntnis der Nocardiose. Med. Welt 1960, 470
Mohr, W.: Die Mykosen. In L.Mohr u. R. Staehelin, Handbuch der inneren Medizin, 4. Aufl., Bd. I, Teil I. Berlin: Springer 1952
Molinas, S.: In vivo screening of antifungal ointments. J. invest. Derm. 25, 33 (1955)
Monash, S.: Fungicidal action of various substances on scalp hairs infected with Microsporum audouini. N.Y. St. J. Med. 52, 1672 (1952)
Moore, M.: Masking of fluorescence by tetrachlorobenzoquinone. A.M.A. Arch. Derm. 66, 621 (1952)
Moore, M., and W. Wooldridge: Antifungal properties of various extracts of Bacillus subtilis (Tracy strain) obtained in the bacitracin recovery process. J. invest. Derm. 14, 265 (1950)
Moran, A. B., and M. T. I. Cronin: The in vitro sensitivity to nitrofurans of organisms isolated from the uteri of thoroughbred mares. J. comp. Path. 67, 106 (1957)
Morginson, W. J.: The clinical use of penicillin in dermatology. Sth. med. J. (Bghm, Ala.) 3, 320 (1945)
Moríame, G.: Un an d’expérience du traitement des teignes microsporiques par applications locales de pénicilline. Arch, belges Derm. 4, 143 (1948)
Moss, E. S., and A. L. McQuown: Atlas of medical mycology. Baltimore: Williams & Wilkins Company 1953
Mosto, S. J.: Blastomicosis sudamericana. A propósito de Scis observaciones. Arch, argent. Derm. 6, 69 (1956)
Mottram, M. E., and H. A. Hill: Radiation therapy of ringworm of the scalp. Calif. Med. 70, 189 (1949)
Mülhens, H. J.: El “Sporotrichon beurmanni” y las especies de “candida” patógenas para el hombre, influidos por la quimioterapia moderna. Med. colon. 23, 212 (1954)
Mülhens, K.: (1) Die Bedeutung der chemischen Desinfizientien in der Therapie der Dermatomykosen. Z. Haut- u. Geschl.-Kr. 6, 406 (1949)
Mülhens, K.: (2) Antimykotische Therapie. Therapiewoche 2, 534 (1951/52)
Mülhens, K.: (3) Über die Bedeutung des Dibromsalizyls (DBS) in der Behandlung der Pilzinfektionen der Haut. Z. Haut- u. Geschl.-Kr. 13, 336 (1952)
Mülhens, K.: (4) Die Mykosen der Schleimhäute und inneren Organe und ihre therapeutische Beeinflussung. Med. Klin. 50, 1415 (1955)
Mijftic, M.: (1) Parenteral treatment of coccidioidomycosis by mycostatin. VI. Internat. Kongr. Trop. Mal. 5.—13.9.1958 Lissabon
Mijftic, M.: (2) Mycostatin in treatment of otomycoses. Mykosen 1, 156 (1958)
Mulholland, T. P. C.: (1) Griseofulvin. Part V. Catalytic reduction
Mulholland, T. P. C.: (2) Griseofulvin. Part VI. Chemistry of the reduction products. J. chem. Soc. 1952, 3987, 3994
Mullins, J. F., N. A. Jampolsky and M. E. Pinkerton: Oral treatment of superficial mycoses with griseofulvin. Tex. Rep. Biol. Med. 17, 411 (1959)
Murphy, J. C.: Chlorquinaldol (Sterosan) in dermatologie therapy. Rocky Mtn med. J. 52, 530 (1953)
Murphy, J. C., and S. Rothman: Artificially induced resistance of Trichophyton gypseum to pelargonio acid. J. invest. Derm. 12, 5 (1949)
Muskatblit, E.: Clinical evaluation of undecylenic acid as a fungicide. A.M.A. Arch. Derm. 56, 256 (1947)
Myers, H. B.: Thymol therapy in actinomycosis. J. Amer, med. Ass. 108, 1875 (1937)
Myhr, I. B.: Systemic blastomycosis; report of a case treated with stilbamidine. Amer. Practit. 5, 64 (1954).
Nakamtjra, S., K. Maeda, Y. Okami and H. Umezawa: J. Antibiot. 7, 57 (1954). Zit. W. S. Spector.
Nakatsuka, M., H. Aratani, K. Oshita, K. Totoki, T. Ikeda, M. Yoshida and H. Nagasaka: Pharmacological studies on nystatin. J. Antibiot. 11, 57 (1958)
Nakayama, K., F. Okamoto and Y. Harada: J. Antibiot. 9, 63 (1956). Zit. W. S. Spector
Napier, E. J., D. I. Turner and A. Rhodes: The in vitro action of griseofulvin against pathogenic fungi of plants. Ann. Botany 20, 461 (1956)
Nasemann, Th.: Orale Behandlung von Haut- und Nagelmykosen mit Griseofulvin. Ärztl. Praxis 11, 1266 (1959)
Nassi, L.: Sull’attività esplicata in vitro da un derivato dell’ammonio quaternario sopra alcuni ceppi de Candida albicans. Boll. Soc. ital. Biol. sper. 31, 363 (1955)
Nauck, E. G.: Lehrbuch der Tropenkrankheiten. Stuttgart: Georg Thieme 1956
Negroni, P.: (1) Dermatomicosis: Diagnòstico y tratamiento. Buenos Aires: A. Lopez 1942
Negroni, P.: (2) Desarollo de los estudios micológice3 en la Argentina en el ultimo decenio. Mycopathologia (Den Haag) 8, 216 (1957)
Negroni, P.: (3) Nuevos agentes en el tratamiento de las micosis. Rev. Asoc. méd. argent. 71, 298 (1957)
Neidig, C. P., and H. Burrell: The esters of parahydroxybenzoic acid as preservatives. Drug and Cosmetic Ind. 54, 408 (1944)
Nejedly, R. F., and L. A. Baker: Treatment of localized histoplasmosis with 2-hydroxystilbamidine. Arch, intern. Med. 95, 37 (1955)
Nékam, L., u. J. Angyal: (1) Über die bakteriostatische und fungistatische Wirkung des Vitamin K. Hautarzt 10, 547 (1959)
Nékam, L., u. J. Angyal: (2) Die bakterio- und mykostatische Wirkung des K-Vitamins auf Grund von Experimenten in vivo und in vitro. Orv. Hetil. 100, 249 (1959)
Nékâm, L., et P. Polgar: (1) L’action des vitamines et des hormones (particulièrement de la vitamine K) sur la croissance des bactéries et des champignons pathogéniques. Acta derm.-venereol. (Stockh.) 30, 200 (1950)
Nékâm, L., et P. Polgar: (2) L’emploi de la vitamine K dans le traitement des dermatomycoses profondes. Acta derm.-venereol. (Stockh.) 31, 344 (1951)
Nettleship, A.: Propionate-caprylate mixtures in treatment of dermatophytosis. A.M.A. Arch. Derm. 61, 669 (1950)
Nettrour, W. S.: Modem treatment of actinomycosis. Penn, med. J. 53, 1089 (1950)
Neuhaus, H.: (1) Behandlung der Dermatomykose mit Fettsäureester. Med. Klin. 47, 1288 (1952)
Neuhaus, H.: (2) Über die fungicide Wirkung der Fettsäureester. Z. H. ut- u. Geschl.-Kr. 15, 14 (1954)
Neumann, E.: Nystatin sensitivity studies with the aid of paper disks. Monogr. Ther. 2, 85 (1957)
Newcomer, V. D., E. T. Wright, A. J. Leeb, J. E. Tarbet and Th. H. Sternberg: The evaluation of nystatin on the course of coccidioidomycosis in mice. J. invest. Derm. 22, 431 (1954)
Newcomer, V. D., E. T. Wright, Th. H. Sternberg, J. H. Graham, R. H. Wier and R. O. Egeberg: Evaluation of nystatin in the treatment of coccidioidomycosis in man. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 260–267
Nichols, D. R., and W. E. Herrell: Penicillin in the treatment of actinomycosis. J. Lab. clin. Med. 33, 521 (1948)
Nickerson, W. J., and S. J. White: Therapeutic value of ammoniacal silver nitrate in fungous infections of the nails. A.M.A. Arch. Derm. 57, 935 (1948)
Niggemann, J.: Zur Kennzeichnung von Wirkstoffen des Torfes. Naturwissenschaften 42, 346 (1955)
Nikolowski, W.: Über Hauterscheinungsbilder der Soormykosen und deren Beziehungen zu den Antibiotika. Dtsch. med. Wschr. 78, 553 (1953)
Nishimura, H., T. Kimura and M. Kuroya: J. Antibiot. 6, 57 (1953). Zit. W. S. Spector
Noguchi, Y., and Y.Kato: Effect of sodium ethylmercurithiosalicylate on succinic dehydrogenase of Candida albicans and its clinical use in dermatomycoses. Yokohama med. Bull. 9, 204 (1958)
Noojin, R. O., and J. L. Callaway: (1) Action of sulfonamide compounds on Blastomyces dermatitidis in vitro. A.M.A. Arch. Derm. 47, 620 (1943)
Noojin, R. O., and J. L. Callaway: (2) Effectiveness in vitro of sulfonamide compounds on Sporotrichum schencki; report of five cases of sporotrichosis in North Carolina. A.M.A. Arch. Derm. 49, 305 (1944)
Noskov, A. I.: Treatment of trichophyton skin infection in calves by use of a power sprayer. Veterinarija (Moskau) 35, 55 (1958). Ref. Rev. Med. Vet. Mycol. 3, 139 (1959)
Novak, M., and Th. Flanders: In vitro responses of Actinomyces bovis to sulfonamides and antibiotics. J. Bact. 54, 79 (1947).
Oberman, J. W., and E.Gilbert: The toxicity of 2-hydroxystilbamidine: probable fatal toxic reaction during treatment of blastomycosis. Ann. intern. Med. 48, 1401 (1958)
Okazaki, K., and T. Kawaguchi: Chemotherapeutics for dermatomycoses. IV. Fungistatic and sporostatic activity of antihistamines. J. pharmaceut. Soc. Jap. 72, 1400 (1952).
Okazaki, K., and S. Oshima: Antibacterial activity of higher plants. XXII. Antibacterial effect of essential oils
Okazaki, K., and S. Oshima: (3) Fungistatic effect of clove oil and eugenol. J. pharmaceut. Soc. Jap. 72, 564 (1952)
Olâh, D., u. G. Màramosi: Zur Methodik der experimentellen Prüfung der Wirksamkeit antimykotischer Mittel. Dermatologica (Basel) 105, 162 (1952)
Onoda, Y., S. Hosoya, M. Soeda, N. Komatsu and S. Watanabe: The clinical application of trichomycin in gynecology. J. Antibiot. 6, 49 (1953)
Oppenheim, B.: Warszaw. Czas. Lek. 14, 614 (1937). Zit. Th. Sabalitschka, H. Marx u. U. Scholz
Ormea, F.: L’azione terapeutica della soluzione di Castellani nella tricofizia sperimentale della cavia. Riv. 1st sieroter. ital. 24, 43 (1949)
Oroshnik, W., L. C. Vining, A. D. Mebane and W. A. Taber: Polyene antibiotics. Nature (Lond.) 121, 147 (1955)
Ortega, R. Y.: Konservative Behandlung der Nagelmykosen mit Onycho-Phytex. Schweiz, med. Wschr. 88, 290 (1958)
Ortenzio, L. F.: (1) Report on fungicide and subculture media for disinfectant testing. J. Ass. agric. Chem. 36, 363 (1953). Ref. Rev. Med. vet. Mycol. 2, 83 (1953)
Ortenzio, L. F.: (2) Report on fungicide and germicidal rinse testing methods. J. Ass. agric. Chem. 37, 616 (1954). Ref. Rev. Med. vet. Mycol. 2, 368 (1956)
Ortenzio, L. F.: (3) Report on fungicide and germicidal rinse testing methods. J. Ass. agric. Chem. 38, 274 (1955). Ref. Rev. Med. vet. Mycol. 2, 368 (1956)
Ortenzio, L. F., L. S. Stuart and J. L. Friedl: The practical value of mercury salts as disinfectants and fungicides for inanimate surfaces. J. Ass. agric. Chem. 39, 476 (1956). Ref. Rev. Med. vet. Mycol. 2, 438 (1957)
Osbotjrn, R. A.: Nystatin topical therapy of moniliasis. A.M.A. Arch. Derm. 72, 371 (1955)
Oster, K. A., and M. J. Golden: (1) Studies on alcohol-soluble fungistatic and fungicidal compounds. I. Evaluation of a fungistatic laboratory test methods. J. Amer, pharm. Ass.; Sci. Ed. 36, 283 (1947)
Oster, K. A., and M. J. Golden: (2) Studies on alcohol-soluble fungistatic and fungicidal compounds. III. Evaluation of the antifungal properties of quinones and quinolines. J. Amer, pharm. Ass.; Sci. Ed. 37, 429 (1948)
Oster, K. A., and M. J. Golden: (3) Studies on alcohol-soluble fungistatic and fungicidal compounds. IV. Treatment of dermytophytosis pedis with 8-hydroxyquinoline. Exp. Med. Surg. 7, 37 (1949)
Oster, K. A., and M. J. Golden: (4) Studies on alcohol-soluble fungistatic and fungicidal compounds. VI. A critical review of fungistatic and fungicidal test methods. Amer. J. Pharm., Sci. Ed. 121, 375 (1949)
Oster, K. A., and M. J. Golden: (5) Fungistatic and fungicidal test methods. Fungistatic and fungicidal compounds. In: Antiseptics, disinfectants, fungicides, and chemical and physical sterilization, pp. 132–141 and 548–565. Connecticut: Lea and Febiger 1954
Ostfeld, A. M.: Effect of stilbamidine on cutaneous blastomycosis. Amer. J. Med. 15, 746 (1953)
Otten, H., u. W. Marget: Über mehrjährige Erfahrungen bei der Behandlung von Monilien-Erkrankungen des Säuglings mit Nystatin. Münch, med. Wschr. 100, 348 (1958)
Ottenstein, B., F. M. Thurmon u. M. J. Bessman: Bakteriostatische und fungistatische Wirkung von Kobalt. Medizinische 1955, 940
Otto, H.: Über die verschiedenen Lokalisationen der Aktinomyzesinfektion im menschlichen Körper. Z. ges. inn. Med. 9, 578 (1954)
Oxford, A. E., H. Raistrick and P. Simonart: XXIX. Studies in the biochemistry of microorganisms. LX. Griseofulvin, C17H1706C1, a metabolic product of Pénicillium griseofulvum Dierckx. Biochem. J. 33, 240 (1939)
Ozaki, M., Y. Kataoka, T. Maesawa, A. Tashima and H. Kijbo: Pharmacological actions of trichomycin. Kumamoto med. J. 7, 80 (1954).
Pätiälä, R.: (1) Allylsénévol (isosulfocyanate d’allyle), antibiotique pour les dermatophytes. Ann. Parasit, hum. comp. 21, 5 (1946)
Pätiälä, R.: (2) Influence de L-éthylsénévol (isosulfocyanate d’éthyle) sur les dermatophytes en culture et sur les trichophyties de la peau glabre. Ann. Parasit, hum. comp. 22, 100 (1947)
Pätiälä, R.: (3) Sur tinea pedis et les matières antihistamines dans le traitement des dermatophyties. Ann. Med. exp. Fenn. 27, 145 (1949)
Pagano, J. F., and H. Stander: Bioassay of nystatin (mycostatin) in body fluids. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 186–194
Paget, G. E.: Experimental toxicology of griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Paget, G. E., and A. L. Walpole: Some cytological effects of griseofulvin. Nature (Lond.) 182, 1320 (1958)
Paine, T. F.: (1) In vitro experiments with Monilia and Escherichia coli to explain moniliasis in patients receiving antibiotics. Antibiot. and Chemother. 2, 653 (1952)
Paine, T. F.: (2) The inhibitory actions of bacteria on Candida growth. Antibiot. and Chemother. 8, 273 (1958)
Paldrok, H.: The effect of temperature on the growth and development of dermatophytes. Acta derm.-venereol. (Stockh.) 35, 1 (1955)
Panshin, A. F.: Die Therapie der Onychomykosen. Vestn. Vener. Derm. 3, 50 (1950). Ref. Rev. Med. vet. Mycol. 1, 536 (1952)
Pappagianis, D., and G. Kobayashi: In vitro inhibition of Coccidioides immitis by antihistaminica. In: Therapy of fungus diseases. Edit, by Th.H. Sternberg and V. D. Newcomer, pp. 316–320
Pappenfort, R. B., and E. S. Schnall: Moniliasis in patients treated with aureomycin. Clinical and laboratory evidence that aureomycin stimulates the growth of Candida albicans. Arch, intern. Med. 88, 729 (1951)
Pardo-Castello, V.: One-year experience in the treatment of dermatomycosis with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Parfentje, I.A.: Prenatal protection of mice by yeast antibiotic (malucidin). Science 126, 928 (1957)
Pariser, H., E. D. P. Levy and A. J. Rawson: Treatment of blastomycosis with stilbamidine. Report of a case. J. Amer. med. Ass. 152, 129 (1953)
Paschoud, J. M.: (1) Verwendung von Undecylensäurephenolester in der Therapie der Fußmykosen. Praxis 43, 1061 (1954)
Paschoud, J. M.: (2) Verwendung von Undecylensäure-Phenolester in neuer Emulsionsgrundlage zur Behandlung von Dermatophytien. Praxis 45, 343 (1956)
Peabody jr., J. W. and J. H. Seabfry: Actinomycosis and nocardiosis. J. chron. Dis. 5, 374 (1957)
Pec, J.: Zur Therapie der Epidermophytien. Wien. med. Wschr. 102, 912 (1952)
Peck, J., and H. Rosenfeld: Effect of hydrogen-ion concentration of fatty acids and vitamin C on the growth of fungi. J. invest. Derm. 1, 23 (1938)
Peck, S. M.: (1) A new method for the evaluation of antifungicidal chemicals. Trans. N.Y. Acad. Sci., Ser. II 11, 112 (1949)
Peck, S. M.: (2) Evaluation of new fungicides. Chem. Prod., N. s. 13, 176 (1951). Ref. Rev. M. d. vet. Mycol. 1, 537 (1952)
Peck, S. M., and K. K. Li: Factors in amorphous penicillin G influencing growth of fungi. I. Effect of elaboration of trichophytin by Trichophyton gypseum. A.M.A. Arch. Derm. 55, 498 (1949)
Peck, S. M., H. Rosenfeld, W. Leifer and W. Bierman: Role of sweat as a fungicide with special reference to use of constituents of sweat in therapy of fungus diseases. A.M.A. Arch. Derm. 39, 126 (1939)
Peck, S. M., and W. R. Russ: Propionate-caprylate mixtures in the treatment of dermatomycoses, with a review of fatty acid therapy in general A. M.A.Arch. Derm. 56, 601 (1947)
Peck, S., and L. Schwartz: A practical plan for the treatment of superficial fungus infection. U.S. Publ. Hlth Rep. 53, 537 (1943)
Peiser, B., u. H. Weyer: Antimykotische Therapie mit Jadit in Klinik und Sprechstunde. Medizinische 22, 1082 (1959)
Perkin, H.A.: Fungicides in medicine and pharmacy. Pharm. J. 162, 471 (1949)
Perry, H. O., and J. A. Ulrich: Laboratory studies on endomycin with special reference to its antifungal effect against Candida albicans. J. invest. Derm. 24, 623 (1955)
Pertjtz, A., C. Siebert u. R. Winterkitz: Pharmakologie der Haut, Arzneimittel, allgemeine Therapie. In J. Jadassohn Handbuch der Haut- und Geschlechtskrankheiten, Bd. Y/1. Berlin: Springer 1930
Peryassu, D.: Sulfamidoterapia de blastomicose brasiliera. An. brasil. Derm. Sif. 17, 261 (1942)
Pesle, G. D., et M. Labeguerie: Deux cas de moniliase digestive au cours de traitement par l’isoniazide. Rev. Tube. (Paris) 17, 881 (1953)
Pettker, K., u. H. Rieth: Mikrosporie-Behandlung mit Griseofulvin bei einer Heimendemie durch Mikrosporum Audouini. Z. Haut- u. Geschl.-Kr. 23, 177 (1960)
Pfleger, R.: Über die fungistatische und kontaktinsektizide Wirkung von Phenyltrichlormethylsulfiden. Angew. Chem. 65, 415 (1953)
Pfleger, R., E. Schraufstätter, F. Gehringer u. J. Sciuk: Zur Chemothera-pie der Pilzinfektionen. I. In vitro-Untersuchungen aromatischer Sulfide. Z. Naturforsch. 4b, 344 (1949)
Phillips, B.: The phenol-camphor treatment of dermatophytosis. Brit. J. Derm. Syph. 56, 219 (1944)
Pierce, H. E.: A clinical evaluation of dichloroxyquinaldine in dermatology. J. nat. med. Ass. (N.Y.) 45, 207 (1953)
Pierini, L. E., y S. J. Mosto: Blastomicosis sudamericana. Arch, argent. Derm. 9, 67 (1959)
Pilcher, K. S., and A. Y. Hamilton: Antifungal activity of a new group of salicylamide derivatives for dermatophytes. II. The relation of chemical structure to activity. Antibiot. and Chemother. 6, 573 (1956)
Pinetti, P.: (1) Impiego della penicillina nel trattamento del kerion tricofitico. Terapia antibiot. (Milano) 3, 194 (1953)
Pinetti, P.: (2) Rivista critica della letteratura micologica medica in Italia tra il 1946 ed il 1956. Mycopathologia (Den Haag) 11, 155 (1959)
Piper, W. N., and R. W. Goldblum: Two treatment failures using diethylstilbestrol in treatment of coccidioido-mycosis. A.M.A. Arch. Derm. 70, 809 (1954)
Pipkin, J. L.: Treatment of endothrix trichophyton infections with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10.1959 Miami/Florida
Pittenger, R. C.: Antibiot. and Chemother. 3, 1268 (1953). Zit. W. S. Spector
Pledger, R.A., and H.A.Lechevalier: Survey of the production of polyenic substances by soil streptomycetes. Antibiot. Ann. 1955/56, 249
Polemann, G.: (1) Hemmwirkung synthetischer Antihistamine auf das Wachstum pathogener Pilze. Arzneimittel-Forsch. 1, 211 (1951)
Polemann, G.: (2) Welches ist die hautschonendste Behandlung bei bakteriell bzw. mykotisch superinfizierten Berufsdermatosen ? Berufsdermatosen 5, 88 (1957)
Polemann, G.: (3) Klinik und Therapie der Pilzkrankheiten. Stuttgart: Georg Thieme 1961
Polemann, G., u. R. Scharfenberger: Experimentelle Hahnenkamm Trichophytie als antimykotisches Testobjekt. Dermatologica (Basel) 109, 137 (1954)
Popoff, L., T. Ivanoff, N. Angeloff and I. Panaiotoff: Fungicides synthétiques. I. Action antimycotique des substances du type des phytohormones et des dérivés naphthaléniques -substitués. C. R. Acad. bulg. Sci. 6, 37 (1953). Ref. Rev. Med. vet. Mycol. 2, 196 (1955)
Pratt, R., P. P. T. Sah, J. Dtjfrenoy and V. L. Pickering: Vitamin K5 as an inhibitor of the growth of fungi and of fermentation of yeast. Proc. nat. Acad. Sci. (Wash.) 34, 323 (1948)
Pratt, R., P. P. T. Sah, J. F. Oneto, D. C. Brodie, J. Dufrenoy, S. Riegleman and V.L. Pickering: VitaminK5 as an antimicrobial medicament and preservative. J. Amer, pharm. Ass., Sci. Ed. 39, 127 (1950)
Prazak, G.: Treatment of tinea pedis with griseofulvin. Symposium griseofulvin and dermatomycoses, 26. u. 27. 10. 1959 Miami/Florida
Price, H.: The local treatment of tinea capitis due to Microsporum audouini. Ann. west. Med. Surg. 3, 210 (1949). Ref. Rev. Med. vet. Mycol. 1, 346 (1950)
Procknow, J. J., and C. G. Loosli: Treatment of the deep mycoses. Arch, intern. Med. 101, 765 (1958).
Qtjiroga, M. I., P. Negroni y A. A. Cordero: Resultados de la terapéutica sulfamídica asociada a la vaccinoterapia específica en cuatro nuevas observaciones de blastomicosis sudamericana. Rev. argent. Dermatosif. 31, 566 (1947).
Rankin, J. L., W. L. Dobes, J. W. Jones and H. S. Alden: Ringworm of the scalp: treatment with tetrachloro-para-benzoquinone: clinical and laboratory analysis. Sth. med. J. (Bgham, Ala.) 44, 616 (1951). Ref. Rev. Med. vet. Mycol. 1, 508 (1952)
Rankin, N. E.: Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Brit. med. J. 1953 I, 918
Ranque, J., et G. le Henaee: Etude du pouvoir inhibiteur de quelques antiseptiques vis-à-vis des dermatophytes et des germes de souillure qui peuvent se développer au cours de leur culture. C.R. Soc. Biol. (Paris) 145, 1702 (1951)
Raubitschek, F.: (1) Antibiotics and their action on pathogenic fungi. I. Penicillin and streptomycin. II. Penicillin and streptomycin; terramycin. J. invest. Derm. 20, 401 (1953); 22, 359 (1954)
Raubitschek, F.: (2) A critical survey of medical mycology in Israel 1946–1956. Mycopathologia (Den Haag) 9, 176 (1958)
Raubitschek, F., R. F. Acker and S. A. Waksman: Production of an antifungal agent of the fungicidin type by Streptomyces aureus. Antibiot. and Chemother. 2, 183 (1952)
Raubitschek, F., and A. Dostrovsky: An antibiotic active against dermatophytes, derived from Bacillus subtilis. Dermatológica (Basel) 100, 45 (1950)
Ravits, H.: Treatment of superficial dermatomycoses with asterol dihydrochloride. J. Amer. med. Ass. 148, 1005 (1952)
Rebell, G., and J. H.Lamb: In vitro study of a group of blockes steroids as antimycotic agents. J. invest. Derm. 21, 331 (1953)
Rehácek, Z.: Produkce antifungálného antibiotika nové isolovanou aktinomycetou. Csl. Mikrobiol. 3, 27 (1958). Ref. Rev. Med. vet. Mycol. 3, 182 (1959)
Rehm, H.-J.: (1) Über Hemm- und Förderungsstoffe aus Streptomyceten der Streptomyces albus-Gruppe. Wiss. Z. Univ. Greifswald 4, 39 (1954/55)
Rehm, H.-J.: (2) Untersuchungen über Hemm- und Förderungsstoffe aus Streptomyceten der Streptomyces albus-Gruppe. Zbl. Bakt., II. Abt. 109, 399 (1956)
Rehm, H.-J., u. U. Stahl: Zur Wirkung antimikrobieller Stoffe in Kombination. Naturwissenschaften 46, 431 (1959)
Reidel, B. B.: Favus and its treatment with a quaternary ammonium compound. Poultry Sci. 29, 741 (1950)
Reifferscheid, M., u. H. P. R. Seeliger: Monosporiose und Maduromykose. Die sogenannte therapieresistente Aktinomy- kose. Dtsch. med. Wschr. 80, 1841 (1955)
Reilly, H. Ch., A. Schatz and S. A. Waksman: Antifungal properties of antibiotic substances. J. Bact. 49, 585 (1945)
Reiss, F.: (1) Medical mycology. A review of the literature from 1945–1948. Dermatológica (Basel) 97, 134 (1948).
Reiss, F.: (2) Antisporulating effect of asterol dihydrochloride. Trans. N.Y. Acad. Sci., Ser. II 13, 28 (1950)
Reiss, F.: (3) The pathogenicity of the genus Candida in relation to antibiotic therapy. Monogr. Ther. 2, 67 (1957)
Reiss, F., and L. Caroline: (1) The effect of trimeton maleate on pathogenic fungi. Exp. Med. Surg. 8, 330 (1950). Ref. Rev. Med. vet. Mycol. 1, 433 (1951)
Reiss, F., and L. Caroline: (2) The metabolism of Blastomyces dermatitidis, antagonists to the growth-inhibiting effect of trimeton maleate. Science 114, 15 (1951)
Reiss, F., L. Caroline and L. Leonard: Experimental Microsporum lanosum infection in dogs, cats and rabbits. I. Observation on the course of the primary infection and attempts to develop a method for screening antifungal agents in laboratory animals. J. invest. Derm. 24, 575 (1955)
Reiss, F., and D. D. Doherty: (1) Fungous infections of the skin and scalp: a new approach to their treatment. N.Y. med. J. 49, 1939 (1950)
Reiss, F., and D. D. Doherty: (2) Podophyllum resin in treatment of tinea capitis. J. Amer. med. Ass. 147, 225 (1951)
Reiss, F., L. Kornblee and B. Gordon: Griseofulvin (fulvicin) in the treatment of fungous infections of the hair, skin and nails with special reference to mycologie changes produced during therapy. J. invest. Derm. 34, 263 (1960)
Reiss, F., and B. Lustig: Evaluation of fungicides. Phenols, quaternary ammonium compounds, undecylenic acid, their mixtures and salts. Dermatológica (Basel) 97, 312 (1948)
Reiss, F., and D. R. Winston: The effect of podophyllin on pathogenic fungi and its clinical application in the treatment of tinea capitis (preliminary report). Exp. Med. Surg. 7, 229 (1949)
Renkin, A.: Observations sur le traitement de diverses affections mycotiques par le 2,2′-dioxy-5,5′-dichlor-diphenyl-sulfur. Arch, belges Derm. 9, 266 (1953)
Rhodes, A., R. Grosse, R. McWilliam, J. P. R. Tootill and A. T. Dunn: Smallplot trials of griseofulvin as a fungicide. Ann. appl. Biol. 45, 215 (1957)
Ribeiro, D. de: Tratamento da blastomicose pelo derivado acetilado das sulfamidas (albucid). Rev. paul. Med. 20, 392 (1942)
Richard, J.: Le traitement par la nystatine (mycostatine) des infections à candida chez le nourrisson et l’enfant. Actapaediat. belg. 10, 5 (1956)
Richter, R.: (1) Zur Chemotherapie der Pilzinfektionen. IV. Klinische Erfahrungen bei der Anwendung von -Dioxy-öjö’-dichlor-diphenylsulfid (D 25) bei Pilzerkrankungen. Arch. Derm. Syph. (Berlin) 190, 563 (1950)
Richter, R.: (2) Therapie der Pilzerkrankungen. Therapiewoche 2, 527 (1951/52)
Richter, R.: (3) Neue Erfahrungen über die Behandlung der Pilzerkrankungen. In A. Marchionini u. H. Götz, Fortschritte der praktischen Dermatologie und Venerologie. Berlin-Göttingen-Heidelberg: Springer 1952
Richter, R.: (4) Der derzeitige Stand der medizinischen Mykologie. Z. Haut- u. Geschl.-Kr. 12, 75, 119, 156 (1952)
Richter, R., u. N. Erbakan: Der heutige Stand der medizinischen Mykologie in der Türkei. Mycopathologia (Den Haag) 10, 41 (1958)
Richter, R., u. E. Schraufstätter: Zur Chemotherapie der Pilzinfektionen. III. Tierexperimentelle Untersuchungen zur Toxicität des 2,2/-Dioxy-5,5′-dichlordiphenyl-sulfids (D 25) und des 2,2/-Dioxy-3,3/,5,5/-tetrachlordiphenylsulfids (D 26). Arch. Derm. Syph. (Beri.) 190, 543 (1950)
Richter, V.: The chemistry of the carbon compounds. New York: Nordemann 1939. Zit. W. S. Spector
Riddell, R. W., and G. T. Stewart: Fungous diseases and their treatment. London: Butterworth & Co. 1958
Riehl, G.: (1) Griseofulvin als peroral wirksames Antimykoticum. Kongreßbericht. Öst. Derm. G. s. Wise., Sitzg 27. 11. 1958. Wien. klin. Wschr. 71, 28 (1959)
Riehl, G.: (2) Griseofulvin, ein per os wirksames Antimykoticum (Demonstration). S.-B. vom 6. 3. 1959 in Wien. Wien. klin. Wschr. 71, 215 (1959)
Riehl, G.: (3) Griseofulvin. Wien. med. Wschr. 109, 258 (1959)
Riehl, G.: (4) Griseofulvin — ein peroral wirkendes Antimykoticum. Hautarzt 10, 136 (1959)
Riehl, G.: (5) Griseofulvin, ein per os wirksames Antimykoticum. Münch, med. Wschr. 101, 1145 (1959)
Rieth, H.: Experimentelle Untersuchungen der antimykotischen Wirkung synthetischer Antihistamine. Hautarzt 4, 474 (1953)
Rieth, H., u. A. Y. El-Fiki: (1) Renaissance der Animalen Mykologie. Beri. Münch, tierärztl. Wschr. 71, 391 (1958)
Rieth, H., u. A. Y. El-Fiki: (2) Die Rinderflechte — ein aktuelles therapeutisches und hygienisches Problem. Beri. Münch, tierärztl. Wschr. 72, 201 (1959)
Rieth, H., u. K. Ito: Griseofulvin, ein oral wirksames antimykotisches Antibioticum. Bull. Pharm. Res. Inst. Osaka Nr 22, 21 (1959)
Rieth, H., K. Ito, P.Hansen u. G.List: Prüfung antimycetischer Substanzen in Gummiqualitäten. Bull. Pharm. Res. Inst. Osaka Nr 15, 9 (1958)
Rieth, H., u. K. Schoderer: Die Mykosen. Entstehung, Erkennung und Behandlung von Pilzerkrankungen. Folia Ichthyol. H. 6, 1 (1957)
Rieth, H., u. J. Schönfeld: (1) Experimentelle Untersuchungen über die sproßpilzhemmende Wirkung einiger chemischer Verbindungen. Hautarzt 5, 120 (1954)
Rieth, H., u. J. Schönfeld: (2) Zur Diagnostik und Therapie der Mykosen durch imperfekte Hefen (Cryptococcaceen). Arch. klin. exp. Derm. 207, 343 (1959).
Riley, K., and H. A. Flower: A comparison of the inhibitory effect of Castellani’s paint and of gentian violet solution on the in vitro growth of Candida albicans. J. invest. Derm. 15, 355 (1950)
Rimbaud, P., H. Harant, J.-A. Rioux et J. Caron: Etude du pouvoir antifongique de la dichloroxyquinaldine. Essai thérapeutique dans la Candidose digestive expérimentale. Sem. Hop. Paris 1957, 431
Rimbaud, P., et J.-A. Rioux: Les moniliases au cours des traitements par les antibiotiques. Conceptions pathogéniques. Presse méd. 63, 701 (1955)
Rimbaud, P., J.-A. Rioux et J. Caron: Propriétés antifungiques de la dichlor- oxychinaldine. Étude expérimentale in vitro. Montpellier méd. 1956, 498
Rioux, J.-A.: Action fongistatique des antihistaminiques. Montpellier Méd. 1953, 51
Rioux, J.-A., et Bousquet: La thérapeutique des aspergilloses du conduit auditif externe. Rev. Laryng. (Bordeaux) 79, Suppl., 958 (1958)
Rivalier, E.: Les microspories spontanément curables. Ann. Derm. Syph. (Paris) 10, 518 (1950)
Rizzo, V. F., y R. M. Arzube: Blastomycosis sudamericana. Tratamiento de un caso con sulfamethoxypyridazine y plastia quirúrgica de la cicatriz. Rev. ecuat. Hig. 14, 7 (1958). Ref. Rev. Med. vet. Mycol. 3, 191 (1959)
Rob- bins, W. J., and I. McVeigh: Effect of hydroxyproline on Trichophyton mentagrophytes and other fungi. Amer. J. Bot. 33, 638 (1946)
Robinson jr., H. M.: Experimental animal studies with griseofulvin. Symposium griseofulvin and dermatomycoses, 26. u. 27. 10. 1959 Miami/Florida
Robinson, H. M., and M. B. Hollander: Topical use of chlorquinaldol. J. invest. Derm. 26, 143 (1953)
Robinson, R. C. V.: (1) Systemic moniliasis treated with mycostatin. J. invest. Derm. 24, 375 (1955)
Robinson, R. C. V.: (2) Nystatin in the treatment of cutaneous moniliasis. Monogr. Ther. 2, 55 (1957)
Robinson, R. C. V.: (3) Resistance to griseofulvin in vitro. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Roda, A. P., S. A. Aghirre and G. S. Mijaro: Incidence of the species candida from different sources and their sensitivity to mycostatin. J. Philipp, med. Ass. 33, 251 (1957). Ref. Rev. Med. vet. Mycol. 3, 115 (1958)
Rodriquez, J.: Stilbamidine (4,4′-stilbene-dicarboxyamidine) therapy in blastomycosis. A.M.A. Arch. Derm. 68, 95 (1953)
Röckl, H.: Dermatologie — Kritische Sammelreferate. Münch, med. Wschr. 101, 1196 (1959)
Rosenkränzer, R.: Erfahrungen mit einem neuen Antimykoticum. Medizin heute 8, 57 (1959)
Rosenthal, M. W., C. W. Daeschner and W. J. Fahlberg: Clinical evaluation of diparalene in the management of tinea capitis. J. invest. Derm. 23, 119 (1954)
Rosenthal, S. A.: Studies on the development of resistance to griseofulvin by dermatophytes. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Rossi, R., e M. Acocella: Frequenza dell’isolamento di miceti del genere Candida dal prematuro in rapporto alle sedi di prelievo, all’età ed all’ambiente. Sensibilità di 140 ceppi di Candida alla nistatina in vitro. G. Mal. infett. 10, 716 (1958)
Rost, G. A.: Über Alopecia atrophicans, eine nicht seltene, aber oft verkannte Haarerkrankung. Beri. Med. 7, 137 (1956)
Roth, M.: Treatment of onychomycosis. J. nat. Ass. Chir. 42, 35 (1952)
Roth, W.: Dermatomykosebehandlung. Z. ärztl. Fortbild. 46, 258 (1952)
Rothman, St.: Some unusual forms of cutaneous moniliasis. A.M.A. Arch. Derm. 79, 598 (1959)
Rothman, S., A.M. Smiljanic and A.L. Shapiro: Fungistatic action of hair fat on Microsporum audouini. Proc. Soc. exp. Biol. (N.Y.) 60, 394 (1945)
Rothman, S., A. M. Smiljanic, A. L. Shapiro and A. W. Weitkamp: The spontaneous cure of tinea capitis in puberty. J. invest. Derm. 8, 81 (1947)
Roxm, T., u. A. Avram: Über Behandlungsmöglichkeiten der oberflächlichen Mykosen der Kopfhaut bei Kindern unter 3 Jahren. Z. ärztl. Fortbild. 52, 412 (1958)
Rubin, H., P. H. Lehan, M. J. Fitzpatrick and M. L. Furcolow: Amphotericin B in the treatment of cryptococcal meningitis. Antibiot. Ann. 1957/58, 71
Rudat, W.: Beitrag zur Therapie der Dermatomykosen unter besonderer Berücksichtigung der Behandlung von Hautkrankheiten mit Undecylensäure. Ther. d. Gegenw. 1951, 99
Rückher, M. M.: Experimentelle Untersuchungen über das Wachstum pathogener Pilze in vitro und über die fungistatische Wirkung chemischer Substanzen. Diss. Heidelberg 1951
Rüther, E., H. Rieth u. H. Koch: Die Bedeutung der Candidamykosen (Moniliasis) für Gynäkologie und Geburtshilfe. Geburtsh. u. Frauenheilk. 18, 22 (1958)
Ruther, H., u. R.Wiehl: Bromosalicyl-Chloranilid-Soventol, ein Beitrag zur Therapie behandlungserschwerter Epidermophytien. Z. Haut- u. Geschl.-Kr. 18, 47 (1955).
Sabalitschka, Th.: Pharm. Mh. 5, 235 (1924). Zit.
Sabalitschka, Th., H. Marx u. U.Scholz: Arzneimittel-Forsch. 5, 259 (1955)
Sabalitschka, Th., H.Marx u. U. Scholz: Zur Wirkung der p-Oxybenzoesäurealkylester auf den Soor-Erreger Candida albicans (Robin) Berkhout. Arzneimittel-Forsch. 5, 259 (1955).
Sabouraud, R.: Les teignes. Paris: Masson & Cie. 1910
Sagher, F., F. Raubitschek and B. Axelrad: Griseofulvin treatment of tinea capitis due to T. violaceum. J. invest. Derm. 33, 85 (1959)
Sakai, S., Kobayashi, G. Saito, S. Takada and A. Sato: Studies on chemotherapy of trichophyton infections. V. Therapeutic efficiency of some dithiocarbamates and thiuram disulfides. J. Sci. Res. Inst. (Tokyo) 50, 98 (1956)
Sakai, S., K. Minoda, G. Saito and A. Sato: Studies on chemotherapy of trichophyton infections. IV. Therapeutic efficiency of p-hydroxybenzoic acid esters. J. Sci. Res. Inst. (Tokyo) 50, 93 (1956)
Sakai, S., G. Saito, T. Kada, N. Muraoka and A. Sato: Studies on chemotherapy of trichophyton infections. II. Antifungal properties of halogen phenol ester and halogen phenol derivatives. J. Sci. Res. Inst. (Tokyo) 48, 38 (1955)
Sakai, S., G. Saito, S. Koshi and A. Sato: Studies on chemotherapy of trichophyton infections. III. Therapeutic efficiency of alkylphenol derivatives. J. Sci. Res. Inst. (Tokyo) 50, 90 (1956)
Sakai, S., G. Saito, K. Minoda, S. Akagi and A. Sato: Studies on chemotherapy of trichophyton infections. VI. Therapeutic efficiency of 1,4-naphthoquinone derivatives. J. Sci. Res. Inst. (Tokyo) 50, 102 (1956)
Salle, A. Y., and G. J. Jann: Proc. Soc. exp. Biol. (N.Y.) 60, 60 (1945). Zit. W. S. Spector
Salvin, S. B.: An antifungal substance from a strain of Aspergillus flavus. J. Bact. 52, 614 (1946)
Sampaio, S. A. P., e C. da S. Lacaz: Agao do sulfisoxazol na actinomicose provocada pelo Actinomyces brasiliensis. O Hospital 10, 795 (1956)
Sams, W. M.: Favus treated with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27.10.1959 Miami/Florida
Saraceni, G.: Attività antimicotica della nistatina, della tricomicina e della dicloro-ossichinaldina. G. Mal. infett. 10, 740 (1958)
Sarewitz, A. B.: Treatment of genitourinary moniliasis with orally administered nystatin. Ann. intern. Med. 42, 1187 (1955)
Sarot, A., M. L. Littman and M. M. Cerruti: Intrathoracic injection of amphotericin B in treatment of monilial empyema. Sea View Hosp. Bull. 17, 95 (1959)
Saslaw, S., and R. MacMillan: Chemotherapy of histoplasmosis in mice with ethylvanillate. Antibiot. Ann. 1954/55, 1008
Schabinski, G.: Grundriß der medizinischen Mykologie. Jena: VEB Gustav Fischer Verlag 1960
Schäfer, R., u. J. Kwoczek: Über die Therapie profunder Dermatomykosen. Med. Klin. 45, 838 (1950)
Schamberg, J.F., and J. A.Kolmer: Studies on the chemotherapy of fungus infection. I. The fungistatic and fungicidal activity of various dyes and medicaments. A.M.A. Arch. Derm. 6, 746 (1922)
Schati, J.: Das mykographische Test verfahren. Diss. Heidelberg 1950
Schatz, A., V. Schatz and G. S. Trelawny: Antifungal properties of tetrazolium compounds. Mycologia (N.Y.) 48, 473 (1956)
Scheffler, K.: Beitrag zur Frage der Penicillinbehandlung der Aktinomykose. Arch. Ohr-, Nas.- u. Kehlk.-Heilk. 155, 639 (1949)
Scheibner, K.: Das Wachstum von Dermatophytenauf Nährböden mit Zusatz von 4-Chlorthymolnicotinsäureester. Mykosen 2, 134 (1959)
Scherr, G. H.: (1) The effect of cortisone, somatotrophic hormone on the course of systemic moniliasis in mice. Riass. VI. Congr. Internat. Microbiol. 3, 44 (1953)
Scherr, G. H.: (2) The use of yeast cells to enhance the virulence of Candida albicans. Mycopathologia (Den Haag) 6, 260 (1953)
Scherr, G. H.: (3) The effect of cortisone on the course of systemic moniliasis in mice. I. The efficacious effect of cortisone for severe infections. Mycopathologia (Den Haag) 6, 325 (1953).
Scherr, G. H.: (4) The effect of environmental temperature on the course of systemic moniliasis in mice. Mycologia (N.Y.) 45, 359 (1953)
Scherr, G. H.: (5) The effect of cortisone, somatotrophic hormone, and piromen on experimental moniliasis in mice. Mycologia (N.Y.) 47, 305 (1955)
Scherr, G. H.: (6) The therapeutic effect of cortisone, somatotrophic hormone and hesperedin methyl chalcone in suppressing experimental moniliasis in mice. Mycopathologia (Den Haag) 7, 321 (1956)
Scherr, G. H.: (7) The influence of hormones on experimental moniliasis. Monogr. Ther. 2, 80 (1957)
Scherr, G. H.: (8) The effect of hormones on experimental moniliasis in mice. I. Sex hormones, cortisone, and somatotrophic hormone. II. Gonadotropins. Mycopathologia (Den Haag) 8, 62 (1957)
Schere, Gr. H., and Z. N. Korth: The therapeutic effectiveness of a fungistatic powder for tinea pedis. Illinois Med. J. 112, No 3 (1957)
Schere, G. H., Z. N. Korth, J. Reynold and J. E. Gotham: The therapeutic effect of fatty acids and the antibiotic M-l 1 on tinea pedis. J. invest. Derm. 25, 335 (1955)
Schirmer, H., u. J. Grantts-Thurner: Über die Abhängigkeit der fungistatischen Wirkung vom Quellungsgrad der Plasmakolloide. Mykosen 1, 141 (1958)
Schirren, C.: Antimykotische Wirksamkeit einer neuen Gummiqualität für Schuhe. Zbl. Arbeitsmed. 7, 13 (1957)
Schirren, C., u. H. Rieth: (1) Folliculitis barbae durch Candida albicans. Arch. klin. exp. Derm. 202, 577 (1956)
Schirren, C., u. H. Rieth: (2) Epidemiologische Untersuchungen zur Rindertrichophytie mit Hinweis auf die antimykotische Therapie. Tierärztl. Umsch. 1957, 310
Schirren, C., u. H. Rieth: (3) Experimentelle Untersuchungen bei einigen durch Haustiere übertragbaren Dermatomykosen. Berufsdermatosen 6, 31 (1958)
Schirren, C., u. H. Rieth: (4) Dermatologische Erfahrungen bei der ambulanten Behandlung von Fußmykosen. Med. Klin. 53, 1789 (1958)
Schirren, C., H. Rieth u. H. Koch: Tierexperimentelle Untersuchungen zur Pathogenität von Hefepilzen. Arch. klin. exp. Derm. 210, 86 (1960)
Schirren, C., H. Rieth, J. Ch. Pingel u. P. Hansen: Dermatophytenflora eines Industriebetriebes unter besonderer Berücksichtigung der Identifizierungsmethode für Dermatophyten. Arch. Hyg. (Berl.) 140, 423 (1956).
Schmidt, E. G., and P. Thorp: The effect of chemotherapeutic agents upon the growth of Cryptococcus neoformans. J. infect. Dis. 103, 142 (1958)
Schmidt, W., u. G. Theissing: Zur Kasuistik der Haut- und Schleimhautsporotrichose. Derm. Wschr. 135, 545 (1957)
Schmitz, A.: Amphotere oberflächenaktive Stoffe als Wasch- und Desinfektionsmittel. Fette u. Scifen 55, 10 (1953)
Schmitz, A., u. F. Kornfeld: AmpholytScifen — eine neue Gruppe von Desinfektionsmitteln. Prakt. Desinfektor H. 4 (1953)
Schmitz, H., and R. Woodside: Mycolutein, a new antifungal antibiotic. Antibiot. and Chemother. 5, 652 (1955).
Schneider-Reinkens, A.: Erfahrungen bei der Therapie hochbakteriellen Fluors durch Fluomycin-Ovula. Med. Klin. 1958, 1497
Schneierson, S. S., D. Amsterdam and M.L. Littman: Inactivation of amphotericin B, chlorquinaldol, gentian violet and nystatin by bile salts. Proc. Soc. exp. Biol. (N.Y.) 99, 241 (1958)
Schoenbach, E. B.: The use of aromatic diamidines for the treatment of systemic fungal diseases. Trans. JST.Y. Acad. Sci. 14, 272 (1952)
Schoenbach, E. B., and E. M. Greenspan: The pharmacology, mode of action and therapeutic potentialities of stilbamidine, pentamidine, propamidine and other aromatic diamidines — a review. Medicine (Baltimore) 27, 327 (1948)
Schoenbach, E. B., J.M.Miller, M.Ginsberg and P.H.Long: Systemic blastomycosis treated with stilbamidine: a preliminary report. J. Amer. med. Ass. 146, 1317 (1951)
Schoenbach, E. B., J. M. Miller and P. H. Long: The treatment of systemic blastomycosis with stilbamidine. Ann. intern. Med. 37, 31 (1952)
Schönfeld, J.: Vergleichende Laboratoriums- und klinische Untersuchungen über einige neuere Antimykotica gegenüber Farbstoffen bei oberflächlichen Dermatomykosen. Derm. Wschr. 130, 1293 (1954)
Schönfeld, J.,u. H. Rieth: Möglichkeiten der Chemotherapie bei inneren Mykosen. Med. Mschr. 12, 447 (1958)
Schönfeld, W.: (1) Die Epidermophytie der weiblichen Brustwarzen unter dem Bilde des Mammaekzems, ihre Erkennung und Behandlung. Dtsch. med. Wschr. 71, 216 (1946)
Schönfeld, W.: (2) Lehrbuch der Haut- und Geschlechtskrankheiten, 8. Aufl. Stuttgart: Georg Thieme 1959
Schönfeld, W., u. J. Kimmig: Sulfonamide und Penicilline. Stuttgart: Georg Thieme 1948
Schoental, R.: Brit. J. exp. Path. 22, 137 (1941). Zit. W. S. Spector
Scholer, H. J.: Experimentelle Aspergillose der Maus (Aspergillus fumigatus) und ihre chemotherapeutische Beeinflussung. Schweiz. Z. Path. 22, 564 (1959)
Schraufstätter, E., R. Bichter u. W. Ditscheid: Zur Chemotherapie der Pilzinfektionen. II. Mitt. Arch. Derm. Syph. (Berl.) 188, 259 (1949)
Schubert, E.: Erfahrungen mit Antimycin forte. Berl. Med. 8, H. 8 (1957)
Schubert, G. E.: Erfahrungen mit den mykoziden und bakteriziden Chemotherapeuticum “Curis”. Ther. Gegenw. 95, H. 9 (1956)
Schubert, M.: Eine einfache und erfolgreiche Behandlungsmethode der Onychomykosen. Medizinische 1955, 1465
Schubert, R.: Erfahrungen mit Sterosan. Z. Haut- u. Geschl.-Kr. 16, 17 (1953)
Schuermann, H.: Krankheiten der Mundschleimhaut und der Lippen. Münch, u. Berlin: Urban & Schwarzenberg 1955
Schürmann, R.: Über Soormykosen nach antibiotischer Behandlung. Ärztl. Wschr. 8, 719 (1953)
Schuldes, H.: Erfahrungen in der Behandlung von Soor, Trichomonaden-Kolpitis und mischinfiziertem Fluor vaginalis mit einem neuen Chemothera- peuticum. Med. Klin. 53, 59 (1958)
Schultze, W.: Die Behandlung von Dermatomykosen mit Dermofonginpräparaten. Dtsch. med. Wschr. 80, 27 (1955)
Schulz, H. J.: Klinische Erfahrungen mit Chlorisept bei mykotischen Erkrankungen der Haut. Z. Haut. u. Geschl.- Kr. 11, 470 (1950)
Schuppli, R.: Über die Wirkung von Sterosan-Hydrocortison-Salbe. Schweiz, med. Wschr. 87, 956 (1957)
Schwartz, L., M.Robinson and J.Q.Gant: A new treatment for superficial mycoses. Industr. Med. (Chicago) 18, 257 (1949)
Schwarz, H. G.: (1) Fettsäuren der mittleren Kettenlänge als therapeutisches Mittel gegen Dermatomykose. Z. Haut- u. Geschl.-Kr. 15, 299 (1954)
Schwarz, H. G.: (2) Die Waschkaue, ein arbeitshygienisches Problem. Aich. G. werbepath. Gewerbehyg. 16, 227 (1958)
Schwarz, J.: Laboratory experiences with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27.10. 1959 Miami/Florida
Schwarz, J., and S. Adriano: Failure of stilbamidine to arrest experimental blastomycosis in mice. J. invest. Derm. 20, 329 (1953)
Schwarz, J., and G. Batjm: A critical review of medical mycology in the United States 1946–1956. Mycopathologia (Den Haag) 8, 271 (1957)
Schwebel, S., W. Snyder and W.N. Slinger: Ineffectiveness and toxicity of podophyllin in treatment of tinea capitis. J. Amer. med. Ass. 149, 261 (1952)
Scigliano, J. C., T. C. Grubb and D. E. Shay: Fungicidal testing of some organo-copper compounds. J. Amer, pharm. Ass., Sci. Ed. 39, 673 (1950)
Scully, J. P., C. S. Livingood and D. M. Pillsbury: The local treatment of tinea capitis due to M. audouini. The importance of inflammatory reaction as an index of curability. J. invest. Derm. 10, 111 (1948)
Seabury, J. H.: Stilbamidine in the treatment of histoplasmosis: two case reports. Ann. intern. Med. 31, 520 (1949)
Seale, E. E.: Studies on the fungistatic powers of a new benzothiazol and an antihistaminic compound. Canad. med. Ass. J. 65, 582 (1951)
Sedlacek, A.: Erfahrungen mit Sterosan als Antimykoticum in der Praxis. Wien. med. Wschr. 1954, 655
Seeliger, H. P. B.: (1) Fortschritte in der Chemotherapie disseminierter Mykosen. Dtsch. med. Wschr. 81, 2041 (1946)
Seeliger, H. P. B.: (2) Successful treatment of mycetoma caused by Monosporium apiospermum. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer, pp. 328–332
Seeliger, H. P. B.: (3) Pilzhemmende Wirkung eines neuen Benzimidazol-Derivates. Mykosen 1, 162 (1958)
Seeya, K.: Therapeutic action of “repare” ointment against fungus skin conditions. Jap. Saf. Fore. Med. J. 3, 718 (1956)
Segretain, G., et E.Drouhet: L’action de la streptomycine sur Torulopsis histolytica (Torulopsis neoformans) in vitro et in vivo. C.R. Soc. Biol. (Paris) 142, 319 (1948)
Seligman, E.: Virulence enhancing activities of aureomycin on Candida albicans. Proc. Soc. exp. Biol. (N.Y.) 79, 481 (1952)
Seligman, S.A.: Treatment of actinomycosis with aureomycin. Brit. med. J. 1954 I, 1421
Seneca, H.: Fungicidal properties of antihistaminica. Science 115, 48 (1952)
Seneca, H., J.H.Kane and J. Bockenbach: Antibiot. and Chemother. 2, 357 (1952). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Serpa, J. d. Melo: Candidamykosen der Haut bei Kindern. J. Pediat. Bio de Janeiro 23, 57 (1958)
Serri, F.: (1) Influence of p-aminobenzoic acid on the growth of some dermatophytes. Acta vitamin. (Milano) 2, 73 (1948). Bef. Bev. Med. vet. Mycol. 1, 343 (1950)
Serri, F.: (2) Pouvoir antifongique de la polymyxine (aérosporine) sur huit souches de dermatomycètes. C.B. Soc. Biol. (Paris) 143, 362 (1949)
Shaffer, L. W., and H. S. Zackheim: Sporotrichosis: report of a case in which treatment with iontophoresis was successful. A.M.A. Arch. Derm. 56, 244 (1947)
Shah, A.M., and J.W.Jones: Synthesis and antifungal studies on new organic compounds. J. Amer, pharm. Ass., Sci. Ed. 47, 399 (1958)
Shapiro, A. L., and S. Bothman: Undecylenic acid in the treatment of dermatomycosis. A.M.A. Arch. Derm. 52, 166 (1945)
Sharp, J. L.: The growth of Candida albicans during antibiotic therapy. Lancet 1954 I, 390
Shidlovsky, B. A., M. Marmell, B. Turell and A. Prigot: The effect of chlorquinaldol alone and in combination with neomycin on the intestinal microbial flora of man. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 154–159
Shumard, B. S., D. J. Beaver and M. C. Hunter: New bacteriostat for soap. An evaluation of biological and chemical properties of “actamer” [2,2/-thiobis(4,6-dichlorophenol)]. Soap (N.Y.) 20, 6 (1953). Bef. Bev. Med. vet. Mycol. 2, 181 (1954)
Sidi, E., et J. Bourgeois Spinasse: Traitement de certaines mycoses rebelles par un extrait de “Pénicillium griseofulvum Dierkx” (per os). Presse méd. 67, 1099 (1959)
Siegel, M.: Fungistatic activity of methylparaben and propylparaben. Antibiot. and Chemother. 3, 478 (1953)
Sierra, G., and H. A. Veringa: The effect of oxy-chlororaphin on the growth in vitro of Streptomyces spp. and some pathogenic fungi. Nature (Lond.) 182, 265 (1958)
Sigg, K.: Traitement des mycoses interdigitales des pieds et les eczémas mycosiques par le sterosan. Schweiz, med. Wschr. 1947, 123
Signorelli, S.: (1) Sulfamidici e penicillina nelFactinomicosi. Progr. med. (Napoli) 1, 18 (1945). Zit. Mycopathologia (Den Haag) 4, 309 (1948)
Signorelli, S.: (2) Considerazioni sulla fisiopatologia délia actinomicosi umana a proposito del meccanismo d’azione délia cura sulfamidica e penicillinica. S. c. Nap. Chir. Seduta del 21. 12.1945. Zit. Mycopathologia (Den Haag) 4, 309 (1948)
Simmonds, W. L.: (1) An in vitro method for the evaluation of water soluble fungicides against trichophyton. Z. Hyg. Infekt.-Kr. 132, 34 (1951). Bef. Bev. Med. vet. Mycol. 1, 474 (1951)
Simmonds, W. L.: (2) A comparison of methods for the evaluation of fungicides. Z. Hyg. Infekt.- Kr. 132, 42 (1951). Bef. Bev. Med. vet. Mycol. 1, 474 (1951)
Simons, B.D. G.Ph.: Medical mycology. Amsterdam, Houston, New York and London: Elsevier Publ. Comp. 1954
Sing, T. B.: (1) Acquired resistance to fatty acid and sulfanilamide of certain Trichophyton-strains. Dermatologica (Basel) 99, 231 (1949)
Sing, T. B.: (2) Clinical observations on the treatment of dermatophytosis with fatty acids. Dermatologica (Basel) 100, 105 (1950).
Sing, T. B., and B. A. Verhagen: Comparative investigation into the fungistatic action of fatty acids and other anti-mycotica in vitro and some observations on the increasing resistance of fungi against drugs. Dermatológica (Basel) 99, 139 (1949)
Siskind, W. M., and D. Richtberg: Tinea capitis in a city hospital. Treatment with X-ray. N.Y. St. J. Med. 58, 2040 (1958)
Slade, P. R., M. A. Haseeb and H. V. Morgan: Oxytetracycline in the treatment of maduromycosis. J. trop. Med. Hyg. 59, 262 (1956)
Slaughter, H. W.: Asteroltreatment of superficial fungus infections. J. med. Ass. Ala. 22, 147 (1952). Ref. Rev. Med. vet. Mycol. 2, 231 (1955)
Slaughter jr., J. C.: Stilbamidine in treatment of widely disseminated blastomycosis (with two year follow-up). A.M.A. Arch. Derm. 70, 663 (1954)
Sloane, M. B.: A new antifungal antibiotic, mycostatin (nystatin), for the treatment of moniliasis: a preliminary report. J. invest. Derm. 24, 569 (1955)
Smith, D. T.: (1) The diagnosis and therapy of mycotic infections. Bull. N.Y. Acad. Med. 29, 778 (1953)
Smith, D. T.: (2) Stilbamidine therapy in blastomycosis. Gen. Practit. 8, 69 (1953)
Smith, D. T.: (3) Therapy for the systemic fungus infections. N.Y. J. Med. 54, 2303 (1954).
Smith, D. T.: (4) Therapy for pulmonary and systemic fungus diseases. Postgrad. Med. 20, 18 (1956)
Smith, G. M., and R. M. Armen: Pulmonary moniliasis treated by brillant green aerosol: report of a case. Ann. intern. Med. 43, 1302 (1955)
Smith jr., J. G.: Widespread T. rubrum granulomas treated with griseofulvin. Symposium griseofulvin and dermatomycoses, 26. u. 27. 10. 1959. Miami/ Florida
Smith, L. M.: Treatment of deep fungous infections. Postgrad. Med. 9, 258 (1951)
Smith, R. M., W.H.Peterson and E. McCoy: Oligomycin, a new antifungal antibiotic. Antibiot. and Chemother. 4, 962 (1954)
Snapper, I., L. A. Baker, B. D. Edidin and D. S. Kushner: The results of 2-hydroxy-stilbamidine therapy in disseminated coccidioidomycosis. Ann. intern. Med. 43, 271 (1955)
Snapper, I., and L. V. McVay: The treatment of North American blastomycosis with 2-hydroxy-stilbamidine. Amer. J. Med. 15, 603 (1953)
Snapper, I., B. Schneid, L. McVay and F. Lieben: Pharmacology and therapeutical value of diamidine derivatives, particularly of 2-hydroxystilbamidine. N.Y. Acad. Sci. 14, 269 (1952)
Snyder, W.: Asterol dihydrochloride therapy of Micro- sporum audouini scalp infections. A.M.A. Arch. Derm. 65, 464 (1952)
Sobin, B. A., and F. W. Tanner jr.: J. Amer. chem. Soc. 76, 4053 (1954). Zit. W. S. Spector
Sokoloff, O. S: Clinical evaluation of “diphenylpyraline” as an antifungal agent. A.M.A. Arch. Derm. 64, 754 (1951)
Solari, M. A., y M.N. G.Fernandez: Nistatina sobre foco intestinal de “Candida albicans” y síndromes alérgicos. Rev. Asoc. méd. argent. 71, 36 (1957)
Solotorovsky, M., and E. J. Bugie: The effect of streptothricin on systemic infection with Cryptococcus neoformans. J. Immunol. 60, 497 (1948)
Solotorovsky, M., E. J. Ironson, J. Gregory and S. Winsten: Activity of certain diamidines against blastomycosis and candida infection in mice. Antibiot. and Chemother. 4, 165 (1954)
Solotorovsky, M., Quabeck and S. Winsten: Antifungal activity of candidin, nystatin, eulicin, and stilbamidine against experimental infections in the mouse. Antibiot. and Chemother. 8, 364 (1958)
Somers, E.: Fungitoxicity of metal ions. Nature (Lond.) 184, 475 (1959)
Soo-Hoo, G., and E. Grunberg: The antifungal activity of metal derivatives of 3-pyridine thiol. J. invest. Derm. 14, 169 (1950)
Southam, C. M.: Antibiotic activity of extract of western red cedar heartwood. Proc. Soc. exp. Biol. (N.Y.) 61, 391 (1946)
Spaulding, E. H., and R. R. Tyson: The role of nystatin in intestinal antisepsis. Monogr. Ther. 2, 38 (1957)
Spector, W. S.: Handbook of toxicology. Vol. II: Antibiotics. Philadelphia and London: W. B. Saunders Company 1957
Sperber, P. A.: Whale oil, trichophytin, and autoserotherapy in the treatment of epidermophytosis. Ann. Allergy 7, 91 (1949)
Srivastava, O. P.: Trichosporon cutaneum from the foot-skin of man and the effect of antifungal drugs on it. J. Indian bot. Soc. 36, 268 (1957).
Städtler, K.: Die Mastitis und ihre Prophylaxe mit Sterosan. Medizinische 1956, 1315
Staib, F., u. S. Ata: Die Desinfektionswirkung des Desinfektionsmittels “Quartasept” gegenüber Hefen und hefeartigen Pilzen. Desinfekt. Gesdh.-Wes. 48, 182 (1957)
Stansly, P. G., and N. H. Ananenko: Arch. Biochem. 23, 256 (1949). Zit. W. S. Spector
Stapff, V., y J. E. MacKinnon: Tratamiento de un caso de histoplasmosis con diamidinodifenilamina. An. Fac. Med. Montevideo 43, 116 (1958)
Stedman, R. L., S. L. Engel and I. M. Bilse: Quaternarya mmonium derivatives of co-amino-acids, a new series of quaternary ammonium compounds. Appl. Microbiol. 1, 142 (1953)
Steinberg, B. A., and W. P. Jambor: The effect of nystatin (mycostatin) on experimental candidiasis in mice and embryonated eggs. In: Therapy of fungus diseases. Edit, by Th. H. Sternberg and V. D. Newcomer, pp. 195–198
Steinberg, B. A., W. P. Jambor and L. O. Suydam: Amphotericin A and B: Two new antifungal antibiotics possessing high activity against deepseated and superficial mycoses. Antibiot. Ann. 1955/56, 574
Stenderup, A.: (1) Effect of diamidines on Candida albicans in vitro. Acta path, microbiol. scand. 36, 361 (1955)
Stenderup, A.: (2) Moniliasis treated with pentamidin. VI. Internat. Kongr. Trop. Mai. 5.—13. 9. 1958 Lissabon
Stenderup, A., J. Bichel and F. Kissmeyer- Nielsen: Pentamidin ved moniliasis. Nord. Med. 55, 589 (1956)
Sternberg, Th. H., and V. D. Newcomer: Therapy of fungus diseases. Boston: Little, Brown & Comp. 1955
Sternberg, Th. EL, J. E. Tarbet, V. D. Newcomer, H. G. Hiddleson, R. H. Weir, E. T. Wright and R. O. Egeberg: Antifungal effects of nystatin on the fecal lora of animals and man. Antibiot. Ann. 1953/54, 199
Sternberg, Th.H., E.T.Wright and M. Oura: A new antifungal antibiotic, amphotericin B. Antibiot. Ann. 1955/56, 566
Stessel, G. J., C. Leben and G. W. Keitt: Phytopathol. 42, 20 (1952); 48, 23 (1953). Zit. W. S. Spector
Stewart, G. T.: Laboratory and clinical studies with nystatin in postantibiotic mycotic infections. Brit. med. J. 1956 I, 658
Stewart, W. D., B. Kanee, J. L. Danto and St. W. Maddin: Griseofulvin: A clinical report. The effect of griseofulvin on some superficial fungal infections and upon the cultures taken from these infections. Canad. med. Ass. J. 81, 726 (1959)
Stokes, J. L., R. L. Peck and C. R. Woodward jr.: Proc. Soc. exp. Biol. (N.Y.) 51, 126 (1946). Zit. W. S. Spector
Stough, A. R.: Amphotericin B, a new antifungal agent for the prophylaxis of antibiotic-induced moniliasis. Antibiot. Med. 6, 653 (1959)
Strauss, T. E., A. M. Kligman and D. M. Pillsbury: The chemotherapy of actinomycosis and nocardiosis. Amer. Rev. Tuberc. 63, 441 (1951)
Strickler, A.: (1) Treatment of tinea capitis with special iodine and dilute acetic acid. A.M.A. Arch. Derm. 53, 454 (1946)
Strickler, A.: (2) The treatment of tinea capitis with special iodine and dilute acetic acid. Report of results in a larger series of patients. Urol, cutan. Rev. 51, 264 (1947)
Stritzler, C., I. M. Fishman and S. Laurens: (1) Treatment of superficial fungus infections with a new antifungal agent. Trans. N. Y. Acad. Sci., ser. II 13, 31 (1950)
Stritzler, C., I. M. Fishman and S. Laurens: (2) Treatment of T. capitis with a new antifungal compound. A.M.A. Arch. Derm. 63, 606 (1951)
Struyk, A. P., G. Drost, J. M. Haisvisz, T. van Eek and J. C. Hoogerheide: Pimaricin, a new antifungal antibiotic. Antibiot. Ann. 1957/58, 878
Suli, M.: Candide alergia facial. Su tratamiento con nistatina (Resumen). Rev. Asoc. méd. argent. 71, 16 (1957)
Sullivan, C. N.: Ringworm of the scalp: Successful treatment of 7 institutional cases by manual epilation and salicylanilide ointment. Conn. med. J. 13, 1125 (1949)
Sullivan, M., and H. A. Fishbein: Field trial of United States Army fungicidal ointment. J. invest. Derm. 10, 293 (1948)
Sulzberger, M. B., and R. L. Baer: (1) Griseofulvin, an oral antibiotic for the treatment of many fungous common infections of the skin, hair and nails. Excerpta med. (Amst.), Sect. XIII 13, 145 (1959)
Sulzberger, M. B., and R. L. Baer: (2) Trichophyton rubrum, generalized five years. A.M.A. Arch. Derm. 80, 630 (1959)
Sulzberger, M. B., and A. Kanof: (1) Comparative evaluation of preparations for the prophylaxis and treatment of fungous infections of feet. Nav. med. Bull. Wash. 46, 822 (1946). Ref. Rev. Med. vet. Mycol. 1, 159 (1947)
Sulzberger, M. B., and A. Kanof: (2) Undecylenic and propionic acids in the prevention and treatment of dermatophytosis. A.M.A. Arch. Derm. 55, 391 (1947)
Sulzberger, M. B., H.C.Shaw and A. Kanof: Evaluation of measures for use against common fungous infections of skin; screening tests by means of paired comparisons on human subjects. Nav. med. Bull. Wash. 45, 237 (1945)
Suter, L. C.: In vitro development of resistance of Actinomyces bovis to antibiotics. Antibiot. and Chemother. 7, 285 (1957)
Suter, L. S., and B. F. Vaughan: The effect of antibacterial agents on the growth of Actinomyces bovis. Antibiot. and Chemother. 5, 557 (1955)
Sutliff, W. D., J. W. Kyle and J. L. Hobson: North American blastomycosis: Clinical forms of the disease and treatment with stilbamidine and 2-hydroxystilbamidine. Ann. intern. Med. 41, 89 (1954)
Swart, E. A., A. H. Romano and S. A. Waksman: Proc. Soc. exp. Biol. (N.Y.) 73, 376 (1950). Zit. W. S. Spector
Szendi, B.: Konservative Behandlung von genitaler Aktinomykose mit Penicillin. Gynaecologia (Basel) 137, 161 (1954).
Tabbr, W. A., and L. C. Yining: Amidomycin, a new antibiotic from a Streptomyces species. Production, isolation, assay, and biological properties. Canad. J. Microbiol. 3, 953 (1957)
Taber, W. A., L. C. Vining and S. A. Waksman: Candidin, a new antifungal antibiotic produced by Streptomyces viridoflavus. Antibiot. and Chemother. 4, 455 (1954)
Tager, M., and T. S. Danowski: Inhibition of the growth of fungi by thiourea derivatives, particularly hydrazine dithiocarbamyl. J. infect. Dis. 82, 126 (1948)
Tager, M., A. B. Hales and T. S. Danowski: Studies on the suppression of fungus growth by thiourea. III. The effects of protein fractions, amino acids, and thiol compounds. J. infect. Dis. 84, 284 (1949)
Taira, T., and S. Fujii: J. Antibiot. 5, 185 (1952). Zit. W. S. Spector
Takahashi, H., E. Tsubfra, H. Tanaka and F. Hirao: Effect of oral administration of nystatin (mycostatin) and tetracycline-nystatin (mysteclin) tablets. J. Antibiot. 11, 30 (1958)
Takahashi, I.: (1) Studies on the antibiotic substances from actinomyces. XX. Antiyeast factors produced by the so-called “first group” actinomyces. J. Antibiot. 5, 188 (1952)
Takahashi, I.: (2) A new antifungal substance “flavacid”. Studies on the antibiotic substances from actinomyces. XXVII. J. Antibiot. 6, 117 (1953)
Takahashi, Y., and K. Kuroda: Clinical experience with nystatin in cutaneous candidiasis and cutaneous mycosis. J. Antibiot. 11, 3 (1958)
Tanioku, K., M. Nakahira and Y. Saida: Clinical experiments with nystatin. J. Antibiot. 11, 6 (1958)
Tanissa, A.: Action fongistatique et fongicide de l’huile de foie de morne et d’un mélange d’acides gras fortement non saturés (thérapique, arachidonique et clupanodonique) provenant de cette huile. Ann. Derm. Syph. (Paris) 9, 654 (1949)
Tanner jr., F. W., A. R. English, T. M. Lees and J. B. Routien: Antibiot. and Chemother. 2, 441 (1952). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Tappeiner, J.: Griseofulvin, ein peroral wirksames Antimykoticum bei Hdb. d. Haut- u. Geschlechtskrankheiten, Erg.-Werk V/l g3 Trichophytia superficialis capillitii et corporis. Derm. Wschr. 1959, 744
Tarbet, J. E., M. Ottra and Th. H. Sternberg: Microassay of antifungal properties of steroid hormones and other compounds. Mycologia (N.Y.) 45, 627 (1953)
Tarbet, J. E., and Th. H. Sternberg: Microbiological estimation of antifungal blood levels following administration of fungicides. Mycologia (N.Y.) 46, 263 (1954)
Taschdjian, C. L.: (1) Resistance of Trichophyton rubrum and Microsporum audouini to 2-hydroxystilbamidine induced in vitro. J. invest. Derm. 23, 385 (1954)
Taschdjian, C. L.: (2) In vitro effects of stilbamidine and 2-hydroxystilbamidine on some pathogenic fungi. J. invest. Derm. 22, 521 (1954)
Tehon, L. R.: Fungistatic potencies of some fluorinated p-benzoquinones. Science 114, 663 (1951)
Teller, H.: Diskussionsbemerkung Tagg Hamburg. Dermat. Ges., 28.11.1959, Hamburg-Eppendorf
Temime, P.: Essais cliniques d’un nouvel antifongique dérivé du benzothiazol dans les mycoses de la peau et des phanères. Sem. Hôp. Paris 1954, 438.
Temime, P., et Y. Privat: A propos de notre premier cas de fa vus traité par griséofulvine, avec des résultats favorables. Bull. Soc. franç. Derm. Syph. 66, 610 (1959)
Temps, W.: Erfahrungen aus der dermatologischen Praxis mit Myxal. Medizinische 1955, 749
Ter Horst, W. P., and E.L.Felix: 2,3-Dichloro- 1,4-naphthoquinone. A potent organic fungicide. Industr. engng. Chem. 35, 1255 (1943)
Thaesler, G.: Die Behandlung der Hautpilzerkrankungen mit Curis. Derm. Wschr. 135, 181 (1957)
Tiessen, H. J.: Die externe Dermatotherapie mit Quecksilberpräparaten. Derm. Wschr. 135, 548 (1957)
Tirunarayanan, M. O., W. A. Vischer u. H. Bruhin: Untersuchungen über den Wirkungsmechanismus der Thiosemicarbazone. Schweiz. Z. Path. 21, 964 (1958)
Tomb, J. W.: The treatment of tinea (dhobie’s itch). J. trop. Med. Hyg. 46, 6 (1943). Ref. Rev. Med. vet. Mycol. 1, 62 (1945)
Tomich, E. G.: Mitteilung an Gentles. Zit. bei J. C. Gentles, The treatment of ringworm with griseofulvin. Brit. J. Derm. 71, 427 (1959)
Torrens, J. A., and M. W. W. Wood: Streptomycin in the treatment of actinomycosis. Report on three cases. Lancet 1949 I, 1091
Traub, E. F., and D. Schultheis: Gassing of fungi: a preliminary report. A.M.A. Arch. Derm. 60, 272 (1949)
Tronstein, A. J.: Beurteilung der Lokalbehandlung mit Dichloroxychinaldin (Sterosan) in der Dermatologie. J. invest. Derm. 13, 119 (1949)
Tsubtjra, E.: Experimental studies on treatment of candidiasis. Chemother. (Jap.) 6, 72 (1958). Ref. Rev. Med. vet. Mycol. 3, 180 (1959)
Tsubura, E., H. Tanaka, F. Hirao, Y. Kawamura and H. Takahashi: Studies on treatment of experimental candidiasis. J. Antibiot. 11, 26 (1958)
Tubbs, O. S.: Treatment of actinomycosis. In R. W. Riddell and G. T. Stewart: Fungous diseases and their treatment. London: Butterworth & Comp. 1958
Twining, H. E., H. M. Dixon and F. D. Weidman: Penicillin in treatment of madura foot: report of two cases. Nav. med. Bull. Wash. 46, 417 (1946)
Tytell, A.A., F. J. McCarthy, W.P.Fisher, W. A. Bolhofer and J. Charney: Fungichromin and fungichromatin : new polyene antifungal agents. Antibiot. Ann. 1954/55, 716.
Uchimura, R., S. Nakazawa, K. Nïïmao and G. Ogawa: Clinical treatment of nystatin. J. Antibiot. 11, 32 (1958)
Ulrich, E. W., L. S. Suter and W. B. Dunham: The sensitivity of Blastomyces dermatitidis to antifungal agents. Mycologia (N.Y.) 44, 115 (1952)
Ulrich, J. A., and T. B. Fitzpatrick: Reversible inhibition of growth of Microsporum audouini with neopyrithiamin. Proc. Soc. exp. Biol. (N.Y.) 76, 346 (1951)
Umezawa, H., T. Takeuchi, K. Nitta and Y. Okami: J. Antibiot. 6, 147 (1953). Zit. W. S. Spector
Umezawa, H., T. Tazaki and S. Fukuyama: Jap. med. J. 4, 331 (1951). Cit. S. A. Waksman and H. A. Lechevalier: Actinomycetes and their antibiotics
Underwood, P. C., J.H.Collins, C. G. Durbin, F.A.Hodges and H.E.Zimmerman: Critical tests with copper sulfate for experimental moniliasis (cropmycosis) of chickens and turkeys. Poultry Sci. 35, 599 (1956). Ref. Rev. Med. vet. Mycol. 2, 478 (1957)
Ungerman, A. H., and M. S. Ungerman: Toxic encephalopathy occuring during topical treatment for tinea capitis. J. Okla. St. med. Ass. 46, 304 (1953). Ref. Rev. Med. vet. Mycol. 2, 234 (1955)
Unsold, H.: Werksärztliche Prophylaxe und Behandlung der Mykose mit Multifungin. Münch, med. Wschr. 101, 1048 (1959)
Urban, H. J.: Die praktische Durchführung eines umfassenden Hautschutzplanes in einem Werk der chemischen Industrie, unter besonderer Berücksichtigung der Dermatomykosen. Berufsdermatosen 2, 54 (1955)
Uri, J.: (1) Further experiments and results on Flavofungin. VI. Internat. Kongr. Trop. Mal. 5.—13. 9. 1958, Lissabon
Uri, J.: (2) Menschenpathogene Pilze in der Antibioticum-Forschung. 1. Mitt. Die Antibioticum-Produktion der Dermatophyten. Arzneimittel-Forsch. 8, 53 (1958)
Uri, J.: (3) Menschenpathogene Pilze in der Antibioticum-Forschung. 2. Mitt. Gegen menschenpathogene Pilze wirksame, von Actinomyceten stammende Antibiotica. Arzneimittel-Forsch. 8, 687 (1958)
Uri, J.: (4) Menschenpathogene Pilze in der Antibioticumforschung. 3. Mitt. Arzneimittelforsch. 9, 175 (1959)
Uri, J.: (5) Menschenpathogene Pilze in der Antibioticumforschung. 4. Mitt. Arzneimittel-Forsch. 9, 326 (1959)
Uri, J., and I. Bekesi: Flavofungin, a new crystalline antibiotic: organic and biological properties. Nature (Lond.) 181, 908 (1958)
Uri, J., R. Bognar, St. Békési u. M. Balçgh: Die antimykotische Wirkung der p-Oxybenzoesäureester. Derm. Wschr. 1955, 942
Uri, J., P. Juhâsz u. G. Csoban: Über die Penicillinbildung von Trichophyton mentagrophytes-Stämmen. Pharmazie 10, 709 (1955)
Uri, J., and Gr. Szabo: The inhibition of the growth of dermatophytes by 8-hydroxyquinoline. Acta physiol. Acad. Sci. hung. 3, 425 (1952)
Tiri, J., S. Szathmáry u. Z. Herpay: Über die Antibioticaproduktion von Pilzen am Ort ihres natürlichen Vorkommens. Der Nachweis der Antibioticaproduktion von in Horngebilden lebenden Dermatophytes Pharmazie 12, 485 (1957)
Utahara, R., Y. Okami, S. Nakamtjra and H. Umezawa: J. Antibiot. 7, 120 (1954). Zit. W. S. Spector
Utz, J. P., D. B. Louria, N. Feder, C. W. Emmons and N. B. McCtjllotjgh: A report of clinical studies on the use of amphotericin in patients with systemic fungal diseases. Antibiot. Ann. 1957/58, 65
Utz, J. P., A. Treger, N. B. McCullough and C. W. Emmons: Amphotericin B: Intravenous use in 21 patients with systemic fungal diseases. Antibiot. Ann. 1958/59, 628.
Valdes, E. F.: Tratamiento de la chromoblastomicosis por el calciferol y el yoduro de potasio. Rev. Sif. Leprol. 12, 58 (1956). Ref. Rev. Med. vet. My col. 3, 52 (1958)
Van Assen, E. J. J.: De behandeling van mycosis vaginae. Ned. T. Geneesk. 94, 3697 (1950)
Vanbreuseghem, R.: (1) Nouvelle technique de détermination du pouvoir fungistatique à l’égard des dermatophytes. Arch, belges Derm. 6, 1 (1950)
Vanbreuseghem, R.: (2) Êpidémiologie et thérapeutique des pieds de Madura au Congo belge. Bull. Soc. Path. exot. 51, 793 (1958)
Vanbreuseghem, R.: (3) Mycoses of man and animals. London: Sir Isaac Pitman & Sons 1958
Vanbreuseghem, R.: (4) Technique simple pour la détermination de la sensibilité d’Actinomyces bovis aux antibiotiques. Ann. Soc. belge Méd. trop. 39, 223 (1959)
Vanbreuseghem, R., et P. Bruaijx: Nouvel essai de traitement des teignes du cuir chevelu par l’asterol au Congo belge. Ann. Soc. belge Med. trop. 37, 933 (1957).
Vanbreuseghem, R., et B. Della Torre: Synergie fungistatique ét fungicide in vitro et in vivo d’un derivé chloré du diphénylméthane associé à un détergent. Arch, belges Derm. 15, 64 (1959)
Vanbreuseghem, R., et R. Eyckmans: Moniliase chronique résistante à nystatin. Arch, belges Derm. 12, 323 (1956)
Vanbreuseghem, R., et F. Gatti: Action fungistatique, fungicide et morphogénétique de l’astérol sur les dermatophytes congolais. Ann. Soc. belge Méd. trop. 33, 697 (1953)
Vandeputte, J., J. L. Wachtel and E. T. Stiller: Amphotericin A and B: Antifungal antibiotics produced by a streptomycete. II. The isolation and properties of the crystalline amphotericins. Antibiot. Ann. 1955/56, 587
Van Vlierberghe, R. G., S. Pattyn et R. Vanbreuseghem: Chromoblastomycose guérie chez un tuberculeux au cours d’un traitement par l’isoniazide. Ann. Soc. belge Méd. trop. 37, 965 (1957)
Veltman, G.: Zur Behandlung der Epidermophytien mit Bradex-Vioform. Derm. Wschr. 129, 363 (1954)
Vercruysse, A.: Résultats comparatifs de divers modes de traitement des teignes microsporiques. Arch, belges Derm. 6, 76 (1950)
Vermeil, C.: Mycologie médicale humaine en Tunisie: revues des principales acquisitions, analyses des données concernant les années 1946–1956.
Vermeil, C.: Mycopathologia (Den Haag) 8, 206 (1957)
Viglioglia, P. A., R. O. Linares y A. Rivero: Los agentes cuaternarios de amino en dermatología. Sem. méd. (B. Aires) Nr 3236, 89 (1956)
Vilanova, X., y M. Casanovas: (1) Acción fungistática y fungicida de las esencias vegetales y de otros perfumes. Act.-dermosifiliogr. (Madr.) 40, 393 (1949)
Vilanova, X., y M. Casanovas: (2) Untersuchungen über fungistatische und fungicide Mittel. Arch. Derm. Syph. (Berl.) 189, 254 (1949)
Vilanova, X., y M. Casanovas: (3) Bestätigung der von einigen Bestandteilen pflanzlicher Essenzen bei Diffusion durch die Luft ausgeübten fungistatischen Wirkung. Act. dermosifiliogr. (Madr.) 40, 787 (1949)
Vilanova, X., y M. Casanovas: (4) Artificially produced resistance in the Trichophyton gypseum in the presence of undecylenic acid and in the presence of some vegetable essences. J. invest. Derm. 15, 161 (1950)
Vilanova, X., y M. Casanovas: (5) The fungistatic and fungicidal activity of vegetable essential oils and their components. J. invest. Derm. 20, 447 (1953)
Vilanova, X., M. Casanovas, F. Garci-Valdecasas y P. Puimuset: (1) Investigaciones sobre los efectos fungicidas y fungistáticas de los ácidos grasos obtenidos del cabello humano del adulto. Med. clin. (Barcelona) 10, 380 (1948)
Vilanova, X., M. Casanovas, F. Garci-Valdecasas y P. Puimuset: (2) Las propriedades fungistáticas y fungicidas de los ácidos grasos. Acido undecilénico. Ensayos experimentales y clínicos. Med. clin. (Barcelona) 11, 224 (1948)
Vilanova, X., M. Casanovas y J. Pujol: Resultados obtenidos en el tratamiento de las tiñas tonsurantes con la sal sódica del ácido paraamino-benzoico y las esencias vegetales. Act. derm.-sifiliogr. (Madr.) 49, 361 (1958)
Vogel, R. A., and J. C. Crutcher: Studies on the bioassay and excretion of amphotericin B in patients with systemic mycoses. Antibiot. Med. 5, 501 (1958)
Volini, M., R. K. Stubbs and N. Ercoli: Trypanocidal, antibacterial and antifungal effectiveness of monothiouronium derivatives. Antibiot. and Chemother. 6, 603 (1956)
Volta, W.: Die antimykotische Wirkung des Vitamin K5 in vitro. Z. Haut- u. Geschl.-Kr. 14, 137 (1953).
Vonkennel, J.: (1) Antibiotische und Chemotherapie der Hautkrankheiten. Therapiewoche 2, 183 (1951/52)
Vonkennel, J.: (2) Die Epidermophytia pedum et manuum. Ciba-Symp. 4, 73, (1956)
Vonkennel, J., u. J. Kimmig: Versuche und Untersuchungen mit neuen Sulfonamiden. Klin. Wschr. 20, 2 (1941)
Vonkennel, J., J. Kimmig u. B. Korth: Versuche und Untersuchungen mit neuen Sulfonamiden. Z. klin. Med. 138, 695 (1940)
Vonkennel, J., J. Kimmig u. A. Lembke: Die Mykoine, eine neue Gruppe therapeutisch wirksamer Substanzen aus Pilzen. Klin. Wschr. 22, 321 (1943).
Wakaki, S., S. Akanabe, K. Hamada and T. Asahina: J. Antibiot. 5, 677 (1952). Zit. S. A. Waksman and H. A. Lechevalier: Actinomycetes and their antibiotics
Wakaki, S., S. Akanabe, K. Hamada and I. Kurihara: J. Antibiot. 5, 24 (1952). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Waksman, S.A.: (1) The actinomycetes. Their nature, occurrence, activities and importance. Chron. bot. (Waltham) 22, 230 (1950)
Waksman, S.A.: (2) Outstanding problems in the study of antibacterial and antifungal antibiotics, with special reference to the antibiotics of actinomycetes. In: Therapy of fungus diseases. Edit, by T. H. Sternberg and V. D. Newcomer, pp. 3–12
Waksman, S. A., and E. S. Horning: The production of two antibacterial substances, fumigacin and clavacin, by Aspergillus fumigatus and Aspergillus clavatus. Science 96, 202 (1942)
Waksman, S.A., E. S. Horning, M.Welsh and H.B.Woodruff: Distribution of antagonistic actinomycetes in nature. Soil Sci. 54, 281 (1942)
Waksman, S. A., and H. A. Lechevalier: (1) Science 109, 305 (1949). Zit. W. S. Spector
Waksman, S. A., and H. A. Lechevalier: (2) Actinomycetes and their antibiotics. Baltimore: Williams and Wilkins Company 1953
Waksman, S. A., and H. C. Reilly: Agarstreak method for assaying antibiotic substances. Industr. engng. Chem. 17, 556 (1945)
Waksman, S. A., A. Schatz and H. C. Reilly: Metabolism and the chemical nature of Streptomyces griseus. J. Bact. 51, 753 (1946)
Waksman, S. A., A. Schatz and D. M. Reynolds: Production of antibiotic substances by actinomycetes. Ann. N.Y. Acad. Sci. 48, 73 (1946)
Waksman, S. A., and H. B. Woodruff: Proc. Soc. exp. Biol. (N.Y.) 45, 609 (1940); 49, 207 (1942). Cit. S. A. Waksman and H. A. Lechevalier, Actinomycetes and their antibiotics
Waldin, G. G.: The “phenol and camphor” treatment of ringworm of the glabrous skin. An interim report. J. roy. army med. Cps 81, 32 (1943)
Walker, J.: Survey of the medical mycological literature of Great Britain 1946 to 1956. Mycopathologia (Den Haag) 9, 307 (1958)
Walker, J., and J. W. Hamilton: The treatment of actinomycosis with penicillin. Ann. Surg. 121, 373 (1945). Ref. Rev. Med. vet. Mycol. 1, 77 (1946)
Wallner, E.: Über Fußmykosen und ihre Behandlung mit Vioform-Creme. Münch, med. Wschr. 94, 1527 (1952)
Walton, R. B., and H. B. Woodruff: A crystalline antifungal agent, mycosubtilin, isolated from subtilin broth. J. clin. Invest. 28, 924 (1950). Ref. Rev. Med. vet. Mycol. 1, 477 (1951)
Warshaw, L. J.: Bactericidal and fungicidal effects of ozone on deliberately contaminated 3-D viewers. Amer. J. publ. Hlth 43, 1558 (1953)
Watts, C. A. H.: Actinomycosis treated with sulphonamides. S. Afr. med. J. 19, 43 (1945)
Watts, G. W. T.: Treatment and control of epidermophytosis and bromidrosis in a state school with cadmium chloride-aerosol solution. J. Lab. clin. Med. 29, 692 (1944)
Weile, H.: Interdigitalmykosen. Z. Haut- u. Geschl.-Kr. 10, 19 (1951)
Weinberg, B. J., C. H. Lawrence and A. Buchholz: Systemic blastomycosis treated with 2-hydroxystilbamidine. A.M.A. Arch, intern. Med. 94, 493 (1954)
Weindling, R.: Phytopathology 22, 837 (1932). Zit. W. S. Spector
Weindling, R., and O. H. Emerson: Phytopathology 26, 1068 (1936). Zit. W. S. Spector.
Weiner, A. L., and J. Schwarz: Fungous infections of the skin treated with pyrrobutamine compounds. A.M.A. Arch. Derm. 76, 783 (1957)
Weissman, G. S., and S. F. Trelease: Influence of sulfur on the toxicity of selenium to aspergillus. Amer. J. Bot. 42, 489 (1955)
Weitzel, G.: Die biologische Sonderstellung der Fettsäuren mittlerer Kettenlänge. Dtsch. med. Wschr. 1950, 1616
Weitzel, G., u. O. Nast: Therapeutische Anwendung mittlerer Fettsäuren in der Dermatologie. Hautarzt 2, 359 (1951)
Wegmann, T., H. Schmid u. H. Brodhage: 5,7-Dichlor-8-oxychinaldin (Siosteran). Klinische Erfahrungen und bakteriologische Untersuchungen. Schweiz, med. Wschr. 84, 1154 (1954)
Wenk, P., u. J. R. Frey: (1) Prüfung von Antimykotica unter Verwendung parasitierter menschlicher Haare als Keimträger. Arch. klin. exp. Derm. 205, 150 (1957)
Wenk, P., u. J. R. Frey: (2) Prüfung von Antimykotica am Meerschweinchen unter Verwendung von zwei Mykoseherden am gleichen Tier (Kombinationsversuch). Dermatologica (Basel) 116, 156 (1958)
Wenk, P., u. J. R. Frey: (3) Untersuchungen über die Wirkungsbedingungen chemischer Verbindungen auf T. mentagrophytes unter Verwendung infizierter Meerschweinchenhaare (Haartest). Arch. klin. exp. Dermat. 207, 1 (1958)
Wenk, P., J. R. Frey u. B.Fijst: Vergleichende Prüfung chemischer Verbindungen auf antimykotische Wirksamkeit in vitro, im Haartest und am Meerschweinchen. Dermatologica (Basel) 116, 167 (1958)
Wernsdörfer, R.: Die Sulfonamidbehandlung der Trichophytia profunda und der Sykosis simplex. Med. Z. (München) 2, 64 (1944)
Whxffen, A. J.: The production, assay, and antibiotic activity of actidion, an antibiotic from Streptomyces griseus. J. Bact. 56, 283 (1948)
Whiffen, A. J., N. Bohonos and R. L. Emerson: The production of an antifungal antibiotic by Streptomyces griseus. J. Bact. 52, 610 (1946)
Whitaker, H. W.: North American blastomycosis: report of a case in which a patient with meningeal involvement was treated with streptomycin and promin. Arch. Path. (Chicago) 48, 212 (1949). Ref. Rev. Med. vet. Mycol. 1, 305 (1950)
White, C. S., J. L. Collins and H. E. Newman: Clinical use of alkyldimethyl-benzylammoniumchloride (Zephiran): prel. report. Amer. J. Surg. 39, 60 (1938)
Whitehill, M. R., and A. J. Rawson: Treatment of generalized cryptococcosis with 2-hydroxystilbamidine. Report of a case with apparent cure. Virginia med. Monthly 81, 591 (1954). Ref. Rev. Med. vet. Mycol. 2, 261 (1955)
Whitemore, C. W.: Probable acrodermatitis enteropathica treated with nystatin (mycostatin). A.M.A. Arch. Derm. 79, 594 (1959)
Widmer, A.: Erfahrungen bei der Behandlung von Fußmykosen mit Undecylenpräparaten. Ther. Umsch. Derm. 8, 45 (1951)
Wied, D. M.: Beitrag zum Problem der interdigitalen Mykose und ihrer Behandlung. Riedel-Arch. 35, Nr 4 (1951)
Wier, R., R. O. Egeberg, A. R. Lack and G. M. Leiby: Amer. J. med. Sci. 224, 70 (1952). Zit. W. S. Spector
Wilde, H.: Zur Behandlung der Pilzerkrankungen, insbesondere der Hand- und Fußmykosen. Therapiewoche 2, 582 (1951/52).
Williams, D. I.: Griseofulvin and Trichophyton rubrum infections. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Williams, D. I., R. H. Marten and I. Sarkany: (1) Oral treatment of ringworm with griseofulvin. Lancet 1958 II, 1212
Williams, D. I., R. H. Marten and I. Sarkany: (2) Griseofulvin. Brit. J. Derm. 71, 434 (1959)
Williams, M. R., and G. B. Skipsworth: Treatment of disseminated coccidioidomycosis with amphotericin B. Report of a case. A.M.A. Arch. Derm. 78, 97 (1958)
Wilson, H. M., and A. W. Duryea: Cryptococcus meningitis (torulosis) treated with a new antibiotic, actidione. A.M.A. Arch. Neurol. Psychiat. 66, 470 (1951)
Wilson, J. E.: Treatment of ringworm of the scalp. Med. Offr 69, 197 (1943). Ref. Rev. Med. vet. Mycol. 1, 60 (1945)
Wilson, J. W., H. Levitt, T.L.Harris and E. M. Heiligman: Toxic encephalopathy occurring during topical therapy with asterol; report of 2 cases. J. Amer. med. Ass. 150, 1002 (1952)
Wilson, J. W., H. Levitt and O. A. Plunkett: Asterol dihydrochloride in the treatment of dermatophytosis caused by Trichophyton rubrum (purpureum). J. invest. Derm. 19, 319 (1952)
Wilson, R. H., F. de Eds and L. J. Rather: Proc. Soc. exp. Biol. (N.Y.) 78, 517 (1951). Zit. W. S. Spector
Wolf, F. T.: (1) The action of sulfonamides in certain fungi pathogenic to man. Mycologia (N.Y.) 38, 213 (1946)
Wolf, F. T.: (2) Inhibition of pathogenic fungi in vitro by p-hydroxy methyl benzoate. Mycopathologia (Den Haag) 5, 117 (1950)
Woods, J. W., J. H. Manning and C.N.Patterson: Monilial infections complicating the thera-peutic use of antibiotics. J. Amer. med. Ass. 145, 207 (1951)
Woodward, R. B., and G. Singh: J. Amer. chem. Soc. 72, 1428 (1950). Zit. W. S. Spector
Wooldridge, W. E.: Antifungal antibiotics of clinical significance. Sth. med. J. (Bgham, Ala.) 45, 350 (1952). Ref. Rev. Med. vet. Mycol. 1, 554 (1953)
Wooldridge, W. E., and M. Hoffman: A new antifungal principle produced by Streptomyces fradiae. J. invest. Derm. 15, 351 (1950). Ref. Rev. Med. vet. Mycol. 1, 445 (1951)
Wrede F., u. O. Hettche: Chem. Ber. 62, 2678 (1929)
Wright,E.T., J.H.Graham and Th.H. Sternberg: Treatment of moniliasis with nystatin. J. Amer. med. Ass. 163, 92 (1957)
Wright, E. T., V. D. Newcomer, C. Halde and Th.H. Sternberg: The use of nystatin for the treatment of candidiasis of the skin and mucous membranes. Monogr. Ther. 2, 12 (1957)
Wright, J. M.: Phytotoxic effects of some antibiotics. Ann. Botany 15, 493 (1951)
Wrong, N. M.: (1) Clinical experiences with griseofulvin. Symposium griseofulvin and dermatomycosis, 26. u. 27. 10. 1959 Miami/Florida
Wrong, N. M.: (2) Griseofulvin in superficial fungous infections. Canad. med. Ass. J. 80, 656 (1959)
Wrong, N. M., M. Rosset, A. L. Hudson and St. Rogers: Griseofulvin in the treatment of superficial fungous infections. Canad. med. Ass. J. 81, 167 (1959)
Wüstenberg, J.: Der Desinfektionswert verschiedener Grobdesinfektionsmittel bei Epidermophyton Kaufmann-Wolf. Z. Hyg. Infekt.-Kr. 141, 460 (1955)
Wybel, R. E.: Mycosis of cervical spinal cord following intrathecal penicillin therapy. Arch. Path. (Chicago) 53, 167 (1952). Ref. Rev. Med. vet. Mycol. 1, 558 (1952)
Wyss, O., B. J. Ludwig and R. R. Joiner: The fungistatic and fungicidal action of fatty acids and related compounds. Arch. Biochem. 7, 415 (1945). Ref. Rev. Med. vet. Mycol. 1, 109 (1946).
Yacowitz, H., S. Wind, W. P. Jambor, R. Semar and J. F. Pagano: Use of myco-statin for the prevention of laboratory cases of moniliasis in chickens. Poultry Sci. 36, 1171 (1957). Ref. Rev. Med. vet. Mycol. 3, 182 (1959)
Yamashita, K., and S. Yano: Clinical experiences and experimental studies on treatment of deep type candidiasis of the upper airway, including cases treated with nystatin. J. Antibiot. 11, 24 (1958)
Yasitda, T., and H. Takahashi: Therapeutic effect of nystatin ointment in dermatology. J. Antibiot. 11, 1 (1958)
Young, C. J.: Podophyllotoxin treatment of Microsporum audouini scalp infections. A.M.A. Arch. Derm. 64, 607 (1951).
Zieler, K., u. C. Siebert: Behandlung der Haut- und Geschlechtskrankheiten, 14. Aufl. Berlin: Urban & Schwarzenberg 1946
Zimmermann, O.: Erfahrungen über Behandlung der Epidermophytien mit Mycoderm. Dtsch. med. J. 3, 218 (1952)
Zinneman, H. H., and W. H. Hall: Chronic pharyngeal and laryngeal histoplasmosis successfully treated with ethyl vanillate. Minn. Med. 36, 249 (1953). Ref. Rev. Med. vet. Mycol. 2, 107 (1954)
Zinzius, J.: Fortschritt in der antimykotischen Therapie? Ärztl. Praxis 11, 1017 (1959)
Ziprkowski, L., G. Altmann, F. Dalith and U. Spitz: Mycetoma pedis. Four cases treated with streptomycin. A.M.A. Arch. Derm. 75, 855 (1957)
Zweiling, G.: Bekämpfung der Pilzerkrankungen in gewerblichen Betrieben. Zbl. Arbeitsmed. 5, 126 (1955).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1961 Springer-Verlag OHG · Berlin · Göttingen · Heidelberg
About this chapter
Cite this chapter
Rieth, H. (1961). Die Antimykotica. In: Herzberg, J.J., et al. Therapie der Haut- und Geschlechtskrankheiten. Handbuch der Haut- und Geschlechtskrankheiten Ergänzungswerk, vol 5 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94850-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-94850-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94851-0
Online ISBN: 978-3-642-94850-3
eBook Packages: Springer Book Archive